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Abstract 
Conventional methods of combining mammalian cells and synthetic polymers for tissue 
engineering applications are frequently problematic. This is due to the incompatibility 
between the sensitive cell component and the harsh polymer processing environments 
required to form the desired porous scaffold e. g. high temperatures and organic solvents. 
This results in the necessity for an often inefficient and time consuming two-step scaffold 
seeding process, whereby mammalian cells are added to a pre-fabricated polymer 
scaffold. High pressure or supercritical CO2 (scCO2) processing is a method of 
fabricating porous polymer scaffolds at ambient temperatures and without using organic 
solvents. When pressurised, CO2 becomes highly soluble in a variety of amorphous 
polymers such as poly(DL-lactic acid) (PDLLA) to produce a high viscosity liquid. 
Subsequent decompression causes the formation of gas bubbles that become permanent 
as the polymer vitrifies. Based upon technology at the University of Nottingham, we 
hypothesised that mammalian cells could be incorporated into poly(DL-lactic acid) 
(PDLLA) scaffolds using a single step scCO2 process. This would not only make the 
process more rapid, but it would remove the inefficient scaffold seeding step required in 
most cell based tissue engineering strategies. 
Mammalian cells were subject to a range of high pressure CO2 and N2 processing 
conditions and assessed for cell survival. It was discovered that primary hepatocytes, 
meniscal fibrochondrocytes, myoblastic C2C12s and 3T3 fibroblasts could survive after 
exposure to both high pressure gases on a time and pressure dependent basis. Cells 
exposed to scCO2 for one minute were then assessed for both gene and enzyme function. 
Using a microarray, it was found that only eight genes (out of 9000) in murine C2C12 
cells were significantly down-regulated when compared to untreated cells. Continued cell 
function was confirmed by measuring BMP-2 induced alkaline phosphatase activity as a 
measure of osteogenic differentiation in myoblastic C2C12 cells. Alkaline phosphatase 
activity was indistinguishable between untreated cells and cells exposed to scCO2 for one 
minute. Additional enzyme and receptor function was confirmed by measuring 
cytochrome P450 activity in primary hepatocytes after one minute of scCO2 processing. 
II 
In the second half of the study, these short processing times were found to be sufficient to 
plasticise and foam porous PDLLA scaffolds. Therefore, cells were incorporated into the 
biodegradable PDLLA foams by pre-mixing the cell suspension with the polymer powder 
and exposing to scCO2. Subsequent decompression caused the polymer to foam with the 
cells trapped within the porous structure. Despite the presence of the plasticised PDLLA, 
cell survival was confirmed by both an Alamar B1ueTM assay and LIVE/DEADTM 
staining. Osteogenic differentiation on the scaffolds was confirmed by a stain and assay 
for BMP-2 induced alkaline phosphatase activity. 
Finally, a second generation processing piece of processing apparatus was designed that 
permitted mammalian cells to be passed into a pressurised vessel containing pre- 
plasticised PDLLA using a novel high-pressure CO2 injection system. This was made 
possible by constant optimisation of the high pressure apparatus and the introduction of a 
cell delivery valve. When injected at high pressures cell survival was found to be reduced 
when compared with previous experiments although this was likely to be due to the 
additional mechanical trauma caused by the injection process. Despite this, the live cell 
population was shown to retain its osteogenic differentiation capacity when induced with 
BMP-2. With further optimisation of the delivery method, cells may survive this process 
in sufficient numbers to suggest that it could be used as a method of seeding tissue 
engineering scaffolds in the future. This development could remove the limitations place 
on polymer processing time by the finite survival period of the cells, permitting tuning of 
the scaffold structure to suit the application 
In summary, this study has demonstrated that mammalian cells can be incorporated into 
biodegradable PDLLA scaffolds using a rapid, one-step scCO2 process without the use of 
toxic solvents or elevated temperatures. Furthermore, the development of the high 
pressure injection system could allow cells to be incorporated during the fabrication step, 
removing the restrictions on polymer processing. This technique could be used for the 
rapid production of tissue cell loaded engineering scaffolds and other associated 
biotechnological applications where cells and synthetic polymers are combined, such as 
cell therapy and recombinant protein production. 
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Chapter 1 
GENERAL INTRODUCTION 
1.1 Tissue Engineering: A Potential Alternative to Organ Replacement 
Tissue engineering is driven by the need for new tissues to replace those lost or 
damaged due to illness or injury (Langer & Vacanti, 1993, Levenberg & Langer, 
2004). Traditionally, there has been little alternative to the millions of intrusive and 
painful surgical procedures carried out every year and the financial costs incurred as 
a result. To put this into figures, in 1999 there were 34 million procedures costing a 
total of $400 million carried out in the USA alone (Langer & Vacanti, 1999). 
However, tissue engineering provides a real alternative to these painful and costly 
surgical procedures, guiding the repair and regeneration of biological tissue through 
the application and control of cells, materials and protein growth factors (Langer & 
Vacanti, 1993, Bonassar & Vacanti, 1998). Porous scaffolds made from a variety of 
materials, are used as the substrate for cell attachment and proliferation (Langer & 
Vacanti, 1993), whilst protein growth factors can control the very cellular processes 
that instigate and control tissue growth (Mckay and Leigh, 1993). This mixture of 
synthetic and biological materials makes tissue engineering a complex field that lies 
at the interface of several disciplines including polymer chemistry, biochemistry and 
drug delivery, whilst retaining its traditional roots in medicine and biology. 
1.2 Tissue Engineering Strategies: Cells, Growth Factors and Scaffolds 
Many strategies have been developed in order to regenerate functional tissue, most 
of which involve the use of polymer scaffolds specifically designed to direct tissue 
growth, as discussed later (Freed et al, 1993a). For example, a technique commonly 
used in cartilage engineering applications is the cell transplantation method 
(Brittberg et al, 2001). Here, tissue is taken from the donor patient and the desired 
cells are isolated from this tissue using enzymatic digestion to remove the extra- 
cellular matrix (ECM). The cells can then be cultured (ex-vivo) to achieve a large 
cell population and can either be `seeded' onto a biodegradable pre-fabricated 
polymer scaffold or implanted back into the patient directly. 
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If a scaffold is used as a carrier, the seeded construct (as it is then known) can be 
transplanted into the wound or defect. This method uses the inherent regenerative 
capabilities of the body to produce new tissue. An alternative approach that is 
commonly taken in cartilage engineering is where functional tissue is regenerated in- 
vitro with the use of a bioreactor or alternative 3D culture system (Freed et al, 
1998). A bioreactor mimics the physiological environment inside the body, 
providing the necessary nutrition and optimal conditions for tissue formation. It is of 
particular use in cartilage engineering, as it can also provide the mechanical forces 
often required to produce phenotypically correct cartilage. This use of bioreactors 
for the synthesis of cartilage tissue has already been comprehensively reviewed 
(LeBaron & Athanasiou, 2000, Darling & Athanasiou, 2003). 
Other techniques have been used which do not involve the transplantation of cells or 
tissues. Conduction for example, is a passive method of engineering new tissue that 
involves the placement of a material, normally a synthetic polymer that simply 
occupies the tissue space left behind. This allows the cells in the surrounding tissues 
to move into that space and regenerate the tissue (Alsberg et al, 2001). There is also 
a more active method known as induction that involves the delivery of peptides and 
proteins to the defective site. This has been used successfully in the formation of 
bone through the delivery of osteoblast stimulating factor-1 (OSF-1) (Yang et al 
2002, Yang et al, 2003 a) and bone morphogenetic protein-2 (BMP-2) (Yang et al, 
2003b). Such bioactive molecules are normally delivered by a polymeric device to a 
specific area where the molecules bind to cells and induce their migration to this 
area, encouraging tissue growth. 
1.2.1 Cells and Tissues 
The ability to take a small population of mammalian cells and provide them with an 
environment that will facilitate the growth of new tissue is the fundamental goal of 
tissue engineering (Langer & Vacanti, 1993). Combine this fact with the clinical 
demand for a variety of tissues and organs and the result is a growing number of cell 
and tissue types under investigation for possible tissue engineering applications. 
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Tissues and organs as diverse as retinas (Dutt et al, 2000), kidney (Humes et al, 
1999) and blood vessels (Peters et al, 2002) have all been investigated for potential 
cell-based tissue engineering applications in recent years. The requirement for blood 
vessel formation (angiogenesis) is of particular importance because of the need for a 
blood supply to provide essential nutrients to many tissues and organs in the body 
(L'Heureux et al, 1998, Levenberg et al, 2005). In fact, large, multi-cellular and 
highly vascular organs such as the liver provide a great challenge to tissue engineers 
due to the requirement for a constant flow of nutrients provided by oxygenated 
blood (Dixit, 1994). This is further complicated by the fact that some cell types can 
only survive for a relatively short period of time when in culture (Bhandari et al, 
2001). These facts make the possibility of engineering a whole organ very much a 
long term aim, although a more realistic short term aim may be to produce realistic 
cellular models for the testing of new drugs in-vitro or as pre-cursors to replacement 
organs (Griffith et al, 1997, Kulig & Vacanti, 2004). Some of the `less complex' 
tissues such as skin (Orgill & Skrabut, 1985, Parenteau et al, 1992), cartilage (Freed 
et al, 1993a, Fuchs et al, 2005) and bone (Laurencin et al, 1996, Yang et al, 2004, 
Service, 2005, Stevens et al, 2005) have been successfully engineered. 
Cartilage, has a largely load bearing or supportive function, with only one cell type 
(chondrocytes) and does not require a blood supply. Along with skin, it was among 
the first tissues to be investigated for tissue engineering applications and as a result 
there have been significant developments from both a clinical and commercial 
viewpoint. In addition to the first cartilage-based product (Genzyme's CarticelTM) 
several skin-based tissue engineering products are also on the market, such as 
EpicelTM (also Genzyme) and AllodermTM (LifeCell). 
Development of stem cell technologies alongside tissue engineering has provided an 
augmentation of the traditional strategies previously mentioned, largely as a result of 
the advantages associated with being pluri-potent. In simple terms, when a stem cell 
divides, each new cell has the ability to either remain a stem cell (self-renewal) or 
differentiate into cell with a more specialised function (Kotobuki et al, 2004). 
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Embryonic stem (ES) cells are of great interest in medicine and biology because of 
their ability to develop into virtually any other type of cell present in the human 
body. However, their use in research as well as therapy is encumbered by ethical 
considerations. In contrast to stem cells from embryonic origin, adult stem cells such 
as mesenchymal stem cells (MSCs) are also multipotent cells that can be isolated 
from adult bone marrow and can be induced in vitro and in vivo to differentiate into 
a variety of mesenchymal tissues of interest to tissue engineers, including bone, 
cartilage and tendon (Oghushi & Caplan, 1999). Recent studies have also 
demonstrated the possibility that MSCs can differentiate into other types of tissue- 
specific cells, such as cardiac myoblasts (Makino et al, 1999), endothelial cells 
(Reyes et al, 2002), hepatocytes (Schwartz et al, 2002) and neural cells (Deng et al, 
2001). In particular, mesenchymal stem cells have been recognised for their 
potential use in cartilage and bone engineering applications. Some researchers have 
already utilised MSCs in the repair of bone tissue (Quarto et al, 2001, Partridge et al, 
2002). 
1.2.2 The Role of the Scaffold 
Within the body cells are surrounded by a physically strong supporting structure 
known as the extracellular matrix (ECM). For example, in cartilage the cells 
(chondrocytes) are surrounded by an ECM made up of collagen, the major structural 
protein of the tissue, and a number of other proteins such as glycosaminoglycan 
(GAG) proteins. These proteins provide the necessary physical and biological 
support to the cellular constituents to produce a mechanically strong but flexible 
tissue that is fit for purpose. Therefore, the role of the polymer scaffold is to provide 
a 3-D micro-environment for cell attachment and growth, thus mimicking the ECM. 
Such is the pivotal role of the ECM, any scaffold made for implantation into the 
body must fulfil a number of stringent criteria in order for it to receive medical 
approval and be fit for purpose. These criteria include; biodegradability, high levels 
of porosity and low toxicity (Table 1-1). In most tissue engineering applications, it is 
important that the scaffold material is biodegradable. 
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However, the material must degrade at such a rate, so as to allow the growth of new 
tissue in the space left behind. High levels of porosity are also required to facilitate 
the spread and growth of cells and to provide a network for the free passage of 
nutrients throughout the construct. In addition to its role as a support for cell 
attachment and growth, many tissue engineering strategies require the scaffold to be 
capable of the delivery of bioactive molecules such as protein growth factors, 
molecules that can promote or inhibit a number of important cellular processes 
(discussed in section 1.2.3). Therefore, the porosity and rate of biodegradation are 
also crucial in determining the release kinetics of the entrapped growth factor(s). 
A number of materials have been trialled as tissue engineering scaffolds including 
synthetic polymers, natural polymers and ceramics. However, once a material has 
been deemed suitable for tissue engineering, there are still issues with 
immunogenicity and toxicity that must pass the stringent guidelines set by the food 
and drug administration (FDA). However, several materials have been approved by 
the FDA for use in medical applications, including synthetic polymers such as the 
poly(a-hydroxy acids) and natural or biopolymers such as collagen. 
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Table 1-I Desirable characteristics for tissue engineering scaffolds. 
Desired property or Justification 
criteria 
Non-toxic To prevent the release of toxic metabolites into the 
bloodstream 
Large surface area To allow adequate seeding densities 
Highly porous For growth factor release, gas and nutrient exchange 
Biocompatibility To allow the cells to adhere to the scaffold without 
adverse reactions to the material 
Biodegradability To complement proliferation of cells, release of growth 
factors and tissue formation 
Good mechanical strength To provide physical support to the growth of the new 
tissue 
Economical To retain feasibility on a large scale 
Ease of processing To provide a rapid, reproducible method of scaffold 
fabrication without the need for toxic organic solvents 
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1.2.3 Growth Factors used in Tissue Engineering Applications 
Growth factors are polypeptides that produce and transmit signals to control cellular 
activities. They can either stimulate or inhibit a number of cellular processes 
including proliferation and differentiation as well as altering gene expression and 
triggering angiogenesis (the formation of blood vessels). As a result, they have a key 
role in the regeneration of both vascular tissue (e. g. skin) and non-vascular tissue 
(e. g. cartilage) (Mckay & Leigh, 1993). Growth factors can initiate their action by 
binding to specific receptors on the surface of target cells. They can act locally 
(paracrine) or systemically (endocrine) and even upon the same cell from which they 
are released (autocrine) (Mckay & Leigh, 1993). Each growth factor can have a 
specific or non-specific role within the body to instigate cellular processes. For 
example, transforming growth factor-n (TGF-ß) is a protein that stimulates ECM 
production in cartilage and bone regeneration (Nicoll et at, 1995, Lind et at, 2001, 
Mann et at, 2001), whilst vascular endothelial growth factor (VEGF) stimulates 
endothelial cell proliferation in blood vessel formation (angiogenesis) (Weatherford 
et at, 1996, Sheridan et at, 2000). However, the situation is much more complex 
than this as the local environment and the concentration of the growth factor are 
influential factors. A summary of the growth factors commonly used in tissue 
engineering can be seen in Table 1-2. 
There are a number of challenges that must be overcome in order to achieve tissue 
regeneration with the use of growth factors. One such challenge is to mimic the 
release profile of growth factors in-vivo, as the release of these molecules is 
intermittent, in response to the needs of the body. They may also have very short 
biological half-lives, sometimes of only a few minutes, leading to a rapid turnover. 
In addition, it may be that a number of growth factors are needed at different stages 
throughout the regeneration process, requiring the independent control of two or 
more growth factor types (Richardson et al, 2001). For example, for the regeneration 
of skin both fibroblastic growth factor (FGF) and keratinocyte growth factor (KGF) 
are required for cell proliferation, whilst interleukin-1 (IL-1) and VEGF are required 
for macrophage activation and angiogenesis respectively (Eming et al, 2002). 
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In addition, the same growth factor can have different effects on different cells and 
even on the same cell at different concentrations. This complicates growth factor 
delivery and it is for this reason that much work has been done to provide effective 
and efficient drug delivery systems in order to target cells and promote tissue 
growth. Ultimately, the main aims, when producing a protein growth factor delivery 
device are: to mimic the release profile, kinetics, dosage, duration and cellular 
targeting found in-vivo (Maquet & Jerome, 1997). In addition to these factors, there 
is the issue of maximising the protein loading capacity of the polymer. By 
incorporating these protein growth factors, into polymeric devices, it is hoped that 
controlled and sustained release profiles can be achieved. Furthermore, by 
implanting the device into the area where regeneration is required, the delivery of 
the protein can be made more efficient. Such devices have been made from a 
number of synthetic polymers and biopolymers, in a variety of morphologies, 
dependent upon the processing method. Indeed, once the target cell is identified, the 
selection of the polymer/fabri cation method is crucial to the successful controlled 
release of the protein. For example, adverse processing conditions, such as the use of 
a toxic solvent, can denature the conformation of a sensitive protein or cause 
aggregation and this needs to be avoided (Van de Weert et al, 2000). Similarly, a 
poor release mechanism as a result of an unsuitable choice of polymer may result in 
poor release kinetics or loss of efficacy. This is because in most cases, the release 
mechanism for the protein is by diffusion through the porous matrix or by 
degradation of the polymer and subsequent release of the entrapped molecules. 
1.2.3.1 The Bone Morphogenetic Proteins 
The first protein growth factors to become commercially available as tissue 
engineering products were the bone morphogenetic proteins (BMPs). BMPs are 
endogenous growth factors that can be extracted from pulverised bone. With the 
exception of bone morphogenetic protein-3 (BMP-3), they are all osteoinductive 
proteins that can be used to repair bone via local administration. Products such as 
Stryker Biotech's OP-1 puttyTM and the InFuse implantTM (Wyeth-Ayerst), have 
both become commercially available after FDA approval. 
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Both of these devices use the induction technique previously described whereby the 
protein growth factor is combined with collagen to provide a controlled release 
device. In the case of the OP-1TM product, bone morphogenetic protein-7 (BMP-7) is 
mixed with type I collagen to form a powder that when hydrated with a saline 
solution forms putty. This putty is then used to fill wound defects and deliver BMP- 
7 to the affected area, actively recruiting stem cells from the surrounding tissue and 
initiating the bone formation cascade starting with osteoblast activity. The InFuseTM 
implant (licensed to Medatronic Sofamor Danek) contains bone morphogenetic 
protein-2 (BMP-2) absorbed onto a highly porous collagen sponge. The sponge acts 
as a controlled release system for the protein that is used to induce spinal fusion 
when rolled inside a titanium cage. 
In addition to the collagen-based systems, BMPs have also been used in tissue 
engineering applications that utilise synthetic polymers as controlled release 
matrices. For example, BMP-2 has been incorporated into porous poly(DL-lactic 
acid) scaffolds to repair both bone and cartilage (Yang et al, 2003b, Yang et al 
2004). It is also useful for the assessment of functionality in cell based tissue 
engineering applications as it can induce an osteogenic response in myogenic cells 
(Tare et al, 2002). This osteogenic response is measured by using markers of 
mineralization such as alkaline phosphatase and osteocalcin (Okubo et al, 1999, Han 
et al, 2003). 
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Table 1-2 Growth factors commonly used in tissue engineering applications. 
Factor Action/activity Use in tissue References 
engineering 
Platelet derived growth Promotes proliferation Angiogenesis, Lohmann et al, 2000, 
factor (PDGF) of endothelial cells bone and Park et al, 2000a & b, 
wound healing Richardson et al, 2001 
Fibroblast growth factor Cell proliferation Nerve growth, Hile et al, 2000, 
(FGF) endothelial cell Sakiyama-Elbert & 
proliferation, Hubbell, 2000b, Tabata 
angiogenesis et al, 2000. 
Epidermal growth factor Cell proliferation Wound healing, Mooney et a!, 
(EGF) and basic differentiation 1996b, Chen et al, 
fibroblast growth factor of neural stem 1997, Von Recum et 
(bFGF) cells al, 1999, Hile et al, 
2000, Kanematsu et 
al, 2004. 
Nerve growth factor Axonal growth and Promotes Krewson & Saltzman, 
(NGF) cholinergic cell neunte 1996, Cao & Shoichet, 
survival extension and 1999, Sakiyama-Elbert 
neural cell and Hubbell, 2000b. 
survival 
Transforming growth ECM protein Angiogenesis, Nicoll et al, 1995, 
factor (TGF-ß) production bone and Mann et al, 2001. 
cartilage repair 
Vascular endothelial Endothelial cell Angiogenesis Ishihara et al, 2003, 
growth factor (VEGF) proliferation Weatherford et al, 
1996, Sheridan et al, 
2000, Sun et al, 2004. 
Bone morphogenetic Cell proliferation Bone repair Partridge et al, 2002, 
protein-2 (BMP-2) Yang et al, 2003b, 
Yang et al, 2004. 
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1.3 Materials used as Tissue Engineering Scaffolds 
A large variety of materials have been used successfully in medical applications 
such as metallic prostheses for hip replacements and synthetic polymers for surgical 
sutures. However, so specific are the desirable criteria for a successful tissue 
engineering scaffold, many materials are not deemed suitable. In this section, the 
materials that have figured most frequently in tissue engineering applications are 
described. 
1.3.1 Synthetic Polymers 
Synthetic polymers have featured in tissue engineering applications more often than 
natural or biopolymers. This is because man-made polymers offer several 
advantages over natural polymers, such as relatively low toxicity and tuneable 
degradability (Lu & Mikos, 1996). However, a key disadvantage of using synthetic 
polymers is their lack of biocompatibility. The surface chemistry of many synthetic 
polymers is not biomimetic, in other words, there is a lack of the functional groups 
required for the long-term adhesion and function of mammalian cells. Therefore a 
number of methods have been used to both alter surface chemistry (Dsouza et al, 
1991, Yang et al, 2001) and screen for compatible polymers (Anderson et al, 2004). 
Table 1.3 shows the structures of the most commonly used synthetic polymers in 
tissue engineering applications. One family of synthetic polymers has featured most 
frequently in tissue engineering applications, namely the poly((x-hydroxyacid)s and 
associated esters such as poly(lactic acid) (PLA), poly(glycolic acid) (PGA), the co- 
polymer poly(lactic-co-glycolic acid) (PLGA) and poly(s-caprolactone) (PCL). 
Several members of this group of synthetic polymers have been given approval by 
the FDA for applications such as orthopaedic implants, surgical sutures and drug 
delivery devices. These polymers fulfil most of the criteria required by a tissue 
engineering device, as they are non-toxic, biodegradable and economical. 
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However, it is the variability in both stereochemistry and co-polymer ratios that, has 
made these polyesters a popular choice in tissue engineering strategies, as this can 
allow the degradation rate to be tailored to match the application. For example, 
poly(DL-lactic acid) (PDLLA) is an amorphous polymer that undergoes hydrolysis 
more slowly than the rigid but hydrophilic PGA (a largely crystalline polymer). This 
is because the large number of methyl groups in the polymer structure and its highly 
hydrophobic nature combine to slow hydrolysis of the ester bonds and increase the 
degradation time when compared to PGA. In contrast poly(L-lactic acid) (PLLA) is a 
semi-crystalline polymer that has the combination of both methyl groups and a 
crystalline structure. Therefore, this can result in longer degradation times, limiting 
its use in tissue engineering applications. However, it is still more popular than the 
D-form, with respect to tissue engineering as it yields the naturally occurring L+- 
lactic acid during hydrolysis (Göpferich, 1996). In addition to changing the 
molecular weight and stereochemistry, degradation times for PLA can also be 
reduced or increased by varying the pore wall thickness and the pore surface to 
volume ratio of the polymer matrix (Lu et al, 2000a). 
Frequently, it has been shown that by changing the surface properties of PLA, a 
more biomimetic environment for mammalian cells can result. This has been 
achieved by methods such as the addition of RGD peptides (Dsouza et al, 1991, 
Yang et al, 2001) and plasma deposition (Barry et al, 2005). However, despite its 
naturally hydrophobic surface properties, PLA has been used as a supporting matrix 
for the culture and growth of many cell types without surface modification. 
Examples include: bone progenitors (Howard et al, 2002), chondrocytes (Park et al, 
2004) and hepatocytes (Riccalton-Banks et al, 2003). Poly(DL-lactic acid) also finds 
many uses in drug delivery applications where it is important to have a homogenous 
dispersion of the bioactive species within a one-phase matrix. As a result, PDLLA has 
been used successfully in the controlled release of model enzymes such as lysozyme 
(Young et al, 1999) and ribonuclease A (Howdle et al, 2001, Watson et al, 2002). 
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The more hydrophilic PGA is often used in tissue engineering applications but 
almost exclusively for the reconstruction of hard tissues, such as cartilage and bone, 
due to its rigidity and improved mechanical strength (Dunkelman et al, 1995, Cao et 
al, 1998, Kellner et al, 2002). It has also been shown that PGA encourages 
chondrocytes to produce more proteoglycans than cells cultured on PLA (Freed & 
Vunjak-Novakovic, 1998). When both lactic and glycolic acid, are co-polymerised 
to form PLGA, the degradation kinetics can be further tailored by altering the ratio 
of lactic acid to glycolic acid (Lu et al, 2000b). In addition, the increased mechanical 
strength and hydrophilicity provided by the PGA molecules provide additional 
properties suitable for cell culture/tissue growth. As a consequence, PLGA scaffolds 
have been used for the culture of smooth muscle cells (Harris et al, 1998), 
osteoblasts (Ishaug-Riley et al, 1998) and mesenchymal stem cells (Uematsu et al, 
2005). In addition to their role as cell support devices, PLGA scaffolds have been 
successfully employed as controlled release matrices in a number of tissue 
engineering applications such as protein release (Howdle et al, 2001, Watson et al, 
2002) and DNA delivery (Shea et al, 1999, Jang & Shea, 2003). 
Other synthetic polymers used in tissue engineering applications include poly(c- 
caprolactone) (PCL) and poly(ethylene glycol) (PEG). Poly(e-caprolactone) is a 
polyester that has found use in tissue engineering despite the fact that it has a very 
long degradation profile (up to one year). This semi-crystalline polymer can be 
blended more easily and is generally more compatible with other polymers 
(Göpferich, 1996). For example, mechanically strong PCL scaffolds have been 
coated with collagen to provide a more biomimetic environment for dermal 
fibroblast culture (Zhang et al, 2005) and smooth muscle cells (Venugopal et al, 
2005). Despite being crystalline, PEG is a very different type of polymer from PCL 
as it is highly soluble in water and has physical properties that are dependent upon 
the molecular weight. By combining PEG molecules with other polymers, the 
surface properties of tissue engineering scaffolds can be changed by reducing non- 
specific protein interactions (Cannizzaro et al, 1998) and increasing the 
hydrophilicity (Han & Hubbell, 1997). 
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Table 1-3 Molecular structures of synthetic polymers commonly used in tissue 
engineering applications. Note the methyl group present in the structure of 
poly(lactic acid) but absent in the otherwise identical poly(glycolic acid). 
Polymer Structure 
Poly(lactic acid) O (1 
---O-C- iHn 
CH3 
Poly(glycolic acid) O 
11 +O-C-CHZ-+ 
n 
Poly(lactic-co-glycolic 000 
acid) II 
H-E-O-C 
-CH_) ( O-C-CH 2-) n-C-OH 
CH3 
Poly(c-caprolactone) 0 
11 
-+-0-C-t-CH2} 
Poly(ethylene glycol) 
HO+CH2 
-CH2--O nH 
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1.3.2 Biopolymers 
Table 1.4 shows the molecular structures of the biopolymers most commonly used in 
tissue engineering applications. These natural polymers such as collagen, gelatin, 
alginate and chitosan have featured frequently as they carry a number of advantages 
over the synthetic polymers already mentioned. One example is the reduced need for 
harsh processing conditions e. g. high temperatures and organic solvents. These 
natural macromolecules can be easily converted into physical or chemical gels that 
can entrap cells and growth factors. 
Collagen is an abundant ECM protein found in many tissues and structures in the 
body. Because its natural function is that of physical support, it is a logical choice as 
a tissue-engineering device (Auger et al, 1995). As a result of variations in this 
structure, collagen comes in many forms (19 types in humans) dependent upon the 
tissue in question. Type I collagen constitutes the main protein component of natural 
ECMs of skin and bone and has an important role in the conduit of tissue repair. In 
addition, type I collagen matrices can be produced as highly porous interconnecting 
networks and as a result have been used as scaffolds to grow skin, bone and blood 
vessels (Auger et al, 1995). Collagen matrices typically exhibit very poor loading 
capacities for growth factors, although this has been modified by varying the cross- 
linking density with glutaraldehyde, thereby reducing the degradation rate and 
prolonging the delivery of VEGF (Tabata et al, 2000). More significantly, FDA 
approval has also lead to the use of bovine type I collagen being used in several 
tissue engineering devices, such as the OP-1 and InFuseTM bone induction products 
already described. However, despite the clinical success of these two devices there 
are a number of disadvantages associated with the use of collagen carriers. 
Immunogenicity arising from the use of collagen, including collagen type I, has been 
recorded in a number of instances (Wangerin & Wottge, 1994, Van de Vord et al, 
2005) and there is also a risk of pathogen transmission if using allograft collagen 
(Tomford, 1995). 
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Perhaps most crucially, control over collagen degradation time is limited by the 
properties of the material resulting in poor release kinetics (Wallace & Rosenblatt, 
2003). Collagen can also come in a denatured form known as gelatin, a substance 
used for some time in both the pharmaceutical and food industries (Wood, 1965, 
Reichelt & Joyner, 1965). Denaturation occurs through a harsh acidification process 
that changes the structure and form of the protein. However, despite this treatment, 
gelatin does retain all of collagen's biological qualities such as adhesiveness and 
proteolytic degradability. This form of collagen has been utilised successfully for the 
culture of chondrocytes with the aid of FGF-9 (Cote et al, 2004), and for the 
delivery of FGF-2 (Au et al, 2004). Gelatin has also found use as a carrier for BMP- 
2 to induce bone regeneration in animal models (Talwar et al, 2001). 
Alginate is an anionic polysaccharide derived from brown algae. It comes in the 
form of a block co-polymer composed of two sub units: ß-D-mannuronic acid (M) 
and a-L-guluronic acid (G), the ratio of which is dependent on the source of the 
alginate (Martinsen et at, 1989). When complexed with divalent cations (Ca2+), 
alginate forms a gel almost independent of temperature, unlike many other 
biopolymers that require 
-37°C. The gelation of alginates is based on their affinity 
towards specific ions, with the G-blocks responsible for specific ionic binding. This 
high level of binding gives the G blocks more rigidity and mechanical strength. 
Therefore, the ratio of G to M blocks can be altered to change the properties of the 
gel, a useful tool when designing drug delivery devices for tissue engineering 
applications (Draget et at, 1997). Alginate gels have been frequently used as cell 
supporting scaffolds for tissue engineering applications and in the majority of cases, 
for the culture of chondrocytes (Guo et at, 1989, Paige et at, 1995). It has also been 
used in a recent bone regeneration study where mesenchymal stem cells were 
layered in an artificial space between the tibia and the periosteum to form an in vivo 
bioreactor (Stevens et at, 2005). Despite the fact that alginate has been shown to 
induce an inflammatory response (Smidsrod & Skjak-Braek, 1990, Otterlei et at, 
1991) it is generally well tolerated and as a gel offers many advantages. 
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These advantages include: controllable levels of porosity in the final gel, simple 
protein entrapment and no requirement for cross-linking agents or solvents in the 
gelation process (Hou et al, 2004). 
Another naturally derived protein used in tissue engineering applications is chitosan. 
Chitosan is a linear glycosaminoglycan made up of D-glucosamine units derived 
from chitin, a natural product found in the shells of crustaceans (Berscht et al, 1994). 
Chitosan is a material that has received much attention in tissue engineering 
applications because of its low cost and ready availability (Suh & Howard, 2000). 
However, because of its weak mechanical properties and limited ability to support 
cells, it is rarely used in tissue engineering applications without the addition of 
another material (Sarasam & Madihally, 2005). Chitosan is often is blended with 
gelatin due to the presence of the Arg-Gly-Asp (RGD) peptide in the latter providing 
a more cell adhesive surface. For example, this combination has been used 
successfully for the culture of human umbilical vein endothelial cells (HUVECs) 
(Huang et al, 2005) and hepatocytes (Moon et al, 2005). 
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Table 1-4 Molecular structures of biopolymers commonly used in tissue engineering 
or drug delivery applications. The primary sequence of type I collagen is made up of 
polypeptides containing the repeating amino acid sequence Gly-X-Y with X and Y 
representing different amino acids with unique functional groups (R1 and R2). The 
structure for alginate is composed of two sub-units: a-(1-4)-L-guluronic acid (a) and 
ß-(1-4)-mannuronic acid (b). Chitosan is made up of repeating D-glucosamine units. 
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1.3.3 Non-Polymeric Materials in Tissue Engineering 
In addition to natural and synthetic polymers, there are a number of other materials 
that have been utilised in tissue engineering strategies. After polymers, metallic 
prostheses and ceramics have been used most extensively in medical applications, 
although the latter are most associated with tissue engineering. Ceramics are known 
for their hard, but sometimes, brittle properties making them useful in medicine and 
dentistry (Denry, 1996). Calcium phosphate is a ceramic material that is particularly 
useful in bone tissue engineering applications as it is analogous to the inorganic 
phase of bone. For example, hydroxyapatite (HA) is a calcium phosphate that is 
frequently used in orthopaedic tissue engineering as it can interact with new bone 
and is therefore known as osteoconductive (Ducheyne & Qui, 1999). In addition, 
HA is approved for human clinical use by the FDA and has been used as a 
macroporous scaffold capable of supporting cell growth (Rose et al, 2004). 
Another ceramic, Bioglass® was also developed as a replacement for osseous 
defects. Bioglass® is a product made from calcium salts, phosphorous, sodium salts 
and silicon, which bonds with living bone tissue, repairing and promoting bone 
regeneration. Bioglass® has been used as both a scaffold material for the culture of 
osteoblasts (Xynos et al, 2000) and as a coating to improve the osteoconductive 
properties of synthetic polymers (Roether et al, 2002). 
20 
1.4 A Summary of Scaffold Fabrication Techniques 
The choice of scaffold fabrication technique depends largely on the material. Water 
soluble biopolymers such as alginate can form porous cross-linked hydrogels that 
can act as tissue engineering matrices, using simple ion-exchange techniques 
(Draget et al, 1997, Suh & Howard, 2000). Collagen can also form networked 
matrices but only when the polymer is induced by cross linking agents such as 
glutaraldehydes (Tabata et al, 2000). However, synthetic polymers frequently 
require the use of toxic organic solvents or high temperatures and/or pressures in 
order to produce tissue engineering scaffolds (table 1-5). Natural hydrogels do offer 
several advantages over synthetic systems as they often provide a more biomimetic 
and porous environment (Zisch et al, 2003). However, synthetic polymers are used 
more frequently in tissue engineering applications as they are non-immunogenic, 
versatile and more economical than natural polymers. The use of toxic organic 
solvents (solvent casting) and high temperatures (compression moulding) have 
frequently been used to fabricate tissue engineering scaffolds (Mooney et al, 1996a, 
Khang et al, 2002). However, high temperatures impose many processing 
restrictions such as the exclusion of thermally labile materials whilst many organic 
solvents are toxic and often leave residues in the resultant scaffolds that exceed the 
safe limits imposed by the authorities (Hile et al, 2000). As a result, new methods of 
processing synthetic polymers into porous tissue engineering scaffolds without the 
use of organic solvents or high temperatures are becoming more attractive. 
Techniques such as gas foaming (Harris et al, 1998) and supercritical fluid 
technology (Howdle et al, 2001) utilise high pressure carbon dioxide as a porogen 
and are known as a form of `clean technology'. Particulate leaching is another 
commonly used method of producing tissue engineering scaffolds, although it can 
only be used as a method of altering or increasing porosity and so must combined 
with another technique such as solvent casting (Khang et al, 2002) or supercritical 
fluid technology (Jang & Shea, 2003). An addition, the use of toxic particulates, 
such as sodium chloride, can also result in high residual levels in the final scaffold 
(Harris et al, 1998). 
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Table 1-5 Techniques commonly used in the fabrication of tissue engineering 
scaffolds from synthetic polymers. 
Fabrication Pore size % Advantages Disadvantages Reference 
Technology (µm) Porosity 
Solvent 50-500 30-60 Pores were Uses toxic Khang et at, 
Casting/Salt uniform, good solvents, NaCl 2002 
Leaching inter-connectivity, residues, time 
consuming 
Gas Foaming/Salt 193-439 97% No toxic solvents, NaCl residues in Harris et al, 
Leaching High porosity, pore scaffolds 1998 
size is controllable, 
Supercritical Fluid 20-30, 
Technology & 
300-600 
70% 
Supercritical Fluid Not given 94 
Technology/ 
Particulate 
Leaching 
Compression 
-500 77 
Moulding/Salt 
Leaching 
Polymer Extrusion 3-33 
-90 
Electrospinning of 25-100 
Polymeric Fibres 
Emulsion 50-100 
Templating 
97 
No toxic solvents Limited to Watson et a/, 
or high polymers with 2002 
temperatures, amorphous 
controllable pore regions 
size 
Good NaCl residues in Sang and 
interconnectivity, scaffold Shea, 2003 
controllable pore 
size, controlled 
release of DNA 
Very large pores, Very high Sohier et al, 
good temperatures 2003 
interconnectivity and pressures, 
Suitable for tissue 
requiring tubular 
scaffolds 
High porosity, 
tensile strength 
NaCl residues in 
scaffold 
Very high 
temperatures 
Requires toxic 
solvents 
Widmer et a!, 
1998 
Li et al, 2002 
Not Good inter- Requires toxic 
given connectivity solvents 
Hayman et 
al, 2005 
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1.5 The Introduction of Cells into Tissue Engineering Scaffolds 
The introduction of cells into a supporting matrix is of critical importance in many 
tissue engineering strategies as the distribution of cells throughout the porous 
material is one critical component determining the success or failure of the device. 
This can influence both the successful integration of the device with the host tissue 
as well as the development of a vascularised network throughout the entire scaffold. 
Therefore, a variety of culture methods have been developed for the `seeding' of 
cells into porous supporting scaffolds. These include: static, dynamic (e. g. stir flask, 
agitation) and perfusion bioreactor cultures (Burg et al, 2000). Scaffold seeding was 
originally performed by adding cells drop-wise (Langer & Vacanti, 1993), before 
other methods were developed, including: culturing in an incubator able to circulate 
cells for attachment (Freed et al, 1993a), incorporation into a material such as 
alginate encapsulation (Atala et al, 1993), self forming peptides (Zhang et al, 1995) 
or addition using a bubble jet type system (Mironov et al, 2003). The latter methods 
are of particular interest as the authors have been able to incorporate living cells into 
the fabrication process. Incorporation of living cells into a scaffold at production 
could allow the distribution of cells throughout the scaffold and negate the 
requirement for the time consuming and often, inefficient second seeding stage 
(Burg et al, 2000). The removal of the additional seeding step could also result in a 
lower risk of infection. However, these novel fabrication methods have been 
restricted to using biopolymers such as alginate that can form porous hydrogels 
without the need for harsh processing environments (Hou et al, 2004). This prevents 
damage to the sensitive cell component without compromising the structural 
properties of the scaffold. This is important, as when combining mammalian cells 
and polymer scaffolds it is important to minimise disruption to the cell component 
from fluctuations in solvent composition, temperature, pressure and shear forces 
(Atala et al, 1993, Anson et al, 1995). However, when fabricating porous scaffolds 
using synthetic polymers, organic solvents, elevated temperatures and/or pressures 
are frequently required to, produce the required three-dimensional form. This has 
thus, prevented the inclusion of cells within the scaffold fabrication process. 
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1.6 Supercritical Fluid Technology 
The excitement about supercritical fluid (SCF) technology first materialised because 
of the apparent environmental benefits associated with their replacement of toxic 
organic solvents. Supercritical fluids have since been shown to have a number of 
interesting properties that enhance many types of chemical process operations and 
have consequently found numerous applications throughout industry and scientific 
research. By definition, supercritical fluids are substances that have been pressurised 
and heated to above their critical values and have a density close to or above their 
critical density (Darr & Poliakoff, 1999). Once above this critical point, a substance 
can exhibit unique properties that are exclusive to neither a gas or liquid. For 
example, when carbon dioxide is raised above its critical point of 73.8 bar and 
31.1 °C, it forms a single phase with liquid-like densities and hence, solvating 
characteristics that are similar to those of liquids, yet with mass transfer properties 
similar to gases (Cooper, 2000) (see figure 1-1). The solvating power of supercritical 
CO2 (scCO2) can be tuned very precisely by small alterations to the processing 
temperature and because CO2 is relatively inert, there are few issues with toxicity. 
The use of CO2 also has a number of other advantages such as its low cost, ready 
availability, stability and environmental acceptability over organic solvents. These 
factors, along with its relatively low critical point, make CO2 the most widely used 
supercritical solvent. 
1.6.1 Supercritical Fluid Extraction and Impregnation 
The high level of diffusivity of CO2 in a number of substances has made it a very 
useful tool for extractions (Maddocks & Gibson, 1977). Carbon dioxide can diffuse 
into a substance and then be used as a vehicle to remove unwanted material during 
decompression into a collection vessel or chromatographic instrument. The most 
common use of supercritical fluid extraction (SFE) is in the removal of caffeine 
from coffee (Peker et al, 1992). This is in preference to using chlorinated solvents 
which could impair the flavour of the coffee. The applications for SFE are now 
becoming numerous, with the extraction of wide variety of materials. 
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A number of anti-oxidants have been extracted from fruit and vegetables using 
scCO2, such as lycopene and beta-carotene (Cadoni et al, 1999). Also, in forensic 
science, a number of extractions have been carried out using scCO2 to remove drugs 
such as cocaine and morphine from hair (Brewer et al, 2001, Goodpaster et al, 
2003). 
Synthetic polymers have been the subject of both extractions and impregnations 
using scCO2. For example, attempts have been made to remove impurities from 
polymers intended for medical applications in order to improve biocompatibility, 
although ultimately an improvement in biocompatibility was not achieved (Popov et 
al, 2004). Similarly, the reverse process of supercritical impregnation (SFI) is used 
to incorporate a number of substances into materials. This can be achieved by the 
dissolution of scCO2 laden with a solute into a synthetic polymer. This is made 
possible by the plasticisation of the polymer by scCO2 without the use of high 
temperatures (see section 1.6.2). Upon decompression, the gas escapes from the 
polymer whilst the solute remains trapped within the polymer. This technique has 
been used to successfully incorporate thermally labile proteins into polymers to 
produce films with bioactive surfaces (Sproule et al, 2004). Guney and Akgerman 
(2002) used a continuous flow method to impregnate PLGA with two drugs: 5- 
fluorouracil (for chemotherapy) and ß-estradiol (for oestrogen hormone therapy). 
Both of these drugs were previously shown to be soluble in scCO2 (Guney & 
Akgerman, 2000) and as a result were incorporated into PLGA matrices. 
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Figure 1-1 Phase diagram showing the point at which a substance ceases to be either 
a liquid or a gas and becomes a supercritical fluid. This occurs when a substance is 
raised above its critical temperature (Ta) and pressure (Pa). 
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1.6.2 The Role of Supercritical Carbon Dioxide in Polymer Synthesis and 
Processing 
In addition to its more traditional role as a method of extraction, scCO2 is commonly 
used by polymer chemists as a method of both synthesising and processing 
polymers. From an industrial point of view, carrying out polymerisation reactions in 
scCO2 holds many advantages. In addition to the low cost, low toxicity and ready 
availability of CO2 it is easily removable from the product as it reverts to its gaseous 
state at atmospheric temperature. It is also chemically inert and as a result can allow 
the synthesis of many polymers via a number of mechanisms (Cooper, 2000). 
Despite the fact that very few polymers are actually soluble in scCO2, the solubility 
of scCO2 in some polymers is very high. Under supercritical conditions, CO2 can 
substantially reduce the glass transition temperature (Tg) of many polymers causing 
plasticisation to occur at ambient temperatures. The plasticisation of polymers is 
fundamental to certain methods of polymer synthesis and a number of polymer 
processing techniques. ScCO2 is an effective plasticiser of many polymers including 
polystyrenes (Arora et al, 1998), polyethylene (Busby et al, 2003), 
polymethacrylates (Goel & Beckman, 1993a) and polyurethanes (Briscoe & Kelly, 
1995). As a result, scCO2 has been used in the production of porous foams or 
matrices (Goel & Beckman, 1994a, Goel & Beckman, 1994b, Parks et al, 1996). It is 
this ability to produce porous materials that has made scCO2 processing an attractive 
method of producing tissue engineering scaffolds and controlled release matrices. At 
high pressure CO2 dissolves into the amorphous regions of polymers such as 
PMMA, PLGA and PDLLA causing a depression of the Tg and allowing them to be 
plasticised at ambient temperatures. A drop in pressure then leads to a 
thermodynamic instability causing the gas molecules to cluster or nucleate, in order 
to minimise the free energy (Goel and Beckman, 1994a). The nucleated gas bubbles 
form pores that become permanent as the Tg rises and the polymer vitrifies (Goel & 
Beckman, 1994b). The resultant three dimensional porous scaffold can then act as a 
support for cell attachment and proliferation or as a controlled release device for the 
delivery of growth factors (Howdle et al, 2001, Yang et al, 2004). 
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The weak solvating power of CO2 is the only major limitation, as a number of 
polymers do not plasticise or foam when exposed to CO2 at high pressure. As 
previously mentioned, it is only polymers with amorphous regions that can be 
processed in this way. It is thought that the electron donating carbonyl groups on the 
polymer backbone exhibit specific interactions with the CO2 of a Lewis acid-base 
nature (Kazarian, 1996). Therefore polymers with a high number of carbonyl groups 
and some amorphous regions, such as the poly(a-hydroxy acids) can be processed 
into porous foams. For those polymers that cannot be processed by sCCO2, 
surfactants have been employed that have an affinity for both the polymer and the 
pressurised gas (Woods et al, 2004). 
1.6.3 The Role of Supercritical Carbon Dioxide in the Pharmaceutical Industry 
The use of scCO2 processes to produce drug delivery devices has gathered pace over 
the last 10 years, with one of the most successful applications of scCO2 being in the 
production of microparticles. The majority of drug delivery strategies focus on the 
production of drug particles, with approximately two thirds of the products used in 
the pharmaceutical industry coming in the form of particulate solids (Roberts & 
Debenedetti, 2002). Control over drug particle size is essential for good targeting 
and efficacy as a smaller particle size leads to higher rates of dissolution. This 
increases the bioavailability of the drug leading to smaller dosages and enhancing 
controlled release (Tom & Debenedetti, 1991). The use of scCO2 has provided a 
more controlled route to producing a variety of drug delivery systems, whilst 
circumventing many of the problems associated with traditional techniques (Foster et 
al, 2003). Despite being successful, traditional drug micronisation techniques such 
as milling, grinding and spray-drying do not provide this level of control and often 
use toxic solvents, high temperatures or mechanical stresses that cause degradation 
of the drug. Furthermore, residual levels of toxic solvents can remain in the product 
after processing, making them unsuitable for pharmaceutical applications (Falk & 
Randolph, 1998). 
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Methods traditionally used for the encapsulation of drugs within polymer particles 
such as phase separation, spray drying and double emulsion techniques are beset 
with the same problems (Hile et al, 2000). Because the use of scCO2 does not 
require high temperatures, toxic solvents or mechanical stresses, it has obvious 
advantages when processing sensitive pharmaceuticals. 
A number of SCF techniques have been used for the micronisation of drug particles. 
Many pharmaceuticals can be dissolved or liquefied in scCO2 before being sprayed 
through a nozzle upon decompression to produce fine drug particles. This can be 
achieved with non-solvent techniques such as the rapid expansion of supercritical 
solutions (RESS) and particles from gas saturated solutions (PGSS). The rapid 
expansion of supercritical solutions (RESS) is the most simplistic SCF technique 
used to produce fine drug particles. Here, the solute (the drug) is dissolved within 
the supercritical gas without the need for additional organic solvents (Debenedetti et 
al, 1993). The mixture is then depressurised through a nozzle resulting in the rapid 
precipitation of the drug particles into a collection chamber (Matson et al, 1986, 
Matson et al, 1987). This method has been used for the precipitation of drug 
particles such as ibuprofen, resulting in greater dissolution rates (Charoenchaitrakool 
et al, 2000, Kayrak et al, 2003). The PGSS process works on the basis that 
pressurised gas can diffuse into a solute, by means of lowering both its melting point 
and viscosity. By continuing to increase the pressure of the gas, the molten solute 
forms a highly saturated solution (Sencar-Bozic et al, 1997). Particles can then be 
formed by depressurising the solution through a nozzle, as the gas is released from 
the condensed phase. Particle size distribution can be controlled by changing the 
processing parameters such as temperature and pressure, although the nozzle 
diameter is the single most important factor. This technique used for the 
micronisation of pharmaceuticals such as nifedipine, an anti-hypertensive drug (Kerc 
et al, 1999). 
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It has been shown that the incorporation or encapsulation of a drug within a 
biodegradable polymer can greatly enhance the controlled release of the particles 
(Sencar-Bozic et al, 1997). The PGSS technique has been used to process nifedipine 
with PEG 4000. The levels of drug dissolution were greater than five times quicker 
than a non-treated mixture of the same material (Sencar-Bozic et al, 1997). An anti- 
angina drug, felodipine, has also been co-precipitated with PEG using scCO2, with 
dissolution rates that better those of the Sencar-Bozic study (Kerc et al, 1999). In 
fact, PEG has been shown to compare favourably to PDLLA when micronised using 
the PGSS technique, in terms of the uniform spherical particle morphology and ease 
of processing (Hao et al, 2004, Hao et al, 2005). Despite this, a number of proteins 
have been incorporated into PDLLA particles using the PGSS process (Whitaker et 
al, 2005). The RESS technique has also been used for this application, the earliest 
example of which involved loading lovastatin, an anti-cholesterol drug, into the 
polymer (Tom et al, 1991). However, the PGSS technique has several benefits when 
compared with RESS including its versatility in terms of the polymers and drugs that 
can be processed in this way. Also, because the PGSS technique does not require the 
polymer/drug to be soluble in the scCO2, it uses lower pressures than RESS resulting 
in lower gas consumption. 
Alternatively, scCO2 can be employed as an anti-solvent for the precipitation of 
drugs already dissolved in organic solvents (Foster et al, 2003). Gas anti-solvent 
techniques differ from either the RESS or the PGSS process, because the gas is used 
as an anti-solvent to reduce the solvating power of the organic solvent in which the 
solute is contained. Because of the ability of pressurised gases such as CO2 to 
dissolve and expand organic solvents, they can be used for the precipitation of solids 
from organic solutions (Foster et al, 2003). The expanded solvent can then be purged 
from the system, with the particular solid washed by the anti-solvent (C02). The 
particles can then be removed from the collection chamber upon decompression 
(Yeo et al, 1993). A number of gas anti-solvent techniques exist, each with a small 
change required in the processing technique to suit a particular application. 
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Some of these techniques include the original gas anti-solvent (GAS) technique 
(Yeo et al, 1993), precipitation from a compressed anti-solvent (PCA) (Falk et al, 
1997) and the aerosol solvent extraction system (ASES) (Bleich et a!, 1993). 
Alternative anti-solvent techniques include such as supercritical assisted atomization 
(SAS) (Reverchon, 2002) and solution enhanced dispersion by supercritical fluids 
(SEDS) (Hannah & York, 1995). 
1.6.4 Supercritical Carbon Dioxide and Tissue Engineering 
Both supercritical and high pressure CO2 processing techniques are commonly used 
to fabricate porous materials for tissue engineering applications (Mooney et al, 
1996a, Howdle et al, 2001). Compared to other methods of scaffold fabrication, 
scCO2 has a number of processing advantages. There is no requirement for toxic 
organic solvents or elevated temperatures in order to plasticise the polymer, so there 
are no toxic residues in the final product and less processing restrictions. In addition, 
CO2 is also relatively inert, environmentally friendly and inexpensive. Supercritical 
CO2 was first used to form micro-porous polymeric structures by Goel & Beckman 
(Goel & Beckman, 1993b). However, the first use of pressurised CO2 to produce 
tissue engineering scaffolds was by Mooney et al, where sub-critical CO2 was used 
to produce porous PLGA foams (Mooney et al, 1996a). Here, PLGA discs formed 
by compression moulding were exposed to sub critical CO2 before rapid 
decompression resulted in the formation of a macroporous structure (100 µm pores, 
93% porosity). In this technique, the CO2 was used as a blowing agent to form pores 
in the already softened polymer. This technique has also been combined with other 
methods such as salt leaching, with the size of the leached particles governing the 
pore size (Harris et al, 1998). It has since been demonstrated that scCO2 can be used 
as a single step process to produce porous scaffolds for tissue engineering 
applications with a variety of polymers such as poly(ethyl methacrylate) (PEMA) 
(Barry et al, 2004), PDLLA (Yang et al, 2001) and PLGA (Howdle et al, 2001, Singh 
et al, 2004). By changing the polymer processing conditions, including the operating 
temperature and/or pressure, CO2 exposure time (soak time) and decompression 
speed, the final properties of the scaffold can be tuned to a specific purpose. 
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For example, the operating pressure and the polymer soak time are both directly 
linked to the level of porosity (Goel & Beckman, 1994a, Goel & Beckman, 1994b) 
and interconnectivity in the scaffold (Park et al, 1995, Baldwin et al, 1995). By 
increasing the pressure and/or processing time, the level of soluble gas molecules in 
the polymer can also be increased, preventing the depletion of dissolved gas in the 
regions around the nucleating pores and allowing the pores to become 
interconnected (Park et al, 1995, Baldwin et al, 1995). Pore interconnectivity is a 
desirable property in tissue engineering scaffolds as it allows cells to interact with 
one another, removing the barrier between host cells and tissues and transplanted 
cells and tissues (Langer and Vacanti, 1993). An open, interconnected structure also 
facilitates the free passage of nutrients to surrounding cells and tissues. 
Pore sizes in scaffolds made by sub and supercritical processing methods in this way 
are largely controlled by both the level of CO2 molecules dissolved in the polymer 
and the rate of the decompression (Parks et al, 1996, Goel & Beckman, 1994b). 
Howdle and co-workers demonstrated the effect of decompression rate on pore size 
and pore size distribution in PDLLA scaffolds, by comparing a slow (two hours) and 
a fast (two minutes) decompression rate. With an equal amount of CO2 dissolved in 
the polymer, the `slow' material possessed a small population of large pores 
(diameter 100-500 µm) whereas the `fast' material had higher porosity and the pore 
size distribution was more heterogeneous. However, producing tissue engineering 
scaffolds with pre-determined pore structures is complicated by factors such as 
interfacial tension, viscosity, molecular weight and polymer stereochemistry 
(Baldwin et al, 1996a, Baldwin et al, 1996b). Despite this seemingly complex 
scaffold formation process, simple systematic changes in the processing conditions 
have provided the information for the successful production of scaffolds with pre- 
determined porosities. This ability to control porosity facilitates the use of different 
cell types, as the optimum pore size is dictated by the type and morphology of the 
cells. For example, hepatocytes, the main functional cellular constituent of the liver, 
require a smaller pore size (-100 µm) than osteoblasts, the main cellular constituent 
of bone (250-400 µm) (Klawitte & Hulbert, 1973, Klawitte et al, 1976). 
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In addition to providing a suitable environment for cell growth and the passage of 
nutrients, these porous scaffolds can also be used as way of controlling protein 
release from tissue engineering scaffolds. In an interesting development, thermally 
labile proteins and growth factors have been incorporated into the scaffold 
fabrication process. A one-step scCO2 mixing technique developed at the University 
of Nottingham has been used to successfully incorporate several proteins into PDLLA 
scaffolds (Howdle et al, 2001, Watson et al, 2002). The protein becomes 
incorporated into the polymer during the plasticisation process and is permanently 
entrapped within the porous matrix as the polymer solidifies during the pressure 
quench (figure 1-2). Because this process does not use elevated temperatures or 
organic solvents, the activity of the protein is retained, despite the fact that pressures 
of 200 bar are used. This work was taken a step further by the incorporation of 
BMP-2 into the polymer matrix during processing, with subsequent controlled 
release of the molecule inducing the formation of new bone tissue in-vivo (Yang et 
al, 2003b, Yang et al, 2004). 
The sub-critical CO2 technique first used to produce tissue engineering scaffolds 
(Mooney et al, 1996) has also been used to form porous gene delivery matrices for 
tissue engineering applications, by fusing together microspheres containing plasmid 
DNA (Shea et al, 1999). Poor transfection data, likely to be due to the minimal 
exposure of the DNA plasmids to the cells in question, has cast doubt over the use of 
this method (Ledley, 1996, Jang & Shea, 2003). However, this gas foaming 
technique has been used to deliver plasmid DNA encoding for platelet-derived 
growth factor (PDGF) into PLGA matrices with controlled release achieved (Shea et 
al, 1999). 
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Figure 1-2 The plasticisation and foaming of PDLLA using scCO2 processing as 
viewed through the sapphire window of a high pressure viewing vessel. Supercritical 
CO2 (200 bar, 35°C) has been used to plasticise the PDLLA (A) before subsequent 
decompression causes nucleation of the CO2 bubbles inside the polymer to produce a 
porous foam as the polymer solidifies (B). 
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1.6.5 Processing Mammalian Cells in Supercritical Carbon Dioxide 
It has already been demonstrated that thermally labile proteins and growth factors 
can be incorporated into PDLLA scaffolds using a scCO2 fabrication process without 
significant loss of activity (Howdle et al, 2001, Yang et al, 2004). The ultimate 
objective of this thesis was to use a similar processing technique to allow 
mammalian cells to be incorporated into scCO2-plasticised PDLLA to produce cell- 
loaded scaffolds for tissue engineering. The incorporation of cells into the scaffold 
fabrication step, could potentially lead to a number of benefits over traditional 
method of incorporating cells into scaffolds. Conventional methods of loading 
(seeding) cells onto pre-fabricated polymer scaffolds are problematic. Scaffold 
seeding, is a frequently inefficient process that requires a large population of cells to 
be added to a solid, porous structure followed by weeks or months of careful culture 
to achieve the desired cell density (Freed et al, 1998, Burg et at, 2000). With these 
time scales and frequent changes in the cellular environment comes increased risk of 
infection and potential for the patient's condition to worsen. If cells were introduced 
during the fabrication process in sufficient densities, it could not only significantly 
reduce this time and increase efficiency, but also have several other potential 
benefits. For example, cells could be suspended in a cryo-preserving medium that 
enables cell-loaded scaffolds to be frozen after processing and remain `on the shelf 
until required. Alternatively, cell loaded scaffolds could be fabricated in surgical 
theatres for immediate implantation back into the patient. This would not only make 
the process more rapid, but it would also be less stressful for the patient as there 
would be only one surgical procedure necessary with a potentially reduced risk of 
infection. 
However, processing mammalian cells in scCO2 has previously never been reported 
with logic suggesting that the combination of high pressure and high concentrations 
of CO2 would result in rapid cell death. In fact, scCO2 has been used as a technique 
for the inactivation of bacterial cells for sterilisation purposes (Fraser, 1951, Dillow 
et al, 1999). 
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1.7 Aims 
We hypothesised that the high solubility of CO2 in amorphous polymers such as 
PDLLA would facilitate the incorporation of mammalian cells into the scaffold 
fabrication process, provided that they could survive for sufficient time to allow the 
CO2 to plasticise and foam the polymer. Therefore there were five main aims to this 
project: 
1. To investigate the effect of scCO2 and associated processing conditions on 
mammalian cell survival 
2. To investigate the possible causes of cell death and effects of scCO2 upon gene 
and cell function. 
3. To investigate the possibility that mammalian cells can be co-processed with 
PDLLA under supercritical CO2 conditions and remain both metabolically active and 
functional. 
4. To design and build a second generation injection system capable of introducing 
liquid suspensions into plasticised PDLLA at high pressure. 
5. To investigate the possibility that mammalian cells can be injected into PDLLA at 
high pressure with cell survival and function retained. 
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Chapter 2 
ASSESSMENT OF MAMMALIAN CELL SURVIVAL 
AFTER PROCESSING IN SUPERCRITICAL CARBON 
DIOXIDE 
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2.1 Introduction 
- 
High Pressure CO2 and Cell Survival 
The survival of mammalian cells after exposure to high pressure CO2 is fundamental 
to the success of fabricating cell loaded tissue engineering scaffolds using a one-step 
process. However, there is no literature describing the effects of high-pressure CO2 
upon mammalian cell survival. In fact, the closest comparison that can be made is 
with that of bacterial systems. There have been a number of studies into the effects 
of high-pressure CO2 on micro-organisms, as this technique has been employed to 
induce bacterial cell death (Fraser, 1951, Foster et al, 1962). Both sub-critical and 
supercritical CO2 have been used to kill bacterial cells when injected into poly(lactic 
acid) for medical sterilisation (Dillow et al, 1999) and for the sterilisation of food 
stuffs (Haas et al, 1989). Even over short exposure times (less than three minutes) it 
has been demonstrated that CO2 at just above its critical point (74 bar, 38°C) is 
sufficient to inactivate both gram-negative and gram-positive bacteria (Spilimbergo 
et al, 2002). A number of conflicting mechanisms have been produced to explain 
this method of inactivation. Cell wall rupture caused by the increase in internal 
pressure (Nakamura et al, 1994) or the extraction of lipids from the cell membrane 
(Enomoto et al, 1997) have been proposed as potential causes of cell death. 
However, changes in the cellular environment that are indirectly linked to the use of 
high pressure such as an increase in acidity or physical trauma are also likely to 
affect cell survival. Increased acidity is caused by the reaction between CO2 and 
water to form carbonic acid (H2CO3). This increase in acidity has been suggested as 
a mechanism for cell death in sterilisation techniques, with scCO2 thought to diffuse 
through the bacterial cell wall and reduce the intracellular pH (Dillow et al, 1999). 
The pH of water/CO2 mixtures under supercritical conditions has been measured at 
3.0 (Holmes et al, 1999) and calculated as 3.12 (Spilimbergo et al, 2002). These 
values are well below the neutral conditions required for normal cellular 
metabolism, although the intracellular pH under sCCO2 conditions is not known. 
Along with the changes in the chemical environment inside the vessel during 
supercritical processing, there are physical forces that need to be considered. 
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A temperature range of 30-37°C is often found to be optimal for the culture of 
mammalian cells and therefore, the effect of temperature increases and decreases on 
cell survival during supercritical processing provide an area for investigation. Heat 
treatment is known to be very effective at killing both mammalian (Gregoriades et 
al, 2003) and bacterial cells (Keswani & Frank, 1998). However, low temperatures 
such as between 0°C and 10°C have been known to reduce the numbers of 
mammalian cells such as hepatocytes, although this has only been seen over the 
course of hours or days, not seconds or minutes (Rauen & de Groot, 1998). 
Combinations of high/low temperatures with high pressures have also been used to 
successfully inactivate bacteria (Spilimbergo et al, 2002). However, the effects of 
rapid changes in temperature on mammalian cells (induced by the rapid increase and 
decrease of pressure) are not known. The act of increasing or decreasing the pressure 
of the gas inside the vessel can cause the temperature to rise or fall very quickly. 
This temperature change is the result of the rapid expansion of a gas through a small 
orifice, a phenomenon known as Joule-Thompson cooling/heating. 
In addition to the changes in temperature, rapid compression and decompression can 
cause the formation of gas bubbles not only in plasticised polymers, but also in 
water-based solutions or suspensions. Bubbles can be problematic in the culture of 
cells for biotechnological applications, such as recombinant protein production and 
can result in reduced cell survival (Kunas & Papoutsakis, 1990, Wu, 1995). 
However, bubble formation in a cell suspension cannot be investigated as easily as 
the chemical changes previously mentioned as it needs to be assessed during and not 
after supercritical processing. The effects of decompression rate have been 
thoroughly investigated in bacterial systems, demonstrating that a more rapid or 
`explosive' pressure drop can have a more lethal effect (Fraser, 1951, Foster et al, 
1962 & Nakamura et ad, 1994). Furthermore, the rate of decompression has been 
shown to be crucial in determining the pore structure of tissue engineering scaffolds 
(Howdle et al, 2001). Therefore, the effect of decompression rate on bubble 
formation and cell survival could have implications when determining conditions 
and processing times for scaffold fabrication. 
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2.1.1 Aims 
The main aim of this first chapter was to investigate the effects of high pressure and 
supercritical CO2 on mammalian cell survival. In addition to the effects of 
processing time and pressure, a number of other conditions that are intrinsically 
linked to the use of high pressure and supercritical CO2 were investigated. 
Ultimately, this provides a set of optimum processing conditions to be taken into the 
rest of the study, ensuring maximum cell survival before the introduction of the 
polymer component. 
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2.2 Methods 
2.2.1 Culture of Secondary Cell Lines 
Both murine 3T3 fibroblasts and C2C12 cells were cultured in complete Dulbecco's 
Modified Eagle's Medium (DMEM) for all cell survival and functionality studies. 
Details of cell culture for 3T3s and C2C12s are given in the materials and methods 
chapter (section 7.1.1). A viable cell count was carried out for both cell lines using 
trypan blue exclusion, full details of which can be seen in the materials and methods 
chapter (section 7.1.3). 
2.2.2 Isolation and Culture of Primary Cells 
Primary rat hepatocytes and ovine fibrochondrocytes were first isolated and then 
cultured in Williams Medium E and complete DMEM respectively. Details of both 
cell isolation and culture techniques can be found in the materials and methods 
chapter (section 7.1.1 and 7.1.2). A viable cell count was carried out for both cell 
types using trypan blue exclusion as described in materials and methods chapter 
(section 7.1.3). 
2.2.3 Exposure of Mammalian Cells to High Pressure CO2 and Associated 
Conditions 
In order to process mammalian cells in supercritical CO2 (scCO2) a generic method 
was used prior to the method optimisation carried out during the course of the study. 
Full details of this can be found in the materials and methods chapter (section 7.2.1). 
Briefly, 3T3 fibroblasts (250,000) were suspended in 200 gl of complete DMEM 
and then placed into custom-made 8-well poly(tetrafluorethylene) (PTFE) moulds. 
Eight samples were processed in triplicate using in CO2 (food grade, Cryoservice) at 
37 or 74 bar (supercritical) with a starting temperature of 35°C. Cells were processed 
at maximum pressure for between 10 seconds and three minutes with an additional 
40 seconds required to depressurise the vessel. After processing, the cells in each 
well were re-suspended in 1 ml of complete DMEM and incubated for 24 hours in 
48-well tissue culture plates (Falcon) before assay. 
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2.2.3.1 The Effect of Gas Bubble Formation on Cell Survival 
Gas bubble formation was determined in 200 µ1 of complete DMEM during the 
decompression stage using a 60 ml clamp sealed autoclave complete with a sapphire 
window for observation. In addition to a standard 40 second pressure drop, a second 
experiment was carried out used whereby a second stage was introduced in order to 
slow the release of the last 25% of the pressure. Therefore, the first 56 bar (-75%) of 
pressure was released within the first twenty seconds and the last 18 bar (-25%) was 
released during the second stage, making it a two-step decompression. Live images 
of this decompression were captured using a video camera (JVC) and edited using 
the Windows movie maker software to form a series of images that show the 
formation of bubbles and foaming during the entire process. The experiment was 
then repeated with a 200 µd cell suspension containing 3T3 fibroblasts, in a standard 
60 ml pressure vessel. All of the other conditions were kept the same as in 2.2.3. 
After processing, the cells in each well were re-suspended in I ml of complete 
DMEM and incubated for 24 hours in 48-well tissue culture plates (Falcon) before 
assay. 
2.2.3.2 The Effect of Decompression Rate on Cell Survival 
To test resilience to prolonged decompression, 3T3 fibroblasts were also subject to 
increasing decompression times (one to seven minutes) after being held at maximum 
pressure for one minute (74 bar & 35°C). After processing, the cells in each well 
were re-suspended in I ml of complete DMEM and incubated for 24 hours in 48- 
well tissue culture plates (Falcon) before assay. 
2.2.3.3 The Effect of Processing Temperature on Cell Survival 
To test the effects of the processing temperature on the survival of 3T3 fibroblasts, 
the starting temperatures of each experiment were varied between 4,22,35,50 and 
65°C. Otherwise the method is identical to that used in section 2.2.3 (74 bar, 35°C). 
After processing, the cells in each well were re-suspended in l ml of complete 
DMEM and incubated for 24 hours in 48-well tissue culture plates (Falcon) before 
assay. 
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2.2.3.4 The Effect of Cell Suspension Volume on Cell Survival 
To show the effect of the suspension volume on 3T3 fibroblast survival, the volume 
of DMEM making up the cell suspension was varied between 25 and 400 µl with all 
of the other conditions kept the same as in section 2.2.3 (74 bar, 35°C). After 
processing, the cells in each well were re-suspended in I ml of complete DMEM and 
incubated for 24 hours in 48-well tissue culture plates (Falcon) before assay. 
2.2.3.5 The Effect of an Acidic Environment on Cell Survival 
In this study, the cells were not exposed to high pressure, but rather the DMEM was 
adjusted to pH3.0 using IM HCL in order to mimic the acidic conditions inside the 
pressure vessel under supercritical conditions. The exposure times used mirror those 
used in previous experiments (10 seconds to three minutes) and the cells were kept 
in ambient conditions throughout (25-37°C). In order to show the effects of such an 
acidic pH on cell viability, subsequent experiments were carried out with Hepes 
buffer (pH of 7.0) added to the DMEM at two different concentrations (0.25M and 
0.5M) in order to neutralise the effects of the acid conditions. After exposure to the 
acidic conditions, the cells were re-suspended in I ml of complete DMEM and 
incubated for 24 hours in 48-well tissue culture plates (Falcon) before assay. 
2.2.3.6 The Effects of Supercritical CO2 on Different Cell Types 
A number of cell types were subjected to supercritical conditions to show if the 
effect of the high pressure CO2 is cell type dependent. Rat hepatocytes, ovine 
chondrocytes 3T3 fibroblasts and C2C 12's were processed in scCO2 (74 bar, 35°C) 
to show any differences in survival between primary cells and secondary cell lines. 
Hepatocytes and C2C 12 cells were of particular interest as they were to be used for 
subsequent functionality assays. The conditions used were identical to those used in 
2.2.3 with the cells suspended in appropriate culture media. After exposure to the 
supercritical conditions, the cells were re-suspended in I ml of complete DMEM and 
incubated for 24 hours in 48-well tissue culture plates (Falcon) before assay. 
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2.2.4 Cell Survival Assessment 
Cells were assayed for metabolic activity by the Alamar B1ueTM (Serotech) cell 
metabolic activity assay as described in the materials and methods chapter (section 
7.3.1). Briefly, cells were removed from culture and the complete media covering 
the cells replaced with an Alamar B1ueTM solution (10% in Hank's Balanced Salt 
Solution (HBSS), Sigma UK). After a 90 minute incubation at 37°C (5% C02) 200 
µl of solution from each well was transferred to a 96-well plate (Falcon). 
Fluorescence readings were then obtained at an emission wavelength of X590 nm 
using x, 560 nm excitation. 
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2.3 Results and Discussion 
2.3.1 The Effects of Processing Time and Pressure on Mammalian Cell Survival 
Alamar B1ueTM data for 3T3 fibroblast survival can be seen in figure 2-1. The 
optimum exposure time for cell survival is between 10 seconds and 30 seconds 
(-82% for both times). After 30 seconds exposure, there is a steep drop in cell 
survival from 70±5% to 32±7% between one minute and one minute 30 seconds. 
This indicates that there is an exposure time dependent relationship, with little or no 
cell survival after two minutes and 30 seconds. There is also a possible link between 
survival and temperature, as at shorter times there less of a net temperature drop 
resulting in a more stable temperature for the cells (table 2-1). This is caused by a 
combination of the increase in temperature during compression and the short time 
for temperature equilibration before decompression (as previously discussed). These 
data show that there is a very finite time for which cells can be exposed to this 
pressure, although there is no indication that the supercritical pressure is significant. 
Therefore, cells were exposed to a sub-critical pressure of 37 bar to show the effects 
of a reduced pressure on cell survival. The comparison between cells exposed to 37 
and 74 bar can be seen in figure 2-2. These data indicate that the effect of dropping 
the pressure by half is only statistically significant at 10 seconds, with a survival rate 
of 98±4% at 37 bar compared to 82±6% at 74 bar. Any subsequent increase in cell 
survival does not appear to be significant although there is a general increase at all 
of the time points. This would indicate that it is largely the exposure time at 
maximum pressure that is causing this reduction in cell survival and not the pressure. 
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Figure 2-1 Survival of the murine 3T3 fibroblast cell line after exposure to scCO2 for 
increasing time periods as measured by the Alamar Blue assay. Mean (n=3) + SD. 
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Table 2-1 Temperature changes inside the pressure vessel during the supercritical 
processing of mammalian cells. 
Exposure Temperature at Temperature at Temperature at Net 
time to 74 bar (°C) start of end of temperature 
maximum decompression decompression drop from 74 
pressure at (°C) (°C) to 0 bar (°C) 
35°C 
10 sec 46 46 21 25 
30 sec 46 42 18 28 
60 min 46 39 17 29 
90 sec 46 38 15 31 
120 min 46 36 12 34 
150 sec 46 35 11 35 
180 sec 46 35 11 35 
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Figure 2-2 Survival of mammalian cells exposed to high pressure and supercritical 
CO2 for increasing exposure times as measured by the Alamar Blue assay. Mean 
(n=3) ± SD. * indicates p<0.05 using T-test. 
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2.3.2 The Effects of Gas Bubble Formation and Decompression Rate on 
Mammalian Cell Survival 
Gas bubble formation during the compression and subsequent decompression of 200 
µl DMEM can be observed in figure 2-3A-H. Figures 2-3E and 2-3F show the 
foaming effect induced by the formation of gas bubbles during the rapid one-step 
decompression from 74 to 0 bar. However, in the case of the two-step 
decompression, there is clearly less foaming visible to the naked eye after the 
decompression (see figures 2-3G and 2-3H). This indicates that a slower release of 
the gas during the second part of the decompression, reduces the number of gas 
bubbles and hence the formation of foam is minimised. Despite this, the cell survival 
data presented in figure 2-4 indicates that the bubble formation and foaming of the 
DMEM does not have an obvious effect on the survival of the cells. 
The effects of the decompression speed from 74 bar to atmospheric pressure can be 
seen in figure 2.5. These data show that there is still 71±7% cell survival after four 
minutes and 47±8% after six minutes of decompression, added to the one minute of 
initial exposure at 74 bar. This suggests that the gradual decrease in pressure results 
in a less physically stressful environment for the cells, such as a reduced net 
temperature change (see table 2-2). This evidence would certainly concur with the 
literature on bacterial systems where a more rapid decompression time was found to 
increase cell inactivation (Nakamura et al, 1994, Enomoto et al, 1997). However, 
there was also some `pressure dumping' during the initial stages of this 
investigation, resulting in a decompression speed that was not constant. Therefore, 
during the latter stages of decompression the pressure would not be as high as would 
be expected with a constant decompression rate. 
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One speed Two speed 
decompression decompression 
Figure 2-3 Effects of a one-step and a two-step decompression on gas bubble 
formation in cell culture medium (200 µl) as seen through the sapphire window of a 
high pressure viewing vessel. Compression from 0-74 bar in 40 seconds (A-B) is 
followed by decompression from 74-37 bar in 20 seconds (C-D) and then from 37-0 
bar in 20 seconds (E-F) (one step decompression). In the two-step decompression, 
only 18 bar of pressure is released during the last 20 seconds (G-H). 
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Figure 2-4 Survival of mammalian cells after exposure to scCO2 using a one step or 
two step pressure quench as illustrated in figure 2-3. Compression from 0-74 bar in 
40 seconds (A-B) is followed by decompression from 74-37 bar in 20 seconds (C-D) 
and then from 37-0 bar in 20 seconds (E-F) (one step decompression). In the two- 
step decompression, only 18 bar of pressure is released during the last 20 seconds 
(G-H). Mean (n=3) ± SD. 
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Figure 2-5 Survival of mammalian cells after exposure to scCO2 for one minute 
followed by increasing decompression times as measured by an Alamar Blue assay. 
Mean (n=3) ± SD. 
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Figure 2-5 Survival of mammalian cells after exposure to scCO2 for one minute 
followed by increasing decompression times as measured by an Alamar Blue assay. 
Mean (n=3) ± SD. 
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1 min 2 min 3 min 4 min 5 min 6 min 7 min 
Table 2-2 Changes in temperature recorded during increasing decompression times. 
Decompression Temperature at start Temperature at Net temperature 
time (min) of decompression end of change during 
(°C) decompression decompression (°C) 
(°C) 
40 sec 39 17 22 
1 min 39 18 21 
2 min 39 20 19 
3 min 39 23 16 
4 min 39 28 11 
5 min 39 34 5 
6 min 39 35 4 
7 min 39 35 4 
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2.3.3 The Effects of Temperature and pH on Mammalian Cell Survival 
The effects of the processing temperature followed by scCO2 processing on cell 
survival are shown in figure 2-6. These data indicate that cell survival is only 
significantly reduced at temperatures below 22°C when exposed to supercritical 
pressures (23±8% at 4°C). The cells appear to tolerate temperatures of up to 60°C, 
concurring with previous evidence where only very high temperatures such as 80°C 
have significantly reduced cell survival in such short time periods (Gregoriades et al, 
2003). However, at 4°C the cells never reach optimal temperatures and during 
decompression, are exposed to a rapid temperature drop from 24°C, to just above the 
freezing point of water (2°C). It has been shown that with some mammalian cells, 
temperatures of between 0-10°C can be sufficient to cause a drop in survival over 
long periods of time (Rauen & de Groot, 1998) but the effects of such a rapid 
temperature drop under these conditions is unknown. However, the fact that the cells 
were suspended in water-based substance suggests that temperatures near to the 
freezing point of water would have a detrimental effect. One possible solution to this 
maybe to suspend the cells in a cryo-preserving reagent such as dimethylsulfoxide 
(DMSO) to prevent cold damage. 
Despite not being able to recreate the supercritical pH by using high pressure C02, 
the pH value of 3.0 has been used to examine the effects of increased acidity on 
mammalian cell survival, as shown figure 2-7. These data indicate that even without 
the addition of buffer, exposure times of 10 and 30 seconds do not have any 
significant effect on cell survival. However, at a one minute exposure there is a 
noticeable drop in survival for those cells processed in standard DMEM to 90±5% 
and those buffered with Hepes. This also coincides with the point at which there is a 
large drop in cell survival in figure 2.1 indicating that the drop in pH could 
exacerbate the effects of high pressure CO2. However, this drop in cell survival is 
only of 7% and was easily corrected by the addition of 0.25M Hepes. In addition, 
because the optimum processing time to be taken forward to the latter stages of the 
thesis from figure 2.1 was 10-30 seconds, the effects of the low pH on cell survival 
are not likely to be of concern. 
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Figure 2-6 Survival of mammalian cells exposed to scCO2 for one minute at 
different processing temperatures as measured by an Alamar Blue assay. Mean 
(n=3) ± SD. * indicates p<0.05 using T-test. 
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Table 2-3 Changes in temperature recorded when mammalian cells are processed at 
74 bar for one minute at different starting temperatures. 
Starting Temperature at Temperature at Temperature at Net 
temperature 74 bar (°C) start of end of temperature 
(°C) decompression decompression change: 74 to 
(°C) (°C) 0 bar (°C) 
4 18 24 2 16 
22 36 35 12 24 
35 46 39 17 29 
50 60 58 32 28 
60 66 67 40 26 
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Figure 2-7 Survival of mammalian cells exposed to acidic conditions (pH3) for 
increasing exposure times, with and without the addition of Hepes buffer (pH7) as 
measured by an Alamar Blue assay. Mean (n=3) ± SD. 
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2.3.4 The Effect of Cell Suspension Volume on Mammalian Cell Survival 
The effects of processing mammalian cells in different volumes of cell culture 
medium (DMEM) under supercritical conditions are presented in figure 2-8. These 
data show that the volume of the cell suspension is crucial in the determining the 
rate of cell survival, with only 30±8% survival recorded with 50 µl of DMEM 
compared with 75±5% survival when using 400 µl. This evidence would suggest 
that higher volumes provide some kind of protection for the cells and act as a 
physical barrier. A greater supply of nutrients and oxygen from the increasing 
volume of media throughout the processing step may be one reason for this increase 
in survival. Despite the highest rate of survival being at 400 Al, this value does not 
appear significantly different to that at 200 gl (70+7%). Furthermore, it is possible 
that the increased volume of the cell suspension may interfere with the polymer 
processing step (due to the presence of water) in future applications. Therefore, 200 
pl was selected as the optimal volume for the processing of mammalian cells in 
scCO2. 
2.3.5 The Effect of Changing Cell Type on Resultant Cell Survival 
The effect of supercritical processing on the survival of four different cell types are 
shown in figure 2-9. Cell survival at 10 seconds, in comparison to an untreated 
control, was over 80% for all cell types (over 90% for the C2C12 cell line). Cell 
survival remained at or above 50% for all cell types at one minute. Between one and 
two minutes exposure, there was a steep decline in cell survival, with little or no 
metabolic activity recorded after three minutes. The secondary murine cell lines 
(3T3 and C2C12) appear to show more resistance to scCO2 than the primary cells 
suggesting a cell type dependent survival rate. However, this could be explained by 
the faster growth rates of 3T3 fibroblasts and C2C 12 cells during the post processing 
24 hour culture stage. 
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Figure 2-8 Survival of mammalian cells exposed to scCO2 when suspended in 
different volumes of cell culture medium as measured by an Alamar Blue assay. All 
data is given with standard deviation. * indicates p<0.05 using T-test. 
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Figure 2-9 Master chart for the survival of four different mammalian cell types when 
subjected to scCO2 for increasing exposure times as measured by an Alamar Blue 
assay. Mean (n=3) ± SD. 
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2.4 Conclusions 
In order to satisfy the aims set out at the beginning of the study, mammalian cells 
have been subjected to all manner of scCO2 processing conditions in order to 
produce optimal conditions for the latter stages of this investigation (measuring cell 
function and co-processing with PDLLA. Of all of the conditions used here, the 
effects of processing time, decompression time and pressure appear to have the most 
obvious effects on cell survival. Processing time is crucial, with anything more than 
60 seconds at maximum pressure resulting in less than 35% survival for all cell types 
and less than 10% for the primary cells (see figure 2-9). Therefore a processing time 
of 10 or 30 seconds would provide the highest live cell population. However, with 
the addition of the polymer phase, a processing time of 30 seconds would allow 
more CO2 to become dissolved in the polymer and provide and longer window for 
any subsequent mixing that may be necessary. The pressure used for co-processing 
was always likely to be 74 bar irrespective of the data at sub critical pressures as this 
would offer polymer processing advantages, particularly over short periods of time. 
The use of a lower pressure did not significantly increase cell survival and may not 
be sufficient to produce a porous structure. Although when increased beyond 40 
seconds the decompression time acted to prolong the survival of the cells under 
pressure, this did not actually increase cell survival. Therefore the decompression 
time subsequently used was retained at 40 seconds for future experiments. The 
effects of bubble formation and foaming during the decompression were not found 
to be detrimental to cell survival. Any changes in temperature and pH were 
insignificant over these short time periods and as a result no change from the starting 
temperature of 35°C was required, nor was the use of buffers to neutralise the pH. 
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Chapter 3 
ELUCIDATING THE CAUSE AND EXTENT OF DAMAGE 
TO MAMMALIAN CELLS AFTER EXPOSURE TO 
SUPERCRITICAL CARBON DIOXIDE 
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3.1 Introduction 
3.1.1 Investigating Potential Causes of Cell Death after Processing in 
Supercritical CO2 
The discovery that mammalian cells can survive in high pressure and supercritical 
CO2 using a variety of processing conditions provided the basis for further 
investigation. However, there was no investigation as to the mechanism or cause of 
cell death from these experiments, except for the observation of a time-dependent 
survival. It was quite possible that cell death was caused by elevated and/or rapid 
changes in pressure as reported with bacterial systems (Fraser, 1951, Foster et al, 
1962. It has also been proposed that weak solvent effects of CO2 are a cause of cell 
death at high pressure either by causing a drop in the intracellular pH (Dillow et al, 
1999) or by lipid extraction through the perforation of the cell membrane (Nakamura 
et al, 1994, Enomoto et al, 1997). Therefore it was considered that a study of CO2 
and a second processing medium would enable a comparison of the effects of both 
high pressure and more specifically high pressure CO2 upon cell survival. Nitrogen 
(N2) was chosen as an alternative processing medium as it is relatively inert. Despite 
the fact that the critical point of N2 is reached at a pressure of 34 bar and a 
temperature of 
-147°C, the conditions had to remain the same from the initial 
experiments so that a direct comparison could be made. 
3.1.2 Measuring the Effects of Supercritical CO2 on Gene Expression and 
Cellular Function 
In addition to investigating the cause of cell death, it was vital that the effects of 
scCO2 processing on more complex aspects of cell machinery were assessed. 
Determining the effect of high pressure CO2 on levels of gene expression is crucial 
to the future success of such a technique. Therefore a gene chip was used to compare 
gene regulation in murine C2C12 cells with and without being processed in scCO2. 
To demonstrate cell function, the murine C2C 12 cell line and primary rat 
hepatocytes were selected. 
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Myoblastic C2C12 cells were chosen for their ability to differentiate into the 
osteogenic lineage when prompted by BMP-2 (Katagiri et al, 1994). This change is 
shown by the production of protein markers indicative of bone formation, two of 
which are alkaline phosphatase (Okubo et a!, 1999) and osteocalcin (Han et a!, 
2003). Therefore, induced protein activity, is seen as evidence of differentiation and 
thus, cellular function. Also chosen were primary hepatocytes, which are the main 
cellular constituent of the liver. Hepatocytes were selected as they have a number of 
important metabolic and catabolic activities. One such important activity is the 
metabolism of testosterone by the cytochrome P450 (CYP450) super-family of 
protein enzymes. Therefore, the activity of cytochrome P450 is used as a suitable 
marker of liver function in the pharmaceutical industry due to its role in the 
metabolism of many drugs. Function of CYP450 enzymes in culture systems is 
assayed via the hydroxylation of testosterone. The 6ß-hydroxylation of testosterone 
is predominantly mediated by CYP 3A, the major isoform being 3A1 in rats 
(Sonderfan et al, 1987). Oxidation of testosterone to 4-androstene-3,17-dione in rats 
is predominantly catalysed by CYP 2B1 (greater than 80%) with minor contribution 
by CYP 2C11 and CYP 2B2.2a-hydroxylation is predominantly CYP 2C11 
mediated in rats. Presence of these metabolites is detected via the use of high 
performance liquid chromatography (HPLC). 
3.1.3 Aims 
The central aim of this chapter was to investigate some of the possible causes of cell 
damage/death after processing in high pressure and supercritical CO2 with a 
comparison made between the effects of CO2 and N2. In addition, it was also 
important to ascertain to what extent damage was affecting those cells that survived. 
Thus, the effects upon important aspects of gene function were estimated using a 
gene chip specific for murine. Finally, important aspects of cell machinery were 
investigated using the differentiation capacity of C2C12 cells and hormone 
metabolism in primary hepatocytes as markers of retained cell function after scCO2 
processing. 
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3.2 Methods 
3.2.1 Culture of the Murine C2C12 Cell Line 
Murine C2C12 cells were cultured in complete DMEM for all cell survival and 
functionality studies. Details of cell culture for 3T3's and C2C12's are given in the 
materials and methods chapter (section 7.1.1). A viable cell count was carried out for 
both cell lines using trypan blue exclusion, full details of which can be seen in the 
materials and methods chapter (section 7.1.3). 
3.2.2 Exposure of Mammalian Cells to Supercritical CO2 and High Pressure N2 
Briefly, C2C12 cells (250,000) were suspended in 200 µl of complete DMEM 
(without phenol red and FCS for the lactate dehydrogenase (LDH) assay) and then 
placed into custom-made 8-well PTFE moulds. Eight samples were processed in 
triplicate using either CO2 (food grade, Cryoservice) or N2 (BOC gases, UK) at 74 
bar with a starting temperature of 35°C. Cells were processed at maximum pressure 
for between 10 seconds and 3 minutes with an additional 40 seconds required to 
depressurise the vessel. After processing, the cells in each well were re-suspended in 
1 ml of complete DMEM and incubated for 24 hours (3 hours for apoptosis assay) in 
48-well tissue culture plates (Falcon) before assay. For the LDH assay, the cell 
suspensions were immediately centrifuged to remove the cells and the assay carried 
out on the 200 µl aliquots of supernatant. For gene expression and functionality 
studies the cells were exposed to scCO2 (74 bar, 35°C) for one minute with the 
additional 40 seconds required for both compression and decompression. 
3.2.3 Measuring the Survival of Murine C2C12 Cells after Processing in High 
Pressure N2 
Cells were assayed for metabolic activity by the Alamar B1ueTM cell metabolic 
activity assay as described in the materials and methods chapter (section 7.3.1). 
Briefly, the complete medium covering the cells in culture was replaced with I ml 
per well of an Alamar B1ueTM solution (10% in HBSS, Sigma UK). 
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After a 90 minute incubation at 37°C (5% CO2) 200 µl of solution from each well 
was transferred to a 96-well plate (Falcon). Fluorescence readings were then 
obtained at an emission wavelength of x, 590 nm using X560 nm excitation. 
3.2.4 Assessment of Cell Membrane Rupture after Processing in Supercritical 
CO2 
As cells release cytosolic LDH when the membrane is ruptured, an assay for levels 
of LDH after exposure to scCO2 was carried out as described in chapter 7.3.3. 
Briefly, C2C12 cells (250,000 per well) were suspended in DMEM (without phenol 
red and FCS) and processed in scCO2 (74 bar, 35°C) for increasing times (10 
seconds 
- 
three minutes) as in previous experiments. The cells were then removed 
by centrifugation and the remaining DMEM assayed for release of LDH using a 
LDH colour substrate system as per manufacturer's instructions (Roche, Penzberg, 
Germany). The results were then compared to a set of controls consisting of both 
live cells (intact) and dead cells (lysed). 
3.2.5 Assessment of Cellular Apoptosis after Processing in Supercritical CO2 
To further elucidate the cause of cell death, C2C 12 cells were assessed for scCO2 
induced apoptosis by way of an enzyme-liked immuno sorbent assay (ELISA) used 
to detect the histone-DNA complexes indicative of apoptotic cells. The full 
methodology can be found in chapter 7.3.4. In brief, C2C12 cells (250,000 per well) 
were suspended in DMEM (without phenol red) and processed in scCO2 (74 bar, 
35°C) for increasing times (10 seconds 
- 
three minutes) as in previous experiments. 
The cells were then cultured for a further 3 hours in fresh DMEM (so as to observe 
apoptosis rather than cell mechanical damage) and then assayed for histone 
associated DNA fragment indicative of cell death. Induced cell death was detected 
via the cell death detection ELISA+ kit (Roche, Penzberg, Germany) used as per 
manufacturers instructions. 
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3.2.6 Assessment of Gene Expression in Murine C2C 12 Cells after Processing in 
Supercritical CO2 
A microarray of over 9000 genes was used to indicate any changes in gene 
expression after processing in scCO2. In brief, murine C2C 12 cells were processed 
for one minute at 74 bar and 35°C as described in the materials and methods chapter 
(section 7.2.1) and cultured for a further three hours in DMEM before being 
homogenised in an RLT (unknown abbreviation) buffer containing ß- 
mercaptoethanol (10 µl per ml). Total RNA content of the cell homogenate was 
assessed using the RNeasy kit (Qiagen, Germany) according to the manufacturer's 
instructions. Slides were OciChipTM 30k set-A arrays (Ocimum Biosolutions) and 
indirectly labelled probes were generated from 5 gg of total sample RNA with 
ambion messageamp II amplification (as per manufacturers instructions). The probes 
were labelled with alexa 555 or 647 NHS ester dyes (InVitrogen) and 0.5 µg 
(approximately 40 pM of dye-label) of each was used for each channel of 2 colour 
hybridisations. Hybridisations were performed for 16 hours on a TEcan HTS 4800 
hybridisation station with moderate agitation, using the Ocimum recommended 
solutions and temperatures. Arrays were scanned with a GenePix 4000b laser 
scanner and primary data obtained using GenePix Pro 6.0 software (Axon). Filtering 
of array data and normalisation using the LOWESS algorithm were performed 
within the University of Nottingham microarray database (a version of BASE 
vi. 2.16, Lund University, Sweden). Further analysis was performed on this data set 
using Multi Experiment Viewer (MEV) software and the statistical analysis of 
microarrays (SAM) algorithm. 
3.2.7 Cell Functionality Assessment by BMP-2 Induced Osteogenic 
Differentiation of the C2C12 Cell Line after Exposure to Supercritical CO2 
For osteogenic culture, C2C12 cells that had been processed in scCO2 for one 
minute at 74 bar (35°C) were cultured overnight in complete DMEM before the 
addition of 500 ng/ml recombinant human bone morphogenetic protein-2 (rhBMP-2) 
in 2% FCS supplemented DMEM. 
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After seven days in osteogenic culture, C2C 12 cells were assayed for the soluble end 
product of alkaline phosphatase activity using the assay described in the materials 
and methods chapter (section 7.4.2). In brief, cell cultures were fixed in 75% ethanol 
for 10 minutes and homogenised in 600 pl of distilled water containing 0.001% 
Tween detergent after 3 cycles of freeze-thawing. The substrate (p-nitrophenyl 
phosphate) (p-NPP) was added to equal volumes of the cell samples, incubated at 
37°C for 1 hour and the rate of conversion into p-nitrophenol (p-NP) measured by a 
change in fluorescence at 405 nm. Values were compared against known p-NP 
standards and the data was corrected to DNA content as a measure of cell number 
and presented as nM of p-NP per hour per ng DNA. The DNA content of the cells 
was assayed using a method also found in the materials and methods chapter 
(section 7.3.2). To observe the osteogenic status of C2C12 cells, a red colour 
substrate was precipitated on the cells by the action of cellular alkaline phosphatase 
activity. The substrate system comprised of Napthol AS-MX buffer solution 
containing I mg/ml Fast Violet B salt, as previously described (Oreffo et al, 1998) 
and can be found in more detail in the materials and methods chapter (section 7.4.3). 
3.2.8 Cell Functionality Assessment by Measurement of Cytochrome P450 
Activity in Rat Hepatocytes after Exposure to Supercritical CO2 
After exposure to scCO2 and 24 hours in culture, rat hepatocytes were assayed for 
function by measuring the metabolic activity of three key cytochrome P450 enzymes 
as described in the materials and methods chapter (section 7.3.3). In brief, rat cell 
cultures were incubated for 1 hour at 37°C in 1.5 ml or 320 µl respectively of Earl's 
buffered saline solution (EBSS) supplemented with 1 mM Ca 2+, 1 mM Mg2+ and 
containing 100 µM testosterone. The supernatant was analysed using a Beckman 
HPLC 1090, with UV absorbance detected at 245 nm using an integral diode array 
detector. The sample injection volume was 40 µl with each run controlled by 
intermittent injection of a 6ß-hydroxytestosterone standard, as well as a mix of all 
metabolite standards. The peak height of each sample was recorded and compared to 
a series of known metabolite standards to calculate the percentage of each metabolite 
present (DNA corrected). 
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3.3 Results and Discussion 
3.3.1 Investigating the Possible Causes of Cell Death 
Mammalian cells were exposed to N2 using identical conditions to those used for the 
CO2 studies and assayed for metabolic activity 24 hours later. The results of these 
studies were compared with values already ascertained for scCO2 and can be seen in 
figure 3-1. C2C12 survival was a 99±8% after exposure to high pressure N2 (74 bar, 
35°C) compared with a survival rate of 66±3% after exposure to CO2 at the same 
pressure and temperature, a difference which has been confirmed as significant by a 
standard T-test. Furthermore, the levels of cell survival are maintained above 70% 
after three minutes exposure to nitrogen compared with total cell death after 
exposure to similar periods of scCO2. Thus, these data indicate that mammalian cells 
are more susceptible to the effects of CO2 than N2 and that elevated pressures are not 
the only mechanism of cell death. The increased cell death after exposure to scCO2 
indicates that it may be a CO2 specific interaction with the cell suspension that is 
adding to the effects of pressure. This would concur with previous literature where a 
C02-instigated drop in pH has been suggested as a mechanism of cell death (Dillow 
et al, 1999). Figure 3-2 shows the data from two separate experiments conducted to 
provide further information as to the cause of cell death. 
The measured release of LDH from the cells exposed to scCO2 under the same 
conditions shows the presence of ruptured cells but not in a consistent manner. This 
indicates that there is some perforation of, or damage to, the cell membrane during 
the rapid compression/decompression of CO2 as reported by Nakamura et al (1994) 
& Enomoto et al (1997). This rupture could be both a direct cause of cell death 
whilst also possibly facilitating a reduction in the intracellular pH. The measurement 
of histone complexes by ELISA showed no observable induced apoptosis (in 
surviving cells) over that of control cells, as can be seen in figure 3.2. Therefore it 
would appear that apoptosis is not a primary cause of the cell death. 
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Figure 3-1 Survival of C2C 12 cells when subjected to 74 bar pressure of scCO2 or 
N2 for increasing exposure times as measured by an Alamar Blue assay. Mean (n=3) 
± SD. ** indicates p<0.01 and *** p<0.001 using T-test. An additional T-test was 
carried between the data sets at three minutes exposure in order to further 
demonstrate the significance of the result. 
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Figure 3-2 Measurement of cell rupture using an LDH assay and apoptosis using an 
ELISA for DNA-histone complexes, after exposure of C2C12 cells to scCO2 for 
increasing time periods. Mean (n=3) ± SD. 
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3.3.2 The Effects of Supercritical CO2 on Gene Expression in C2C12 Cells 
Changes in gene expression after exposure to scCO2 were measured in murine 
C2C12 cells using the OciChipTM mouse 30k set A (Ocimum Biosolutions). RNA 
was harvested from C2C12 cells after scCO2 processing for one minute (74bar/35°C) 
labelled and hybridised to the OciChipTM in comparison to RNA from untreated 
control cells. Filtering of array data and normalization using the LOWESS algorithm 
were performed within the University of Nottingham microarray database (a version 
of BASE vl. 2.16, Lund University, Sweden). From the OciChipTM arrays, (9853 
mouse specific probes), 4418 genes were found to be detected in 3 or more arrays 
and showed a reproducible linear relationship indicating little significant change at 
mRNA level (figure 3-3). Stringent filtering was used to examine only genes which 
were well detected across all samples. A Further analysis was performed on this data 
set using Multi Experiment Viewer (MEV) software. An initial single class T-test of 
the data set (against threshold P values = 0.01 with standard Bonferroni correction) 
did not reveal any significant changes from the control samples. 
The statistical analysis of microarrays (SAM) algorithm as implemented with MEV 
found eight significantly down-regulated genes based on aS value of 1.0125 and 
false discovery of 0 (table 3-1). Of the eight genes that were significantly down- 
regulated, survivin121, clast4 protein and glutathione-s-transferase could play a role 
in a biochemical response from the cell to the extreme changes in environment. 
Survivin121 is a component of the chromosomal passenger complex that acts as an 
inhibitor of apoptosis (Wheatley & McNeish, 2005). Down-regulation of 
survivin 121 is the only marker of an apoptotic response recorded here further 
indicating that apoptosis is not a major cause of cell death. 
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Figure 3-3 Log-log plots of normalised intensity (arbitrary units on both axes) for 
genes after microarray analysis of the murine C2C 12 cell line after exposure to 
scCO2. Sample genes (channel 1, x-axis) are plotted against control genes (channel 
2, y-axis) with colours used to identify the four biological replicates. 
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Table 3-1 Genes shown to have significant down regulation when analysed with the 
SAM algorithm, as implemented within MEV. 
Accession No. Description Sample 1 Sample 2 Sample 3 Sample 4 
AK011893.1 homolog to 
-1.782 -1.398 -1.506 -0.591 
ad024 
AK003722.1 homolog to 
-1.963 -1.216 -1.481 -0.534 
ubiquitin- 
conjugating 
enzyme e2 h10 
(ec 6.3.2.19) 
(ubiquitin- 
protein ligase) 
(ubiquitin 
carrier protein) 
AF115517.1 survivinl2l 
-1.272 -1.227 -1.003 -0.391 
NM_011526.1 transgelin; 
-0.660 -0.575 -0.496 -0.579 
tagln 
AK010877.1 homolog to NaN* 
-0.821 -1.166 -0.898 
ran binding 
protein 11 
NM_023743.1 clast4 protein; 
-0.677 NaN* -0.806 -0.795 
2610509104rik 
NM_010358.1 glutathione-s- 
-0.789 -0.516 -0.877 -0.523 
transferase; 
mu 1; gstm 1 
NM_025377.1 riken cdna 
-0.922 NaN* -0.881 -0.728 
111000la07; 
1110001a07rik 
*NaN = Not a Number 
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3.3.3 The Effects of Supercritical CO2 on Important Aspects of Mammalian 
Cell Function 
Retention of functionality in the C2C 12 cell line was assessed by their ability to 
undergo osteogenic differentiation as observed by the expression of alkaline 
phosphatase (Okubo et al, 1999, Han et al, 2003) after a one minute exposure to 
scCO2. Alkaline phosphatase activity was detected using staining and a colorimetric 
assay (see figures 3-4 AlB). Alkaline phosphatase levels, indicated by the red- 
stained cells, were indistinguishable between the untreated control and the scCO2- 
exposed cells after DNA correction. This evidence suggests that the C2C12 cells 
have retained the ability to undergo osteogenic differentiation and therefore an 
important aspect of their function. 
In addition to studies with the C2C12 cell line, primary hepatocytes were treated to 
three scCO2 exposure times (10,30,60 seconds) and assayed for important aspects 
of cytochrome P450 activity. The levels of each metabolite are presented as a 
percentage of an untreated control as detected by HPLC analysis and are seen in 
figure 3-5. These data indicate that several important metabolic functions of 
cytochrome P450 in rats are unaffected by exposure to scCO2 for up to 60 seconds. 
The presence of 6-0-OH testosterone despite scCO2 processing, provides evidence 
for the continued functioning of CYT 3A1. Furthermore, there is no significant 
difference between the increasing exposure times, indicating that this function is 
unaffected after up to 60 seconds exposure to scCO2.2a-hydroxylation in rats also 
appears to be unaffected by this treatment, with no indication of a loss in enzyme 
activity (CYP 2C 11) irrespective of the exposure time. Oxidation of testosterone to 
4-androstene-3,17-dione in rats is predominantly catalysed by CYP 2B I (greater 
than 80%) with minor contributions by CYP 2C 11 and CYP 2B2 (Sonderfan et al, 
1989). Therefore the continued production of this metabolite after scCO2 processing 
also indicates continued function of these three enzymes, although this does appear 
to be reduced after 60 seconds of exposure to scCO2. 
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Figure 3-4 Specific alkaline phosphatase activity of C2C12 cells after scCO2 
processing for one minute as measured by the p-NPP substrate system. Cells were 
both stained (A) and assayed (B) for alkaline phosphatase activity after supercritical 
CO2 processing and subsequent osteogenic culture in cell culture medium containing 
500 ng/ml BMP-2. Mean (n=3) ± SD. 
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Figure 3-5 Assay data measuring the metabolism of testosterone by cytochrome 
P450 activity in rat hepatocytes after scCO2 processing for increasing exposure 
times. The presence of each metabolite is detected by high performance liquid 
chromatography and all data is corrected to recovered DNA. Mean (n=2) ± SD. 
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3.4 Conclusions 
Cell survival data suggests that CO2 under pressure is more damaging than the 
equivalent pressure of N2. However, N2 neither plasticises nor foams amorphous 
polymers and could not replace CO2 in this application. A rise in released LDH also 
suggests that there has been damage to the cell membrane, with the ELISA data 
suggesting that this is not likely to be a result of apoptosis. 
The effects of scCO2 upon relative gene expression were minimal in the C2C12 cell 
line with small down-regulations of survivin, clast4 protein and glutathione-s- 
transferase providing some evidence of subtle changes at the mRNA level that do 
not lead to significant apoptosis. Therefore, this represents an acceptable degree of 
change. Demonstration of the retained osteogenic differentiation capacity of the 
C2C 12 cell line and the activity of CYP450 in hepatocytes after a one minute 
exposure to scCO2 shows retention of receptor, cell pathway and enzyme function. 
In summary, this chapter provides powerful evidence that mammalian cells can be 
processed in scCO, for up to one minute without significant changes in gene 
expression and cell function. 
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Chapter 4 
CO-PROCESSING MAMMALIAN CELLS & POLY(DL- 
LACTIC ACID) IN SUPERCRITICAL CARBON DIOXIDE 
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4.1 Introduction 
With the exception of the work done with micro-organisms (Dillow et al, 1999) 
there has been no documented evidence describing the co-processing of mammalian 
cells with synthetic polymers under high pressure or otherwise. However, as 
previously discussed, synthetic polymers have been mixed with sensitive biological 
species such as nucleic acids, proteins and growth factors under high pressure or 
supercritical CO2 conditions and co-processed into porous controlled release devices 
(Shea et al, 1999, Howdle et al, 2001, Watson et al, 2002, Yang et al, 2003b, Yang 
et al, 2004). In all of these studies, the amorphous PDLLA has been used either 
individually or as part of the PLGA co-polymer, as a cell support and or controlled 
release device for tissue engineering and drug delivery applications. Poly(DL-lactic 
acid) fulfils most of the desirable criteria as a support for cellular attachment as it is 
non-toxic, economical and biodegradable. Most importantly however, scCO2 is 
highly soluble in PDLLA at ambient temperatures facilitating the plasticisation and 
foaming of the polymer without toxic solvents or chemical foaming agents. 
Therefore PDLLA was selected as the most suitable choice of polymer for this 
application. 
4.1.1 Characterising Tissue Engineering Scaffolds 
A number of techniques have been used to characterise tissue engineering scaffolds 
and ensure that they are fit for purpose. The type of technique/test used is largely 
dependent upon the material and the application. Properties such as low toxicity, 
biodegradability and biocompatibility are generally considered to be pre-requisites 
for most tissue engineering applications. However, the desired levels of porosity, 
pore size and mechanical strength are largely dependent upon the cell or tissue type 
and final use of the scaffold. Most scaffold characterisation techniques focus on 
measuring these parameters as they often govern the success or failure of any tissue 
engineering device. 
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This scCO2 techniques discussed in this study (Howdle et al, 2001, Yang et al, 
2004) have never previously been used to fabricate PDLLA scaffolds using the short 
processing times imposed by mammalian cell survival in scCO2. Thus, it was 
necessary to confirm that solid 3D porous structures could be formed using such 
truncated processing times and that these structures could support cell attachment 
and growth over days and weeks. To further assess the properties of these scaffolds, 
basic information on the gross morphology, porosity and pore size distribution of the 
scaffolds was required. A number of methods can be used to assess the porosity and 
pore architecture of tissue engineering scaffolds. In this study, three techniques were 
chosen that are commonly used in tissue engineering applications: light microscopy, 
scanning electron microscopy and micro computed tomography. 
4.1.1.1 Light and Fluorescent Microscopy 
Light microscopy is a simple technique that can provide a two dimensional image of 
an object. In terms of scaffold characterisation this technique is very limited, but it is 
useful as a quick and simple method of observing the gross morphology of scaffolds 
and has the added advantage of providing colour images. When fluorescent light is 
added to a sample of interest that has been impregnated or tagged with a fluorescent 
marker, the microscope can be used to select this fluorescent marker against the 
background. As a result, fluorescence microscopy has been used in tissue 
engineering applications (Patz et al, 2005). 
4.1.1.2 Scanning Electron Microscopy 
Scanning electron microscopy (SEM) is a commonly used characterisation technique 
for tissue engineering and drug delivery applications (Mooney et a!, 1996a, Howdle 
et a!, 2001). SEM works by passing a concentrated beam of electrons through an 
electrically charged (gold coated) sample, whilst under vacuum. This beam is 
focussed by a series of lenses to displace secondary electrons in the sample, which 
when counted and detected, build up into a topographical image of the specimen. 
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Because the SEM has a relatively high resolution (2 nm) when compared to the light 
microscope (approximately 0.2 µm) it can provide a more detailed 2D image of 
scaffold pore structure at high magnification, as shown in figure 4-1. As a result, the 
pore size and morphology of tissue engineering scaffolds or micro/nano particles can 
be determined (Howdle et al, 2001, Whitaker et al, 2005). In addition to this, SEM is 
also an effective way to show the distribution of mammalian cells that have been 
seeded onto polymer scaffolds for tissue engineering applications (Murphy et a!, 
2000, Unsworth 2003). However, SEM is limited as it can only provide a 2D, grey 
scale image of the scaffold topography. 
4.1.1.3 Micro-Computed Tomography 
Micro-computed tomography (p-CT) is a non-destructive, non-invasive technique 
that uses a sealed x-ray source to produce both 2D and 3D images of porous 
structures (see figure 4-2). The x-rays are passed through the scaffold and isotropic 
slice data are obtained and reconstructed into 2D images, which are compiled and 
analysed to generate 3D images and obtain quantitative morphological detail. This 
gives it several advantages over SEM as a technique for the characterisation of tissue 
engineering scaffolds. Micro-CT has frequently been used to examine porous 
ceramic and polymeric structures and found particular application in orthopaedic 
tissue engineering strategies as it can be used to measure and quantify bone repair 
(Cartmell et al, 2004, Lin et al, 2003). In addition, organic matter within porous 
scaffolds can be visualised by staining with x-ray absorptive agents that provide 
contrast in the resulting tomograms (Thurner et al, 2003, Thurner et al, 2004). 
Therefore, the distribution of cells within porous scaffolds can be assessed by pre- 
staining samples with electron dense chemicals. 
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Figure 4-1 A typical SEM image showing the internal pore structure of a PDLLA 
scaffold fabricated using scCO2 processing at the University of Nottingham. Note 
the presence of both open (A) and closed (B) pores. Open pores are so-called as they 
are connected to others permitting the passage of nutrients and gaseous exchange 
unlike closed pores which are isolated from the rest of the porous structure. The pore 
window size (C) is defined as the diameter across the opening of the pores and does 
not take into account the size of the channel itself due to the limitations of the 2D 
image. 
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Figure 4-2 Micro-computed tomography images of PDLLA scaffolds fabricated by 
scCO2 processing at the University of Nottingham. X-rays passed through the 
sample produce 2D contours or slices (A) that can be compiled into 3D images (B) 
by the computer software. 
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4.1.2 Aims 
The initial aim of this chapter was to show that porous PDLLA scaffolds could be 
fabricated in the short time periods already dictated by mammalian cell survival. 
However, the main aim was then to investigate the effects of mixing mammalian 
cells with PDLLA and exposing the mixture to sCCO2. There were three main 
objectives within the main aim: (i) to show that cells are evenly distributed 
throughout the scaffolds, (ii) to show that mammalian cells survive the process 
(short term and long term) and adhere to the porous structures and (iii) to show that 
cells remain functional despite this mixing process. 
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4.2. Methods 
4.2.1 Fabrication of PDLLA Scaffolds 
The full method for scaffold fabrication can be found in the materials and methods 
chapter (section 7.2.2). In brief, PULA (100 mg) was weighed out into PTFE 
moulds in triplicate and processed in a 60 ml clamp sealed pressure vessel using 
scCO2 (74 bar, 35°C) for 10,30 and 60 seconds, with an additional 40 seconds 
required for both compression and decompression. This process was repeated three 
times for each sample and a sample from each replicate was used for light 
microscopy, SEM or t-CT analysis. 
4.2.2 Characterisation of PDLLA Scaffolds 
After fabrication, macroporous PDLLA scaffolds were characterised by a variety of 
overlapping imaging techniques. 
4.2.2.1 Light and Fluorescence Microscopy 
Scaffolds were prepared and visualised using the protocol found in the materials and 
methods chapter (section 7.7.1). In brief, scaffolds were cut transversely using a 
scalpel, placed on a white background for contrast and the cross sections imaged 
using a light microscope (Nikon, SMZ1500). 
4.2.2.2 Scanning Electron Microscopy 
Samples were prepared for non-biological SEM and scanned as described in the 
materials and methods chapter (section 7.7.2). Briefly, scaffolds were gold coated 
(Baltzers union, SCD030 sputter coater) before being scanned at 15-20 kV using a 
Philips 505 scanning electron microscope. The average pore window size (diameter) 
was calculated from three scaffolds at each processing time by taking 50 random 
pore measurements and calculating the mean for each scaffold. Histograms of the 
frequency of pores within each range were constructed to determine the pore size 
distribution. 
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4.2.2.3 Micro-Computed Tomography 
The process of scanning the polymer scaffolds using p-CT is described in the 
materials and methods chapter (section 7.7.3). Briefly, scaffolds were scanned at 
55kV and a current of 145mA using a high resolution micro-computed tomography 
system (µ-CT 40, Scanco Medical, Bassersdorf, Switzerland). Calculations were 
performed by the Scanco software provided to attain the pore size distribution and 
total porosity for each scaffold. 
4.2.3 Investigation of the Cell/Polymer Mixing Technique 
As there is no mixing of the polymer and cell components under pressure, the 
presentation of the cells to the polymer powder is vital to ensure that the cells are 
incorporated into final product. Therefore the value of pre-mixing the two 
components was assessed in terms of the distribution of the suspension in the 
foamed scaffold. 
4.2.3.1 Investigating the Effects of Pre-Mixing a Liquid Dye and POLLA Powder 
on the Final Distribution of the Dye in the Scaffold 
The distribution of both mixed and unmixed cell suspensions in the final scaffold 
were compared using a dead cell suspension and food dye. Dead C2C 12 cells were 
collected and a cell count was carried out using trypan blue exclusion as described in 
the materials and methods chapter (section 7.1.3) to make a stock solution of 1 
million cells per ml, which was then re-suspended in complete DMEM (2 ml). A 
black food dye was then added to the cell suspension to provide contrast against the 
white polymer. 100 mg of PDLLA powder was then weighed out into 8 PTFE moulds 
and 200 µl of the cell suspension was either dropped into each well, or mixed into 
the polymer powder with a small spatula to make a polymer/cell slurry (250,000 
cells per well). The cell/polymer mixtures were then processed in scCO2 and 
observed using light microscopy. 
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4.2.3.2 Investigating the Effects of Pre-Mixing Cells Fixed with Osmium 
Tetroxide and PDLLA Powder on the Final Distribution of the Cells in the 
Scaffold 
To show the actual distribution of the cells, live C2C 12 cells were fixed in osmium 
tetroxide to show a contrast against the polymer. Fixing the cells in osmium 
tetroxide increases their electron density, allowing them to be contrasted against the 
less electron dense polymer when scanned with the p-CT system. C2C12 cells were 
trypsinised and a small sample removed for fixing with 10% formyl saline (Sigma) 
and then with 1% osmium tetroxide (Fisher, UK) overnight. This cell suspension 
(200 µl) was then taken and mixed with the polymer as described in section 4.2.3.1. 
This mixture was then processed in scCO2 and kept for p-CT analysis. 
4.2.3.3 Co-processing Dead and Fixed Cells with PDLLA in Supercritical CO2 
The cells were co processed with the polymer at 74 bar and 35°C as previously 
described in 4.2.1, for 30 seconds with an additional 40 seconds required for both 
compression and decompression. After processing the foamed constructs were 
subject to analysis by either light microscopy or µ-CT. 
4.2.3.4 Light Microscopy Analysis 
Scaffolds loaded with food dye were viewed under the light microscope to enable 
comparison between the distribution of the dye in mixed and non-mixed samples. 
Scaffolds were captured by a digital camera to show their gross morphology and 
then cut transversely to show the distribution of the food dye within. The full 
protocol for light microscopy can be found in the materials and methods chapter 
(section 7.7.1). 
4.2.3.5 Micro-Computed Tomographic Analysis of Cell Loaded Scaffolds 
The construct was imaged using a high-resolution micro computed tomography 
system (µ-CT 40, Scanco Medical, Bassersdorf, Switzerland) set to a voltage of 55 
kV and a current of 145 mA. 
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Samples were scanned at 8 µm voxel (3D pixel) resolution with an integration time 
of 120 ms to produce 3D reconstructed images. The cell-loaded scaffolds were 
thresholded at 60 (an arbitrary number) to view the porous scaffold and then at 190 
to view the osmium stained cells contained within. 
4.2.4 Co-Processing Live Cells with PDLLA 
4.2.4.1 Cell Isolation and Culture 
Murine C2C12 cells, 3T3 fibroblasts, rat hepatocytes and ovine fibrochondrocytes, 
were isolated and/or cultured as described in the materials and methods chapter 
(sections 7.1.1 and 7.1.2). A viable cell count was carried out with trypan blue to 
achieve a suitable concentration of cells in suspension, as described in the materials 
and methods chapter (section 7.1.3). 
4.2.4.2 Fabrication of Cell-Loaded PDLLA Scaffolds using Supercritical CO2 
All four mammalian cell types were used for the investigation as detailed in chapter 
2. The cell suspensions (250,000 cells in 200 µl) were mixed with the polymer (100 
mg) using the technique described in section 4.2.3.3. The cell/polymer slurries were 
then processed in scCO2 (74 bar and 35°C) for 30 seconds, with an additional 40 
seconds required for compression and decompression (80 seconds in total). After 
processing the foamed constructs were cut into 4 equal pieces, cultured in complete 
medium for 24 hours and analysed using a variety of techniques. 
4.2.4.3 Assessment of Cell Survival in PULLA Scaffolds 
All cell types loaded onto PDLLA scaffolds were assayed for continued metabolic 
activity using the Alamar BlueTM assay (see materials and methods chapter, section 
7.3.1) and compared to untreated controls to provide some quantitative data. Briefly, 
media was aspirated from the processed cells after 24 hours in culture and replaced 
by lml solution of 10% Alamar Blue TM solution (v/v; Serotech Ltd UK) in, phenol 
red-free HBSS, Sigma UK). The cells were incubated for 90 minutes before 200 µl 
of solution from each well was transferred to a 96-well plate (Falcon). 
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Fluorescence readings were then obtained at an emission wavelength of X590 nm 
using X560 nm excitation. After processing Scaffolds containing C2C 12 cells 
cultured for 34 hours in complete DMEM were stained for continued cell survival 
using the LIVE/DEADTM stain (Molecular Probes, UK) at days I and 28 as 
described in the materials and methods chapter (section 7.6.1). Briefly, The cells and 
polymers were incubated in 10 ml of complete DMEM containing 20 µl of Ethidium 
Homodimer-1 (to highlight the dead cells red) and 5 µl of Calcein AM (to highlight 
the live cells green) for 1 hour. The cells were then rinsed (x4) in phosphate buffered 
saline (PBS) for 1 hour, before being observed using fluorescence microscopy 
(Leica DM IRB). 
4.2.4.4 Histological Assessment of Cell Survival and Distribution 
In order to observe the presence and viability of cells in the centre of the constructs, 
the cell loaded scaffolds were prepared for histology as described in the materials 
and methods chapter (section 7.6.2) Briefly, the cell loaded scaffolds were fixed in 
70% methanol for 30 minutes, before drying overnight and subsequent infiltration 
with 65°C paraplast wax (Sigma UK). Sections (10 µm) were then cut using a 
microtome and observed using a fluorescence microscope for either propidium 
iodide stained nuclei (for identification of the cells location within the scaffolds) or 
for LIVE/DEADTM stained cells (to show location and metabolic activity). 
4.2.4.5 Scanning Electron Microscopy of Cell Loaded PDLLA Scaffolds 
Scanning electron microscopy was used to observe the cells attaching to and 
spreading on, the surfaces of the scaffolds after supercritical processing. The 
scaffolds loaded with C2C 12 and 3T3 fibroblasts were prepared for biological SEM 
as described in the materials and methods chapter (section 7.7.2). The samples were 
then gold coated, using a Balzers Union SCD030 sputter coater, before being 
scanned at 20 kV with a Philips 505 scanning electron microscope. 
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4.2.5 Assessment of Cell Function using BMP-2 Induced Alkaline Phosphatase 
Activity 
For functional assessment, an alkaline phosphatase stain and assay was carried out 
on scCO2 processed scaffolds loaded with C2C12 cells after BMP-2 induced 
osteogenic differentiation. Two methods were used to deliver the BMP-2 to the cells. 
In the first method, BMP-2 was delivered to pre-fabricated cell loaded scaffolds by 
culturing the cell loaded scaffolds in DMEM containing 500 ng/ml of BMP-2 for 
seven days. In addition, a second method was used whereby the growth factor was 
included in the fabrication process along with the cells. The use of a one-step scCO2 
processing technique for the production of PDLLA scaffolds loaded with BMP-2 has 
already been reported (Yang et al, 2003b, Yang et al, 2004). Here, C2C 12 cells were 
mixed with PDLLA pre-loaded with BMP-2 to demonstrate the possibility of a 
complete tissue engineering construct in a single step. 
4.2.5.1 Addition of BMP-2 after Scaffold Fabrication 
Cell loaded scaffolds were fabricated by using the method described in 4.2.4.2 and 
cut into four pieces. After 24 hours culture in complete DMEM, the scaffolds were 
cultured for a further seven days in osteogenic DMEM containing 500 ng/ml BMP- 
2. 
4.2.5.2 Addition of BMP-2 before Scaffold Fabrication 
Before the cells could be processed with the polymer, the BMP-2 was adsorbed onto 
the surface of the polymer particles by using a freeze drying process. The BMP-2 (3 
pg) was suspended in 600 pl added to 600 mg of PDLLA powder and placed into 6 
wells of a PTFE plate to give 100 mg PDLLA/500 ng BMP-2 per well. The 
polymer/protein mixtures were then frozen in liquid nitrogen and freeze dried 
overnight to adsorb the protein to the polymer particles. The cell loaded scaffolds 
were fabricated by using the method described in 4.2.4.2 and cut into four pieces 
before seven days culture in complete DMEM. 
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4.2.5.3 Assay and Stain for Alkaline Phosphatase Activity 
After removal from the scaffolds, C2C12 cells were also assayed for alkaline 
phosphatase activity using the method described in the materials and methods 
chapter (section 7.4.2). Briefly, cell cultures were fixed in 75% ethanol for 10 
minutes and homogenized in 600 µl of distilled water containing 0.001% Tween 
detergent after 3 cycles of freeze-thawing. The substrate (p-nitrophenyl phosphate) 
(p-NPP) was added to equal volumes of the cell samples, incubated at 37°C for I 
hour and the rate of conversion into p-nitrophenol (p-NP) measured by a change in 
fluorescence at 405 nm. Values were compared against known p-NP standards with 
DNA correction. 
As a further measure of the osteogenic status of C2C 12 cells, a red color substrate 
was precipitated on the cells by the action of cellular alkaline phosphatase activity. 
The substrate system comprised of Napthol AS-MX buffer solution containing I 
mg/ml Fast Violet B salt, as described previously by Oreffo and co-workers (Oreffo 
et al, 1998). This technique is described in full in the materials and methods chapter 
(section 7.4.3). 
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4.3 Results & Discussion 
4.3.1 Characterisation of PDLLA Scaffolds Fabricated in Supercritical CO2 
Polymer processing time limitations imposed by cell survival only permitted the 
fabrication of PDLLA scaffolds over 10,30 and 60 seconds with an additional 80 
seconds for compression and decompression. Cross sectional images of these PDLLA 
foams can be seen in figure 4-3. These images confirm that even over short sCCO2 
exposure times, highly porous structures can be produced. These macroporous 
structures are highly heterogeneous with a non-uniform morphology. The SEM 
images in figure 4-4 also show that there are many closed pores indicating limited 
interconnectivity and little similarity in pore structure between the samples. This 
heterogeneity and limited interconnectivity is likely to be due to the limited 
processing pressure and perhaps more crucially, processing time (Goel & Beckman, 
1994a, Parks et al, 1996). Despite this, the data in table 4-1 shows that the scaffolds 
have a high level of porosity (82-88%) with no significant difference between the 
scaffolds exposed to sCCO2 for 10,30 and 60 seconds. The pore size measurements 
are in excess of 500 µm for each scaffold, providing large areas in which cells could 
attach and interact, although a lack of interconnectivity may restrict any interaction 
between pores. The mean pore size for each scaffold is highly variable, as previously 
suggested by the microscopic images and is partially dependent upon the method 
used to calculate it. The mean pore sizes calculated from µ-CT are lower than those 
observed on the SEM images. Because the µ-CT does not use a subjective method of 
calculating pore size, many of the smaller pores that are not visible on the SEM, 
have been included in the calculation. As a result, these pore size measurements are 
more likely to be an accurate representation of the actual values. The pore size 
distribution data in figures 4-5 & 4-6 indicates that there is a broad range of pore 
sizes with a lot of similarity in the patterns for both Ii-CT and SEM data. Such a 
large pore size range is likely to be a result of the fast decompression rate, which has 
previously been shown to provide control over pore size and distribution (Howdle et 
al, 2001, Watson et al, 2002). 
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Figure 4-3 Images of PDLLA scaffolds taken using a light microscope after scCO2 
processing for 10,30 and 60 seconds (A, B and C respectively) at 74 bar, 35°C. 
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Figure 4-4 Scanning electron micrographs of PDLLA scaffolds after scCO2 
processing for 10,30 and 60 seconds (A, B and C respectively) at 74 bar, 35°C. 
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Table 4-1 A summary of pore size and porosity data for PD LA scaffolds after scCO2 
processing at 74 bar and 35°C. All data is given with standard deviation. 
Processing time at 74 bar Porosity (%) Average pore Average pore 
(IA-CT) size size 
µ-CT (µm) SEM (µm) 
10 seconds 82±12 623±120 723±205 
30 seconds 88±14 589±103 603±189 
60 seconds 88±12 604±109 685±187 
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Figure 4-5 Pore size distributions calculated from SEM for PDLLA scaffolds after 
scCO2 processing for up to 60 seconds at 74 bar, 35°C. 
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Figure 4-6 Pore size distributions calculated from µ-CT for PDLLA scaffolds after 
scCO2 processing for up to 60 seconds at 74 bar, 35°C. 
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4.3.2 Investigation of the Polymer/Cell Mixing Technique 
The effect of pre mixing PDLLA granules with a food dye solution can be seen in 
figures 4-7 & 4-8. The darker scaffolds (mixed) in figure 4-7 (A & B) indicate a 
better distribution of the dye throughout the polymer foam when compared to the 
un-mixed scaffolds (C & D). It appears that when the solution is dropped into the 
polymer granules there is little or no mixing between the two components when the 
polymer is subsequently plasticised in scCO2. This is further shown by the light 
microscope images in figure 4-8A and B where the dye is only present in the upper 
part of the scaffold, unlike the mixed scaffolds in figure 4-8C and D. Therefore some 
small amount of mixing between the two components before supercritical processing 
appears to provide a more homogeneous distribution of the liquid throughout the 
scaffold. 
Cells stained with osmium tetroxide were pre-mixed with the PDLLA granules, 
processed in scCO2 and the resultant foam imaged using g-CT (figure 4-9). The µ- 
CT image of a cross section through the porous scaffold (on the left) shows that the 
cells (on the right) are well distributed throughout the structure. A greater proportion 
of the cells appear to be present at the base of the scaffold which is most likely a 
result of gravity and the foaming of the scaffold over the top of the suspension. 
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Figure 4-7 Gross morphology of PDLLA scaffolds showing the effects of pre-mixing 
the polymer powder with a food dye solution on the final distribution of the liquid in 
the foamed scaffold. Scaffolds A&B show the result of pre-mixing the two 
components whereas scaffolds C&D show the final scaffolds after no pre-mixing 
took place. 
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Figure 4-8 Cross-sections of pre-mixed and unmixed PDLLA/food dye scaffolds as 
viewed on the light microscope. The dark areas at the top of scaffolds A&B 
(unmixed) indicate the need for pre-mixing the solution with the polymer as shown 
in scaffolds C&D where there are clear patches of black dye present in the central 
areas of the structures. 
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Figure 4-9 Distribution of pre-mixed, osmium stained cells (right) in a PDLLA 
scaffold (left). Note: the cells have been visually enhanced to show the distribution 
more clearly. 
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4.3.3 Confirmation of Cell Attachment and Survival in PDLLA Scaffolds 
When the polymer/cell mixing experiment was repeated with live 3T3 fibroblasts, 
attached and spreading cells were observed on the interior and exterior of the PDLLA 
scaffolds using scanning electron microscopy (figure 4-10). These images confirmed 
that cells could not only survive when co-processed with the polymer, but also attach 
and spread on the surfaces. However, to quantify this cell survival, an Alamar 
B1ueTM metabolic activity assay was carried out for the PDLLA scaffolds loaded with 
4 different cell types (figure 4-11). Alamar BlueTM data indicates that cells do 
remain metabolically active after co-processing with PDLLA in scCO2 and that there 
are no obvious differences between the cell types. These survival rates are lower 
when than that of cells processed for the same time period (30 seconds) without 
PDLLA as previously discussed in chapter two. However, this result may not be a 
true indication of cell survival due to several limitations imposed by the co- 
processing of the polymer and cells. A visible lack of interconnectivity within the 
scaffolds caused by the formation of closed pores may have limited the cells contact 
with the Alamar BlueTM solution. In addition, the physical process of cutting the 
scaffolds before cell attachment may have reduced the cell numbers. The control cell 
samples were not co-processed with the polymer and did therefore not suffer from 
any of these limitations, possibly skewing the cell survival rates further. 
As an additional method of confirming metabolic activity in the short term and in the 
long term, PDLLA scaffolds loaded with C2C12 cells were cultured in the 
LIVE/DEADTM stain after supercritical processing (figure 4-12). The images taken 
at 24 hours and 6 weeks clearly show a large population of live cells (green) after 
processing into PDLLA scaffolds. Histological sections of cell loaded scaffolds show 
that this survival and distribution is not restricted to the outer surfaces of the 
scaffolds (see figure 4-13). Sections stained for (A) propidium iodide and (B) 
LIVE/DEADTM indicate the presence of both cell nuclei and live cells respectively, 
on the internal surfaces of the scaffolds. 
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Figure 4-10 SEM images of 3T3 fibroblasts spreading on PDLLA scaffolds. These 
images clearly show that the cells are attached to both the external (A & B) and 
internal (C) surfaces. 
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Figure 4-11 Survival data for four cell types after processing into PDLLA scaffolds 
using scCO2 for 30 seconds as measured by an Alamar Blue assay. Mean (n=4) f 
SD. 
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Figure 4-12 Images of cell loaded PDLLA scaffolds processed in scCO2 and stained 
with LIVE/DEADTM. Live cells (green) are clearly more abundant than dead cells 
(red) after 24 hours (A) and 6 weeks (B) in culture. 
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Figure 4-13 Thin cut sections of PDLLA scaffolds loaded with C2C12 cells using a 
one-step scCO2 process. Cells are clearly visible on the internal surfaces of the 
scaffolds using (A) the propidium iodide stain for cell nuclei (red) and (B) the 
LIVE/DEADTM stain for cytotoxicity (green indicates live cells and red indicates 
dead cells). 
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4.3.4 Confirmation of Alkaline Phosphatase Activity in Cell Loaded Scaffolds 
Confirmation of osteogenic differentiation on cell loaded scaffolds can be observed 
in figures 4-14,4-15 and 4-16. The data in figure 4-14 shows the result of an assay 
carried out on the cell loaded scaffolds, whereby alkaline phosphatase expression (in 
the form of the p-NP end product) was compared to a series of controls. These data 
indicate an indistinguishable level of alkaline phosphatase between the cell-loaded 
scaffolds (cultured in osteogenic medium) and the scCO2 processed cells without 
PDLLA. This suggests that presence of the polymer did not impair cellular alkaline 
phosphatase activity any more than the effects of sCCO2 alone (when corrected to the 
levels of DNA retrieved). An alternative method that has already been used to 
successfully control the release of proteins including BMP-2 (Howdle et al, 2001, 
Yang et al, 2003) was also used to induce osteogenic differentiation on PDLLA 
scaffolds. Here the BMP-2 was adsorbed onto the PDLLA powder and pre-mixed 
with C202 cells before processing into porous foams using scCO2. The levels of 
alkaline phosphatase activity in these scaffolds are significantly lower than in the 
scaffolds that were cultured in an osteogenic medium (figure 4-14). The images in 
figures 4-15 and 4-16 further demonstrate this reduced osteogenic effect, with 
visibly less red-stained areas in the BMP-2 loaded scaffolds. This would further 
indicate that the technique of adsorbing the protein onto the PDLLA and thus, 
allowing release to be controlled by the porous structure, induces a reduced 
osteogenic response. However, this has previously been shown to be a very effective 
method of inducing an osteogenic response from PDLLA scaffolds as the BMP-2 
activity is not significantly reduced by the sCCO2 process (Yang et al, 2003b, Yang 
et al, 2004). It is possible that the limitations of the PDLLA scaffolds made using the 
truncated processing times (as previously discussed) have prevented BMP-2 gaining 
sufficient access to the cell population to induce the same osteogenic response. 
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Figure 4-14 Confirmation of alkaline phosphatase activity in PDLLA scaffolds loaded 
with C2C12 cells using a one-step scCO2 process after induction into the osteogenic 
lineage with 500 ng/ml rhBMP-2. Mean (n=3) ± SD. * indicates p<0.05 using T-test. 
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Figure 4-15 Visual confirmation of alkaline phosphatase activity in PDLLA scaffolds 
loaded with C2C12 cells using scCO2 after subsequent osteogenic culture in 500 
ng/ml rhBMP-2. Alkaline phosphatase activity is shown by the precipitation of a red 
colour substrate indicated by the arrow, compared to a scaffold without cells (inset). 
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Figure 4-16 Confirmation of alkaline phosphatase activity in PDLLA scaffolds loaded 
with C2C 12 cells and 500 ng of rhBMP-2 using scCO2 processing. The precipitation 
of a red colour substrate is indicated by the arrow and compared to a scaffold 
without cells (inset). 
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4.4 Conclusions 
It has been demonstrated that solid, porous PDLLA scaffolds can be produced using 
truncated processing times and reduced pressures, compared to previous studies 
(Howdle et al, 2001, Watson et al, 2002). The final scaffold characteristics are not 
necessarily suitable for tissue engineering applications although this is due to the 
limited processing conditions imposed by the survival of mammalian cells as 
discussed in chapter two. A more significant result is the survival of cells when co- 
processed into these porous structures, indicating the feasibility of a scCO2-based 
one-step scaffold seeding process. In addition to surviving the process, the cells were 
also shown to be evenly distributed throughout the porous scaffolds despite minimal 
levels of mixing. 
Perhaps most remarkably, the attached C2C 12 cells have been able to undergo 
osteogenic differentiation when prompted with BMP-2 before and after processing 
into the PDLLA scaffold. Thus, it has been shown that growth factors, mammalian 
cells and polymer powder can be processed into 3D, cell loaded constructs by using 
a single scCO2 processing step. By addressing the limitations of the polymer 
processing time, this method could be used to produce cell loaded scaffolds for 
tissue engineering purposes. In this way, the exposure of the cells to the scCO2 must 
be minimised, whereas the exposure of the polymer needs to be maximised. This 
way, the scaffold properties can be tuned to fit the application and cell survival is 
optimised. This could not be achieved with the equipment used thus far. Therefore 
some modification to the high pressure apparatus was required to facilitate this. 
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Chapter 5 
PASSING MAMMALIAN CELLS INTO PLASTICISED 
POLY(DL-LACTIC ACID) USING A HIGH PRESSURE 
CARBON DIOXIDE INJECTION SYSTEM 
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5.1 Introduction 
When fabricating scaffolds using scCO2, both the pressure and the exposure time are 
directly linked to the level of porosity and interconnectivity in porous polymer 
materials as previously discussed (Goel & Beckman, 1994a, Goel & Beckman, 
1994b, Park et al, 1995, Baldwin et al, 1995). By increasing the pressure/processing 
time, the level of soluble gas molecules in the polymer can also be increased, 
preventing the depletion of dissolved gas in the regions around the nucleating pores 
and allowing the pores to become interconnected during decompression. These are 
desirable properties in tissue engineering scaffolds as they permit cellular interaction 
and the passage of nutrients to surrounding cells and tissues (Mooney et al, 1996). It 
was therefore important to devise a new method of delivering the cells to the 
polymer at a later stage of the fabrication process. This would allow the polymer 
processing time to be extended indefinitely and the exposure of cells to high 
pressure CO2 to be minimised. Thus, a new piece of equipment had to be designed in 
order to achieve this. 
5.1.1 Designing the Cell Injection System 
The equipment used for the cell injection system was based on the high pressure 
CO2 apparatus already used in this study. The cells and the polymer were still 
processed together inside a 60 ml pressure vessel before controlled decompression 
with a back pressure regulator. However, a mechanism for delivering the cells into 
the pressure vessel was required along with the apparatus to facilitate this. As a 
result, there were three main challenges associated with delivering the cells into a 
high pressure environment, as described overleaf. 
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1. The cells had to be delivered into the polymer under pressure (in a plasticised 
state). This involved using a mechanism of delivery that would allow the 
cells to be passed from atmospheric pressure into the pressurised vessel. This 
had to be carried out without compromising both safety and cell survival. 
2. Once inside the vessel, the cells had to be delivered to, and penetrate, the 
surface of the plasticised polymer which was likely to be considerably more 
viscous than the cell suspension. 
3. The cell/polymer mixture had to be contained within a suitable mould that 
would allow the quick and easy removal of the cell loaded scaffolds upon 
decompression. 
Points one and two provided the biggest challenge due to the delicate nature of the 
cells. Therefore, to avoid any further complications it was decided that high pressure 
gas should be used to inject the cells into the vessel. The theory was that by storing a 
reservoir of CO2 or N2 set at a higher pressure than that in the vessel containing the 
plasticised polymer, the pressure differential would force the cell suspension into the 
vessel through a piece of tubing. Because frequent re-designing and building of the 
apparatus was required in this chapter, many small changes were made to the 
experimental methods along the way. Therefore, the whole process was split into the 
three distinct stages with each step broken down for optimisation. The original set up 
for the high pressure injection equipment can be seen in figure 5-1. 
5.1.2 Aims 
The central aim of this final experimental chapter was to provide evidence for a new 
technique that would allow mammalian cells to be incorporated into the scaffold 
fabrication step with cell survival and functionality retained in the final foamed 
structure. Within this main aim, there were three smaller objectives; (i) to show that 
this mechanism can be used to deliver cells efficiently into the desired mould, (ii) to 
show that cells can survive and retain important aspects of functionality despite this 
high pressure injection process and (iii) to provide evidence for continued cell 
survival/functionality within the foamed scaffold. 
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Figure 5-1 Original set-up for the high pressure CO2 injection system. The gas 
reservoir was pressurised along with the 60 ml collection vessel. The cell suspension 
was stored in the '/ inch stainless steel sample tubing before being injected into the 
high pressure vessel by opening valves A and B and passing through the '/ inch 
tubing. Once inside the vessel, the pressure was quenched and the cell suspension 
collected. 
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5.2 Methods 
5.2.1 Testing the Injection Mechanism with Dead Cells 
In the first of three sub sections describing the progression of this technique, the 
initial priority was to test the delivery mechanism with a series of simple 
experiments. 
5.2.1.1 Preparation of Dead C2C12 Cells for Injection Experiments 
Murine C2C 12 cells were cultured as described in the materials and methods chapter 
(section 7.1.1) over a number of weeks with all dead cells collected and kept for trial 
injection experiments. A trypan blue cell count was carried out to confirm that the 
cells were both dead and in sufficient number for the experiment as described in the 
materials and methods chapter (section 7.1.3). These cells were re-suspended in 
complete DMEM to retain the correct viscosity of a live cell suspension. 
5.2.1.2 Delivering Cell Suspensions into the 60 ml Vessel using High Pressure 
C02 
In order to show that liquids can be passed through the tubing and reach the 
collection vessel with the use of high pressure, it was important to carry out a simple 
experiment using a liquid suspension. Dead C2C 12 cells (250,000) were added to 
200 µl of DMEM in order to make a realistic suspension that could be passed 
through the injection system. The cells were added to the sample tubing and the 
valves either side closed. The vessel was heated to 35°C and kept at atmospheric 
pressure. The gas reservoir was then pressurised with 5,37 and 74 bars of CO2 and 
the valves opened sequentially (A then B) to allow the CO2 to pass through the 
sample tubing and pass into the vessel, carrying the dead cell suspension. The 
system was decompressed immediately and the volume of liquid retrieved from the 
vessel was then recorded as a mean percentage of the initial volume. 
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5.2.1.3 Delivering Cell Suspensions into a High Pressure CO2 Environment 
To find the minimum pressure differential required to allow the cells to reach the 
vessel the cells were injected at three different pressures with the pressure in the 
collection vessel altered accordingly. Dead C2C 12 cells (250,000) were suspended 
in 200 pl DMEM and added to the sample tubing and the gas reservoir was 
pressurised to 5,37 and 74 bars of CO2 as in 5.2.1.2 The pressure inside the vessel 
was increased to equal that of inside the injection reservoir and then reduced to 
pressures that were 1 and 5 bars lower (see processing matrix 
- 
table 5-1). The vessel 
was heated to 35°C and the cell suspension was then injected at each pressure by 
opening the 2 valves sequentially (A then B). The valves were then closed and the 
decompression stage (40 seconds) was started after 10 seconds at maximum 
pressure. The volume of liquid retrieved from the vessel was then recorded as a 
percentage of the initial volume injected. 
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Table 5-1 Processing matrix for the injection of cells into reduced pressures with 
C02- 
Injection pressure (bar) Vessel pressure Vessel pressure 
-1 (bar) -5 (bar) 
540 
37 36 32 
74 73 69 
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5.2.1.4 Delivering Cell Suspensions into a Collection Mould using High Pressure 
C02 
Although a 60 ml vessel was used in the previous experiment, it was considered that 
such a relatively large volume may be an inefficient way to collect the sample, with 
to large a surface area. Therefore, it was decided that a smaller collection mould 
would be beneficial in terms of retaining the maximum amount of cell suspension 
after injection. It also facilitates the formation of a PDLLA scaffold with the desired 
morphology by restricting the foaming to a pre-defined shape. For these reasons, the 
equipment was modified in order to facilitate a collection mould (see figure 5-2). A 
thick walled mould was designed from PTFE (see figure 5-3) to provide a collection 
volume of 15 ml. It was considered that the hydrophobic surface combined with the 
smaller volume would facilitate improved sample recovery. A piece of '/8" piping 
was passed down through a drilled hole (3 mm wide at the top) in the thick 
surrounding wall of the mould to allow the cell suspension to reach the bottom of the 
mould. Furthermore, the bottom of the mould was removable to allow easy sample 
collection after decompression. The mould was then placed into the vessel and the 
dead C2C12 cells (250,000 suspended in 200 pl DMEM) were loaded into the 
sample tubing. A pressure difference of one bar was used between sample injection 
(5,37 and 74 bar) and the collection vessel (4,36,73 bar). The collection vessel was 
heated to 35°C and the cell suspension was then injected at each pressure by opening 
the two valves (A & B). The valves were then closed and after 10 seconds at 
maximum pressure, the system was decompressed over 40 seconds. The volume of 
liquid retrieved from the vessel was then recorded as a percentage of the initial 
volume injected. 
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Figure 5-2 Modifications made to the high pressure CO2 injection system in order to 
incorporate a collection mould. The bottom of the mould had a diameter of 15 mm 
with a think wall surrounding it through which the cell delivery tubing was passed. 
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Connected to the 
injection pipe 
Figure 5-3 A PTFE mould used to collect samples from the high pressure CO2 
injection system. The mould and removable base (A) were used to collect the 
samples and a2 mm hole (B) drilled through the wall at the top of the mould 
allowed the passage of the cell suspension into the base of the mould. 
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5.2.2. The Injection of Live Cells into High Pressure CO2 
The second step in this process investigated the effects of the injection mechanism 
and high pressure injection on live cells. After injection, cell survival, cytosolic 
LDH release and BMP-2 induced alkaline phosphatase activity were all assessed. 
5.2.2.1 Cell Culture 
Murine C2C12 cells were cultured in complete DMEM for all cell survival studies 
with full details given in the materials and methods chapter (section 7.1.1). A viable 
cell count was carried out for both cell lines using trypan blue exclusion, full details 
of which can be seen in the materials and methods chapter (section 7.1.3). 
5.2.2.2 Investigating the Effect of Injection Pressure on Cell Survival 
To test the resilience of the murine C2C12 cell line, live cells (250,000) were 
suspended in 200 pl of DMEM and placed into the cell storage tubing. The high- 
pressure reservoir above the cell storage tubing was pressurised to 5,37 and 74 bar 
and the pressure inside the vessel was increased to 4,36 and 73 respectively. The 
higher of the two valves (A) was the opened to expose the cell suspension to the 
pressurised gas. The second valve (B) was then opened to push the cells through the 
tubing and into a PTFE mould in the base of the vessel. The system was then 
decompressed over 40 seconds and the cell suspension removed and placed into 
DMEM overnight. 
5.2.2.3 Investigating the Effects of the Injection Mechanism and Medium on 
Cell Survival and Function 
In order to show any differences between the valve opening sequence two alternative 
methods were employed. The method is the same as in 5.2.2.2, with the exception of 
the opening of the valves. In the first alternative, the two valves were opened in the 
same order (A - B), but at a slower rate (approximately 10 seconds per valve). This 
would show any difference between an instant increase in pressure and a more 
gradual increase. In the second alternative, the order of the valve opening was 
reversed from A-B, to B-A. 
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This would allow the cells to pass through an already open valve (B) when valve A 
was opened to allow the cells to be pushed into the vessel. This was done to provide 
some indication of the effects of the valve mechanism on cell survival at high 
pressure. In order to further examine the cause of cell death after high pressure 
injection, high pressure N2 was also used as a cell storage/injection medium and 
compared with CO2. The B-A valve opening sequence was also used before 
assessment of cellular alkaline phosphatase activity (injection at 35°C/74 bars of 
C02) and LDH release (injection at 35°C/5-74 bars of C02). 
5.2.2.4 Assessment of Cell Survival after injection with High Pressure CO2 and 
N2 
Cells were assayed for metabolic activity using the Alamar BIueTM (Serotech, UK) 
cell metabolic activity assay as described in the materials and methods chapter 
(section 7.3.1). Briefly, cells were removed from culture and the complete medium 
covering the cells replaced with an Alamar B1ueTM solution (10% v/v in HBSS, 
Sigma UK). After a 90 minute incubation at 37°C (5% C02) 200 µl of solution from 
each well was transferred to a 96-well plate (Falcon). Fluorescence readings were 
then obtained at an emission wavelength of x, 590 nm using ?. 560 nm excitation. 
5.2.2.5 Assessment of Cell Membrane Rupture after Injection with High 
Pressure CO2 
As cells release cytosolic LDH when the membrane is ruptured, an assay for levels 
of LDH after exposure to scCO2 was carried out as described in the materials and 
methods chapter (section 7.3.3). Briefly, C2C12 cells (250,000 per well) were 
removed by centrifugation and the remaining DMEM assayed for release of LDH 
using an LDH colour substrate system as per manufacturer's instructions (Roche, 
Penzberg, Germany). The results were then compared to cells processed for 10 
seconds at equivalent pressures (5 to 74 bar) using the method previously described 
in section 2.2.3 as a positive control and dead (lysed) cells used as a negative 
control. 
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5.2.2.6 Assessment of Cell Functionality after Injection with High Pressure CO2 
All of the following methods for alkaline phosphatase activity assessment are 
included in more detail in the materials and methods chapter (section 7.4). For 
osteogenic culture, C2C 12 cells that had been injected using sCCO2 for 10 exposure 
seconds at 74 bar (35°C) were cultured in complete DMEM overnight before 
addition of 500 ng/ml recombinant human bone morphogenetic protein-2 (rhBMP-2) 
in 2% FCS supplemented DMEM media. After seven days in culture, C2C12 cells 
were assayed for the p-NP soluble end product of alkaline phosphatase activity using 
the assay described in the materials and methods chapter (section 7.4.2). Briefly, cell 
cultures were fixed in 75% ethanol for 10 minutes and homogenised in 600 µl of 
distilled water containing 0.001% Tween detergent after 3 cycles of freeze-thawing. 
The substrate (p-NPP) was added to equal volumes of the cell samples, incubated at 
37°C for 1 hour and the rate of conversion into p-NP measured by a change in 
fluorescence at 405 nm. Values were compared against known p-NP standards, 
corrected to DNA content and presented as nM of p-NP per hour per ng DNA. The 
DNA content of the cells was calculated using the method found in the materials and 
methods chapter (section 7.3.2). 
5.2.3 The Injection of Live Cells into Plasticised PDLLA 
The final step in this part of the study was to investigate the suitability of this high 
pressure CO2 injection system for use in tissue engineering and other 
biotechnological applications. To achieve this, the cells had to be injected into the 
pre-plasticised polymer (under pressure) before subsequent assessment of cell 
survival and functionality was carried out on the foamed structures. 
5.2.3.1 Cell Culture 
Murine C2C 12 cells were cultured in complete DMEM for all cell survival studies 
with full details given in the materials and methods chapter (section 7.1.1). A viable 
cell count was carried out for both cell lines using trypan blue exclusion, full details 
of which can be seen in the materials and methods chapter (section 7.1.3). 
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5.2.3.2 The Injection of Fixed and Live Mammalian Cells into Plasticised 
PDLLA 
A method was devised in order to show the distribution of the cells in the scaffold 
based upon that previously used in section 4.2.3.2. C2C12 cells (1,000,000) were 
suspended in 800 pl of osmium tetroxide overnight and separated into four x 200 µl 
aliquots (250,000 cells per aliquot). The aliquots were injected using the method in 
5.2.2.3. In brief, each aliquot of the osmium cell suspension was placed in the 
sample tubing and the PDLLA plasticised in the 60 ml collection vessel at 73 bar 
(35°C). An injection pressure of 74 bar was used before equilibrating for 10 seconds 
and decompression over 40 seconds. This experiment was repeated with live C2C 12 
cells to show the presence of the live and spreading cells on the inner and outer 
surfaces of the scaffolds. 
5.2.3.3 Microscopic Analysis of Foamed PDLLA Scaffolds 
In order to show the gross morphology of the injected scaffolds, images of the 
PDLLA foams were viewed and captured using the light microscope. This technique 
is described in more detail in the materials and methods chapter (section 7.7.1). 
Scanning electron microscopy was also used to show the presence of attached and 
spreading cells. Samples were prepared for biological SEM and scanned as 
described in the materials and methods chapter (section 7.7.2). In brief, scaffolds 
were cut, mounted and gold coated (Baltzers union, SCD030 sputter coater) before 
being scanned at 20 kV using a Philips 505 scanning electron microscope. 
5.2.3.4 Micro-Computed Tomographic Analysis of Cell Loaded Scaffolds 
Constructs of PDLLA and osmium stained C2C12 cells were kept in tact to observe 
the distribution of the cells within. These constructs were imaged using a high- 
resolution micro-computed tomography system (µ-CT 40, Scanco Medical, 
Bassersdorf, Switzerland). The scanner was set to a voltage of 55 kVp and a current 
of 145 mA. Samples were scanned at 8 µm voxel (3D pixel) resolution with an 
integration time of 120 ms to produce 3D reconstructed images. 
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The cell-loaded scaffolds were thresholded at 60 (arbitrary number) to view the 
porous scaffold and then at 190 to view the osmium stained cells contained within. 
5.2.3.5 Assessment of Cell Survival after Injection into Plasticised PDLLA 
Both cell viability and location were assessed with the use of the LIVE/DEADTM 
stain as described in the materials and methods chapter (section 7.5.1). In brief, the 
cell loaded PDLLA foams were incubated in 10 ml of complete DMEM containing 
20 pl of Ethidium Homodimer-1 (to highlight the dead cells red) and 5 . tl of Calcein 
AM (to highlight the live cells green) for 1 hour. The cells were then rinsed (x4) in 
phosphate buffered saline (PBS) for 1 hour, before being observed using 
fluorescence microscopy (Leica DM IRB). 
5.2.3.6 Assessment of Cell Functionality after Injection into Plasticised PDLLA 
For functional assessment, an alkaline phosphatase stain was carried out on the cell 
loaded scaffolds. In brief, the cell loaded scaffolds were cut into four pieces and 
cultured for seven days in DMEM containing 500 ng/ml of rhBMP-2. A red colour 
substrate was then precipitated on the cells by the action of cellular alkaline 
phosphatase activity. The substrate system comprised of Napthol AS-MX buffer 
solution containing I mg/ml Fast Violet B salt, as described previously by Oreffo 
and co-workers (Oreffo et al, 1998). This technique is described in the materials and 
methods chapter (section 7.4.3). 
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5.3 Results and Discussion 
5.3.1 Testing the Injection Mechanism 
The data presented in figures 5-4 and 5-5 shows that at least 50% of the cell 
suspension was lost after injection into the vessel, irrespective of the injection 
pressure. The largest volume of cell suspension recovered after injection into 
atmospheric pressure was 45±15% (figure 5-4). The effects of injecting into a high 
pressure environment provided little increase in recovered cell suspension with a 
maximum value of 53±16% (figure 5-5). However, the addition of a collection 
mould increased the percentage of recovered cell suspension with minimum of 
84±14% at 74 bar and a maximum of 95±4% at 5 bar (figure 5-6). This 
development, coupled with an additional piece of tubing to allow the cells to pass 
directly into the mould, increased the levels of recovered cell suspension. This is 
likely to be due to the restrictions placed upon the final destination of the cells, as 
without a mould and the associated tubing there is a larger surface area over which 
the cell suspension can be spread (the 60 ml vessel). In addition, it is possible that 
the hydrophobic surface provided by the PTFE material facilitates the rapid and 
efficient collection of the water-based suspension from within the mould. 
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Figure 5-4 Percentage recovery of a dead cell suspension after high pressure CO2 
injection into a 60 ml vessel retained at atmospheric pressure. Mean (n=5) ± SD. 
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Figure 5-5 Percentage recovery of a dead cell suspension after high pressure CO2 
injection into a vessel already pressurised with CO2. Mean (n=5) ± SD. 
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Figure 5-6 Percentage recovery of a dead cell suspension after high pressure CO2 
injection into a PTFE mould within a vessel pressurised with CO2. Mean (n=5) f 
SD. 
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5.3.2 The Injection of Live Cells into High Pressure CO2 
The results of cell survival assays after the initial high pressure CO2 injection into 
the PTFE moulds can be seen in figures 5-7 and 5-8. The key difference between 
these experiments was the speed and sequence of the opening of the valves (A & B) 
controlling the injection of the cell suspension into the vessel. The low levels of cell 
survival seen in figure 5-7 (less than 10% for all pressures) are comparable with 
those seen in figure 5-8. The pictures of the cells after injection confirm that there 
are very few live or attached cells to the tissue culture plate 24 hours after 
processing. There is also a lot of cell debris present in the images suggesting that the 
cell membrane damage is prevalent. 
In both cases the valves were opened in the A-B (upper 
- 
lower) sequence, but at 
different rates. Therefore, survival data resulting from the instant opening of the 
valve (figure 5-7) showed little difference when compared with the more gradual 
opening of the valve (figure 5-8). From this it was concluded that it may not be the 
speed of the release that was affecting the survival. 
In a final variation, the lower valve (B) was opened first to allow the CO2 from the 
vessel to pressurise the cell suspension and permit the passage of the cells through 
an already open valve when the second valve (A) was opened to inject the cells. This 
change in the valve opening sequence from A-B to B-A resulted in a minimum of 
45±17% cell survival at 74 bar with a maximum of 54±24% at 37 bar (figure 5-9). 
This represents a significant improvement in cell survival data when compared with 
that from the A-B opening sequence. It would appear that the opening of the valve 
may have caused the cells to be crushed as the valve is only fully open at the very 
end of the injection process, by which stage many of the cells would have passed 
through a smaller orifice. When injected with N2, the data was comparable to that 
using injected with CO2, as there was a minimum of 48±23% cell survival at 74 bar 
and a maximum of 55±13% at 37 bar (figure 5-10). This indicates that the damage 
caused to the cells is not specific to the effects of CO2. 
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Figure 5-7 Cell survival data and visual confirmation after injection into high 
pressure CO2 using the A-B valve opening sequence. Mean (n=3) ± SD. The 
physical appearance of the cells after injection at the highest pressure (74 bar) can be 
seen inset. This shows the cell debris that is indicative of damage to the cell 
membrane. 
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Figure 5-8 Cell survival and visual confirmation after a slow injection into high 
pressure CO2 using the A-B valve opening sequence. All data is given with standard 
deviation. The physical appearance of the cells after injection at the highest pressure 
(74 bar) can be seen inset. This shows the cell debris that is indicative of damage to 
the cell membrane. 
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Figure 5-9 Cell survival data after injection into high pressure CO2 using the B-A 
valve opening-sequence. Mean (n=3) ± SD. 
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Figure 5-10 Cell survival data after injection into high pressure CO2 using the B-A 
valve-opening sequence and N2 as the injection medium. Mean (n=3) ± SD. 
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The work described in chapter four indicated that scCO2 had a more toxic effect on 
mammalian cells than N2, nonetheless, cell survival was still above 90% after 10 
seconds exposure to 74 bar of CO2 (see figure 3-1). Here, despite the same 
processing times cell survival is -50%. Thus, the effects of both pressure and 
injection medium do not appear to be primary cause of cell death in this injection 
study. This is more likely to be due to the mechanical/shear forces acting upon the 
cells as they pass through a series of narrow orifices at high pressure. For example, 
the hole cut into the side of the PTFE mould was only 3 mm in diameter but this 
could not be changed within the time constraints of the study and neither could the 
diameter of the tubing (W'). This type of stress/shear caused by the passage of cells 
through a small orifice has previously been reported as a cause of cell rupture/death 
in mammalian cell spraying studies (Roberts et al, 2005). The increased levels of 
LDH release when compared to cells processed for 10 seconds but without injection, 
also suggest further damage to the cell membrane than caused by CO2 alone with a 
significant difference at 74 bar (figure 5-11). However, with only minimal cell 
damage specifically from the effects of C02, optimisation of the delivery method 
may eliminate the additional damage caused by the injection process itself. 
With cell (C2C 12) survival confirmed after injection using 74 bar pressure of C02, 
the cells were then assessed for functionality after the same process. As described in 
previous chapters, this was carried out by measuring the capacity of C2C 12 cells to 
differentiate into the osteogenic lineage via BMP-2 induced alkaline phosphatase 
activity (see figure 5-12). When corrected to the retrievable DNA, levels of alkaline 
phosphatase are indistinguishable between the control sample and those cells 
injected at 74 bar. This indicates that providing the cells survive the injection 
process, they retain their ability to undergo osteogenic differentiation. Therefore 
once cell survival has been confirmed the cell injection process would appear to 
have no a detrimental effect upon this aspect of cellular function than the previous 
method used to process cells in scCO2 (see chapter three). 
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Figure 5-11 Measurement of cell rupture using an LDH assay after exposure of 
C2C 12 cells to increasing pressures of CO2. Cells were injected using high pressure 
CO., and the resultant LDH levels compared with cells processed in high pressure 
CO2 without injection. Mean (n=3) ± SD. * indicates p<0.05 using T-test. 
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Figure 5-12 Specific alkaline phosphatase activity of C2C12 cells after injection into 
a high pressure environment with scCO2. Mean (n=3) ± SD. 
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5.3.3 The Injection of Live Cells into Plasticised PDLLA 
Mammalian cells pre-fixed with osmium tetroxide were entrapped within PDLLA 
foams using the scCO2 injection system and the gross morphology of these foams 
can be seen in figure 5-13. These porous foams were subject to analysis on a µ-CT 
unit to show the distribution of the cells within the 3D structure (see figure 5-14). 
Micro-CT analysis showed the scaffolds to be 91±17% porous with cells well 
distributed throughout. This distribution is visible in both the whole scaffold (figure 
5-14A) and in the cross section taken through the centre of the scaffold (5-14B). 
There is a greater density of cells situated near to the top of the scaffold. This was 
expected as the cells enter the polymer at the surface and there was no mixing of the 
two components during processing. This situation, combined with the likely higher 
viscosity of the polymer, has probably prevented the cells from reaching the base of 
the scaffold in the same numbers. This is in direct contrast with the µ-CT images of 
cells introduced by pre-mixing with the powder, where a greater number of cells 
were observed nearer to the base of the scaffold. 
After the injection of live mammalian cells into the PDLLA, both SEM and 
LIVE/DEADTM analysis were carried out to verify the presence of live and 
spreading cells. Figure 5-15 shows SEM images of PDLLA scaffolds injected with 
live 3T3 fibroblasts. It can clearly be observed that the cells are attaching and 
spreading on the inner and outer surfaces of the porous structure. The 
LIVE/DEADTM images in figure 5-16 show that a large proportion of the cells are 
metabolically active (green). The cells do not appear to be as abundant as in the 
LIVE/DEADTM images in chapter four but this is likely to be due to the lower 
proportion of cells that survived the process (see figures 5-9 and 5-10) when 
compared with the better survival rates seen in chapter two (figure 2-9). The three 
images seen in figure 5-16 are representative of the variation in cell survival that 
exists between the samples. 
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Figure 5-13 Gross morphology of a PDLLA scaffold produced using the scCO2 
injection system. 
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Figure 5-14 Micro-computed tomographic images of (A) whole PDLLA scaffolds and 
(B) scaffold cross sections, showing the distribution of mammalian cells pre-fixed 
with electron dense osmium tetroxide and subsequently injected into the polymer 
using scCO2. The osmium stained cells have been visually enhanced for clarity. 
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Figure 5-15 Scanning electron micrographs of PDLLA scaffolds after the injection of 
mammalian cells using scCO2. Attached and spreading cells can be seen inside and 
around the mouth of a large pore (A) as well as on the flat outer surface of the 
scaffold (B). 
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Figure 5-16 LIVE/DEADTM images of PDLLA scaffolds loaded with mammalian 
cells using the high pressure CO2 injection system. 
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5.3.4 Cell Functionality Studies 
Scaffolds injected with C2C12 cells using 74 bar of CO2 were cultured in an 
osteogenic medium (DMEM containing 500 ng of BMP-2) and stained for alkaline 
phosphatase activity. Assays were not carried out on these scaffolds as the 
subsequent recovery of DNA was inconsistent and there was not sufficient time to 
repeat the experiment. 
The stained scaffolds seen in figure 5-17 do show localised alkaline phosphatase 
activity, as shown by the red stained areas. This provides evidence of BMP-2 
induced osteogenic differentiation of the C2C12 cell line when injected into the 
PDLLA. The stained areas of the scaffold do not appear as abundant as in chapter 
four, when the cells were pre-mixed with the PDLLA before processing in scCO2. 
However, the number of live cells present in the injected PDLLA scaffolds was 
limited to 50% or less as can be seen from the survival data in figure 5-9. This may 
explain both this apparent reduction in cellular alkaline phosphatase activity and the 
poor recovery of DNA from the scaffolds. As in the previous chapter, the issue here 
was merely of proving the concept and this has been achieved. 
This injection process may not be as efficient as the pre-mixing technique, but it 
represents a significant step in the development of a technique for the production of 
cell loaded tissue engineering scaffolds using a single processing step. Further 
optimisation of the cell delivery method in the future may result in a more abundant 
cell population on which to conduct these functionality studies. 
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Figure 5-17 PDLLA scaffolds loaded with C2C12 cells using the supercritical CO2 
injection system and stained for BMP-2 induced alkaline phosphatase activity. Red 
stained cells (arrow) indicate localised alkaline phosphatase activity. 
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5.4 Conclusions 
The main challenge in this phase of the study involved the design and construction 
of high pressure polymer processing apparatus capable of allowing the introduction 
of liquid suspensions into the mixing chamber, whilst under pressure. This was 
achieved by adapting the existing stainless steel high pressure vessels used for 
polymerisations and polymer processing at the University of Nottingham. An 
additional source of high pressure CO2 was used as the method of forcing the cells 
suspension into the vessel. In addition, a series of valves were used to prevent rapid 
decompression from the chamber but while still permitting the opening of the 
mixing chamber to allow the cell suspension to enter. It has been demonstrated that 
this mechanism was sufficient to pass liquids suspensions into the vessel when at 
atmospheric, sub and supercritical pressures, whilst the addition of a PTFE mould 
made collection of the samples a more efficient process. The mould was adapted to 
allow the cell suspension to be guided into the well at the base where the polymer 
was pre-plasticised. Thus, the cells were entrapped in the porous structure when the 
system was decompressed. 
Cell survival and function were confirmed despite this injection process, with and 
without the presence of a polymer scaffold. Despite the convoluted path for the cell 
suspension to take and the potential level of cellular perturbation, Alamar BlueTM 
assays indicated that 50% of the cells could survive this process without the addition 
of the polymer and with no apparent loss of their capacity to differentiate into the 
osteogenic lineage when prompted with BMP-2. When injected into the polymer, the 
cells were shown to survive in good numbers as indicated by the LIVE/DEADTM 
stained scaffolds. Where viable C2C12 cells were found, their ability to undergo 
osteogenic differentiation was also demonstrated when prompted with BMP-2. 
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Chapter 6 
GENERAL DISCUSSION AND CONCLUSIONS 
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6.1 Discussion 
The possibility of a rapid, one-step technique for the production of cell-loaded 
scaffolds for tissue engineering applications is appealing for a number of reasons. 
Traditional methods of seeding tissue engineering scaffolds are frequently inefficient 
and time consuming processes that requires a large population of cells to be added to 
a solid, porous structure followed by weeks or months of careful culture to achieve 
the desired cell density (Freed et al, 1998). If sufficient numbers of cells were 
introduced into scaffolds during the fabrication process, it could potentially 
eliminate the requirement for the subsequent scaffold culture stage and also increase 
the seeding efficiency. In theory, cell loaded scaffolds could be fabricated in surgical 
theatres with the patients own cell sample, before immediate implantation back into 
the patient. This would not only make the process more rapid, but it would also be 
less stressful for the patient as there would be only one surgical procedure necessary 
with reduced risk of infection. 
Therefore, at the start of this study it was hypothesised that if cells could survive and 
remain functional after exposure to scCO2, it may be possible to co-process 
mammalian cells and amorphous PDLLA into porous tissue engineering constructs in 
a single processing step. To achieve this, the study was split into five smaller areas 
of investigation across four chapters of this PhD thesis. 
In chapter two, cells alone were exposed to both high pressure and supercritical CO2 
processing conditions and assessed for metabolic activity. This was carried out not 
only to confirm the survival of cells and allow the study to proceed further, but also 
to produce optimal processing conditions for the later stages of this study. A variety 
of cells demonstrated a time-dependent survival after exposure to scCO, (74 bar, 
35°C) that could be extended by increasing the decompression time to four minutes. 
The survival of mammalian cells after scCO2 processing has never been recorded in 
the literature, although it has been reported that similar conditions (75 bar, 38°C) 
could be used to kill and inactivate bacterial cell populations (Spilimbergo et al, 
2002). 
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Exposure time was shown to have the most damaging effects on cell survival with a 
secondary role taken by pressure along with other conditions such as temperature, 
gas bubble formation and pH. These factors are already known to have detrimental 
effects on cell survival (Gregoriades et al, 2003, Wu, 1995, Dillow et a/, 1999). 
Changes in temperature were recorded and shown to both increase and decrease 
rapidly during compression and decompression respectively. This was due to the 
effects of Joule-Thompson heating/cooling, an occurrence which could not he 
avoided as a result of the short compression and decompression times required to 
ensure cell viability. The toxic effects of sCCO2 did change with cell type, as the 
secondary cell lines appeared to be more resistant than the primary cells. However, 
the secondary cell lines are more proliferative when in culture, and therefore this 
may explain their ability to regain their numbers in the culture period of 24 hours 
between scCO2 processing and assay. 
Despite the reduction in cell survival resulting from the scCO2 process, it must be 
mentioned that many conventional methods of seeding tissue engineering scaffolds 
can also affect cell viability. Frequently, the incorporation of cells into scaffolds is 
carried out by using mechanical agitation (dynamic seeding) due to the reduced 
seeding efficiencies often associated with static culture methods (Burg et a!, 2000, 
Unsworth et al, 2002). However, despite increasing cell proliferation in the long- 
term, dynamic seeding methods have also been shown to reduce the viability of 
mammalian cells (Kim et al, 2004) sometimes by as much as 50% when compared 
to static or perfusion bioreactor methods alone (Burg et a!, 2000). Even cells that 
have been encapsulated within biopolymers such as alginate have shown some 
reduction in cell viability (5-10%) despite the fact that the encapsulation process 
used no toxic or harmful treatments (Maguire et al, 2005). Therefore, the use of any 
technique to incorporate cells into porous polymer scaffolds will not be without 
damage or risk to the cell component and some loss of cell viability is acceptable 
when producing cell-based tissue engineering devices. Thus, a survival rate of 
between 70 and 90% after 30 seconds exposure to scCO2 may well not be an issue, 
particularly if there is a subsequent culture period to increase the cell population. 
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However, the confirmation of cell survival after using a scCO2 processing step was 
not the only factor that required investigation. Although it was obvious that 
prolonged exposure to scCO2 had a toxic effect on mammalian cells, it was 
necessary to further investigate the some of the potential causes of cell death and to 
test the functional machinery of the cells after scCO2 processing (chapter three). 
Mammalian cells were processed under the same conditions (74 bar, 35°C) but using 
another gas (N2) to separate the effects of high pressure and processing medium on 
cell survival. Nitrogen was shown to have a less detrimental effect over the same 
processing times, indicating a CO2-specific interaction with the cells with the effects 
of pressure only a secondary factor. Data from previous studies with bacterial cells 
has suggested that CO2 induces cell death by reducing the intracellular pH after first 
damaging the cell membrane (Dillow et al, 1999). Significant damage to the cell 
membrane was confirmed by an assay for LDH, providing evidence that this 
combination of events may be the primary cause of cell death. However, CO-2 could 
not be replaced with N2 for this application as it neither plasticises nor foams 
amorphous polymers. 
Gene microarray analysis of four RNA samples that were independently exposed to 
scCO2 confirmed that very few changes in gene expression were induced by the 
high-pressure CO2 environment and rapid pressure fluctuations. Of eight genes that 
were significantly down-regulated, survivinl2l, clast4 protein, and glutathione S- 
transferase could play a role in a biochemical response from the cell to the extreme 
changes in environment. Survivinl2l is a component of the chromosomal passenger 
complex that acts as an inhibitor of apoptosis (Wheatley & McNeish, 2005). 
However, down-regulation of survivin was the only change associated with an 
apoptotic response here, indicating only a minor role for apoptosis. Further evidence 
for this was provided by the results of an ELISA, showing low levels of the historic 
complexes that are indicative of an apoptotic response. Cell enzyme and receptor 
function were tested by means of induced testosterone metabolism in primary 
hepatocytes (Seglen, 1987) and the BMP-2 induced osteogenic differentiation of 
murine C2C 12 cells (Katagiri et al, 1994). 
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Despite processing for one minute in scCO2, both cell types were shown to retain 
their respective functions with no distinguishable difference between scCO, treated 
and untreated control cells. 
In chapter four, it was confirmed that solid, porous PDLLA scaffolds could be 
processed within the time limitations imposed by cell survival. Both cells and 
PDLLA were processed together using the optimal conditions from chapter two (30 
seconds at 74 bar/35°C with cells suspended in 200 gl of DMEM). Despite the crude 
mixing technique, visual assessment of the cell loaded scaffolds by microscopic 
techniques, indicated that the cells were not only attaching and spreading to the 
internal surfaces, but also remained viable, as shown by the LIVE/DEADTM stain. 
This represents the first time that cells have been incorporated into a synthetic 
polymer scaffold during the fabrications step with cell viability retained. 
Furthermore, this was achieved despite the possibility of cell entrapment within 
closed pores and a potentially more acidic environment due to the combination of 
water and lactic acid. For this work to be taken further it would require efficient 
mixing of the cells and polymer during polymer processing. This is vital to 
achieving a homogeneous distribution of cells throughout the scaffolds and in close 
proximity to one another, thus, facilitating the important processes that lead to tissue 
formation such as cell-cell signalling. During the latter stages of the study this 
problem was addressed by creating a new cell injection system with a static mixer 
incorporated into the design. The mixer was a simple stainless steel tube containing 
a series of blades that are specifically designed to mix the two components as they 
pass through at high pressure. However, this system had yet to be trialled as this 
PhD thesis was written. Once processed into the PDLLA scaffolds using sCCO2, 
murine C2C 12 cells demonstrated their ability to undergo osteogenic differentiation 
as measured by BMP-2 induced alkaline phosphatase activity. In an interesting 
development, it was also demonstrated that BMP-2, C2C12 cells and PDLLA could 
be processed together to form a composite structure, capable of inducing osteogenic 
differentiation of the attached cells by controlled release of the protein from the 
scaffold. 
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After successfully co-processing the cells into the PDLLA scaffolds, the final stage in 
this study was to design and build a novel high pressure injection system to facilitate 
the incorporation of the cells into the plasticised polymer. By adding the cells at a 
later stage in the fabrication process, it would be possible to circumvent the 
limitations of the polymer processing time imposed by the finite survival time of 
mammalian cells. Some modification to the high pressure apparatus was required to 
facilitate this. The main challenge in chapter five of the study involved the design 
and construction of a high pressure polymer processing apparatus capable of 
allowing the introduction of liquid cell suspensions into the mixing chamber, already 
pressurised with CO2 and containing plasticised polymer. This was achieved by 
adapting the existing stainless steel high pressure vessels, fabricated in-house at the 
University of Nottingham, used for polymer synthesis and processing. An additional 
source of high pressure CO2 or N2 at a greater pressure than that in the mixing 
chamber was used as the method of injecting the cell suspension. Two valves were 
utilised to allow the cells to be injected into the chamber without loss of pressure. It 
was demonstrated that this mechanism was sufficient to pass cell suspensions into 
the vessel when at atmospheric, sub and supercritical pressures and that the addition 
of a custom-made PTFE mould made collection of the samples a more efficient 
process. 
Despite the longer path for the cell suspension to take and the potential increased 
level of cellular perturbation through the narrow orifices, Alamar BlueTM assays 
indicated that more than 50% of the cells could survive this high pressure injection 
process although cell survival was not pressure dependent over these short times (10 
seconds at 5,37 and 74 bar). This is comparable with the 70%+ cell viability 
reported by Roberts et al, who used either nitrogen or air to propel bovine 
chondrocytes and epithelial cells through an atomizer onto a microscope slide 
(Roberts et al, 2005). Despite the use of a different orifice size (0.8 mm), carrier 
medium (phosphate buffered saline) and a gas that is not C02, this acts of further 
evidence for the potential of such a high pressure cell delivery system to be used. 
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In this study, the difference in cell survival after injection with CO-, and N2 was 
indistinguishable indicating that high pressure CO2 was not the only cause of cell 
death in this system. An increase in the release of cytosolic LDH was observed from 
the injected C2C12 cells when compared to cells processed in CO2 using the method 
described in chapter two, indicating further mechanical rupture of the cell 
membrane. Furthermore, alkaline phosphatase data indicated that those C2C12 cells 
that did survive the injection process did not lose their capacity to differentiate into 
the osteogenic lineage when prompted with BMP-2. 
Finally the cells were injected into plasticised PDLLA before subsequent 
decompression caused the polymer to foam with the cells entrapped within the 
porous structure. A proportion of these cells were shown to survive within indicated 
by the LIVE/DEADTM stained scaffolds. Where live C2C12 cells were found, their 
ability to undergo BMP-2 induced osteogenic differentiation was also demonstrated. 
This injection step represents an important proof of concept for the addition of cells 
to a pre-plasticised polymer. If mechanical damage to the cells could be reduced by 
the use of an optimised delivery method, this technique could be used for the 
fabrication of cell loaded scaffolds in single step process that is free of some of the 
processing restrictions imposed by the pre-mixing technique. One approach could be 
to change the cell entry method or to create a pressure gradient as the cells are 
passed into the vessel to reduce the levels of trauma they are subjected to. Cell 
survival could be further optimised with a more sterile environment retained 
throughout the process. This could be implemented by moving the high pressure 
processing equipment into a sterile tissue culture facility and the routine sterilisation 
of the pressure vessel. With cell survival optimised, the final issue is that of the 
scaffold micro-architecture as in order to produce scaffolds capable of supporting 
tissue formation, the polymer processing conditions would have to be optimised. 
The advantage of using scCO2 is that the processing conditions such as the 
temperature, pressure and decompression rate can easily be tuned to provide 
scaffolds with the desired characteristics (Goel & Beckman, 1994b, Howdle et al, 
2001) and permit tissue formation in vivo (Yang et al, 2003b, Yang et al, 2004). 
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6.2 Conclusions 
This study shows that mammalian cells are able to survive exposure to scCO' for 
sufficient time for the scCO2 to plasticise and foam PDLLA. This study has provided 
evidence for a rapid, one-step technique for combining mammalian cells and 
synthetic polymers into biodegradable scaffolds without the use of toxic solvents or 
elevated temperatures. After exposure to sCCO2 and rapid decompression, both 
C2C12 cells and primary hepatocytes demonstrated retention of functionality. In 
addition, the effects of sCCO2 exposure upon gene expression were minimal in the 
C2C 12 cell line. ScCO2 was found to have a more detrimental effect on cell survival 
than N2 under the same conditions, although N2 could not replace CO' fier this 
application as it neither plasticises nor foams amorphous polymers. 
Cells were shown to survive and remain functional after co-processing with the 
polymer although this did place restrictions on the polymer processing time. 
However, the implementation of a new high pressure CO2 injection system 
succeeded in allowing the cells to be introduced into the pre-plasticised polymer. 
This could facilitate the extension of polymer processing times/pressures and enable 
cell loaded scaffolds to be fabricated with pre-determined characteristics that fit the 
application. 
In addition to tissue engineering, this technology could be used in other applications 
where mammalian cells are combined with synthetic polymers. For example, cells 
and synthetic polymers are combined in cell therapy strategies (Emerich et a/, 1992) 
and recombinant protein production, where cell anchorage is necessary for the 
production of protein drugs and enzymes (Ryu et al, 2003). 
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Chapter 7 
MATERIALS AND METHODS 
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7.1 Cell Culture 
7.1.1 Culture of Primary and Secondary Cells 
Complete medium for 3T3 fibroblasts, ovine meniscal fibrochondrocytes and murine 
C2C12 cells contained Dulbecco's Modified Eagle's Medium (DMEM) 
supplemented with 10% foetal calf serum (FCS), 2% non-essential amino acids, 2% 
L-glutamine and 2% antibiotic/antimycotic solution. In addition, the complete 
medium for the chondrocyte cells contained L-proline (Fisher Scientific) and 
ascorbic acid-2-phosphate (Sigma, UK). Complete medium for hepatocytes 
contained Williams Medium E (InVitrogen), supplemented with 10% FCS and 20 
mM L-glutamine containing penicillin. Murine C2C12 and 3T3 fibroblasts were 
cultured in T75 cell culture flasks (Falcon) and chondrocytes in T180 flasks (Falcon) 
until 80% confluent, before removal by a three minute incubation with an 
EDTA/trypsin solution (2 ml per flask) (Sigma). Hepatocytes were used on the day 
of the isolation due to their sensitivity to trypsin and short life span in culture. The 
C2C12 cells were kindly provided by Dr Richard Oreffo (University of 
Southampton). 
7.1.2 Isolation of Primary Cells 
Ovine knee joints were kindly provided by Broomhill's Butchers (Gloucestershire, 
UK) on the morning of the isolation. The fibrochondrocytes were isolated from the 
ovine knee joint meniscus using a method adapted from the one previously described 
by Collier and Ghosh (1995) and is detailed in figure 7-1. The menisci were then 
each placed in 50 ml universals (Falcon) containing 20 ml of phosphate buffered 
saline (PBS). The tissue was then diced into 2 mm3 pieces and incubated for 2 hours 
in a pronase E solution (5 mg in 50 ml DMEM) (VWR international) at 37°C and 
5% CO2. This solution was aspirated and replaced with a type II collagenase solution 
(100 mg in 50 ml DMEM) (Lorne laboratories, UK) and left overnight. This 
enzymatic digestion process was necessary to remove the cells from the extra 
cellular matrix proteins. The following day, the cloudy cell suspension was passed 
through a 70 pm nylon filter (Sartorius) to remove any large pieces of tissue. 
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The cells were centrifuged using 1200 rpm (Sigma 3K15, SciQuip) for five minutes 
before being re-suspended in complete medium. 
Hepatocytes were isolated from healthy rat liver using a method modified fron 
Seglen (1976). Rats were sacrificed on the morning of isolation using cervical 
dislocation. The body cavity of the animal was then opened and the liver carefully 
removed, avoiding damage to the lobes. The liver was then placed on a petri-dish 
(Nunc, Denmark) and lobes removed. An incision was then made along the edge the 
lobe to expose the large central vessels. The lobes were then perfused for 10 minutes 
using EGTA (ethylene-glycol tetra-acetic acid) metal ion chelating buffer solution, 
followed by a 20 minute perfusion using a solution containing collagenase type 11 
and IV (Sigma). After perfusion, each lobe was placed in a petri-dish containing 
complete tissue culture medium. The cells, tissue and media were then poured 
through sterile gauze (64 gm) into two 50 ml universals (Falcon). Released 
parenchymal cells were further purified from other cell types using a percol (Sigma) 
density gradient. 
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Figure 7-1 Isolation of the cartilage menisci from the ovine knee joint. The leg is 
first transferred to a class I cabinet (A) before an incision is made across the top of 
the knee joint with a size 22 scalpel blade and the connective tissue cut away (B). 
The ligaments are then severed to expose the two menisci (C 
- 
with arrows) before 
they are cut away from the surrounding connective tissue (D). 
-_ 
ý ýý 
1* 
V ý` 
0 
MOW) 
3 
159 
7.1.3 Viable Cell Counts using Trypan Blue Exclusion 
In order to determine correct numbers of cells, a viable cell count is carried out to 
ascertain both the total number of cells and the number of viable (live) cells within a 
given population. This method is based upon the principle that viable cells do no 
take up certain dyes, where as non-viable cells do. Trypan blue is a commonly used 
blue dye that is taken up by non-viable cells, normally as a result of cell membrane 
perforation. Therefore any cells that are stained blue are counted as non-viable. 
The following procedure was used to count the number of viable cells before 
supercritical processing: The cell suspension to be counted was centrifuged using 
1200 rpm (Sigma 3K 15, SciQuip) for 5 minutes, the supernatant removed to and the 
pellet re-suspended in a small volume of complete medium. A 50 µl aliquot of the 
cell suspension was taken and mixed with an equal volume of 0.4% (w/v) trypan 
blue solution (Sigma, UK) and allowed to stand for 5-10 minutes. With a cover-slip 
in place, the solution was transferred to a haemocytometer (Weber Scientific 
International, UK) and placed under a microscope (1 Ox objective). Starting with the 
centre square of the haemocytometer, (see figure 7-2) the cells in the 1 mm middle 
square and the four adjacent 1 mm corner squares were counted (see figure 7-2). 
Each square of the haemocytometer represents a total volume 0.1 mm3. As 1 cm3 is 
equivalent to approximately 1 ml, the subsequent cell concentration per ml (and total 
number of cells) was determined using the following equations. 
Average total number of cells in 1x0.1 mm3: 
= total number viable cells + total number of non-viable cells 
Cell concentration (cells/ml): 
= 
Total number of cells in Ix0.1 mm3 square x (1 x 104) x2 
(1 x 104 is the multiplication factor used to gain cells in volume of I ml and 2 is the 
dilution factor of the trypan blue) 
Total number of cells: 
= total number cells (viable and non-viable) x original volume of cell suspension 
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Figure 7-2 Layout of the five chambers on the haemocytometer (1-5) used to 
calculate cell number. 
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7.2 High Pressure Carbon Dioxide Processing 
7.2.1 Processing of Mammalian Cells in High Pressure CO2 and N2 
In these experiments, four cell types were exposed to a variety of high pressure CO2 
conditions to show their effect on cell survival. The set up of the equipment used can 
be seen in figure 7-3. The high pressure equipment was all made in-house (School 
of Chemistry workshops) with the exception of the back pressure regulator 
(Bronkhorst, Netherlands), the steel tubing and the fittings (Manchester Fluid 
Systems, UK). 
The cell types used were murine 3T3 fibroblasts and C2C12 cells, along with 
primary rat hepatocytes and ovine fibrochondrocytes. Cells were cultured using the 
protocols given in section 7.1. After isolation/culture, cells were removed from cell 
culture flasks (if necessary) and a cell count was performed. The cells were then re- 
suspended in complete media to provide the required concentration, before being 
placed in custom-made poly(tetrafluoroethylene) (PTFE) 8-well tissue culture 
moulds at 2X 105 cells per well (see figure 7-4A). The moulds were then placed into 
a 60 ml clamp-sealed pressure vessel (see figure 7-4B) that was pre heated to a 
specific temperature (dependent upon experiment). The cells were then pressurised 
in 40 seconds and exposed to pressures from 5 to 74 bars of CO2 (food grade CO2 
supplied by Cryoservice UK) or nitrogen (BOC gases, UK) for a set time limit 
thereafter. The exposure times used were 10,30,60,120 and 180 seconds 
(dependent upon the experiment). The process was controlled using a Bronkhorst 
High-Tec BV series flow meter connected to a PC. This acted as a sensitive back 
pressure regulator (BPR) and allowed the pressure to be ramped up and down within 
very short time periods. Once the system had depressurised, the clamp was removed 
from the vessel and the cells removed. The cells were re-suspended in complete 
media (I ml per well) and cultured for 24 hours in tissue culture treated plates 
(Primaria & Falcon). 
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Figure 7-3 Schematic of the equipment used to process mammalian cells and 
synthetic polymers in high pressure and supercritical CO2. The PTFE mould is 
placed in the 60 ml pressure vessel (D) and the temperature is set and controlled via 
a thermocouple on the inside of the vessel and read on the monitor (E). The CO2 is 
then released from the cylinder (I) and pumped into the vessel via a Pickel pump (H) 
and two taps. The pressure inside the vessel is measured by a pressure transducer 
(G) and the pressure displayed on the pressure monitor (F). The pressure is 
controlled by a back pressure regulator (C) attached to a power source (B) and a PC 
(A). 
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Figure 7-4 Apparatus used to process of both mammalian cells and PDLLA scaffolds 
in high pressure and supercritical CO2. The cell suspension and or polymer was 
added to the poly(tetrafluoroethylene) (PTFE) mould (A) before inserting the mould 
into the 60 ml clamp sealed pressure vessel (B). 
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7.2.2 Supercritical Processing of PDLLA Scaffolds 
In order to produce scaffolds for characterisation purposes only, neither cells nor 
additional proteins were included in the fabrication process. Poly(DL-lactic acid) 
powder was weighed out into 12 well PTFE moulds (see figure 7-4A) at 100 mg per 
well and placed inside the 60 ml stainless steel vessel seen in figure 7-4B. The 
autoclave was pre-heated to 35°C and the system pressurised to 74 bars of CO2 in 40 
seconds and held at this pressure for 10,30 or 60 seconds. The system was then 
decompressed over 40 seconds and the scaffolds removed for analysis. 
7.2.3 Supercritical Processing of Live Mammalian Cells with PDLLA 
Poly(DL-lactic acid) powder was weighed out into 8 well PTFE moulds (see figure 
7-4) at 100 mg per well. Aliquots of cell suspension (200 µl containing 250,000 
cells) were placed into each well containing the polymer and gently stirred in using a 
pipette tip to form a cell/polymer slurry. The pressure vessel was pre-heated to 35°C 
and pressurised with CO2 (74 bar) inside 40 seconds. The cell/polymer mixture was 
held at this pressure for 30 seconds before being decompressed over 40 seconds. The 
clamp was then removed from the vessel and the cell loaded scaffolds removed. The 
scaffolds were then cut into 4 equal pieces using a size 22 scalpel blade and either, 
suspended in complete media (I ml per well) for 24 hours/six weeks before further 
analysis or, cultured in complete media containing 500 ng/ml of rhBMP-2 for 
osteogenic differentiation studies. The culture of all cell loaded scaffolds was carried 
out in non-treated tissue culture plates (Falcon). 
7.2.4 Injecting Cells into High Pressure Environments and PDLLA 
In the polymer injection process PULA powder (100 mg) was first weighed out into 
the cylindrical PTFE mould (see figure 7-5) and the mould placed in the 60 ml 
clamp sealed autoclave. In all experiments: the sample (250,000 cells in 200 µl or 
the dye solution) was placed in the tubing separated from the pressure reservoir and 
the 60 ml vessel by two valves (A & B). The tubing and the valves were then closed 
and the 60 ml vessel was pre-heated to 35°C. The vessel was then slowly pressurised 
with CO2 (pressure dependent upon experiment). 
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During this time, the pressure reservoir above the 60 ml vessel was also pressurised 
with CO2 or N2 (pressure dependent upon experiment) and after the polymer had 
been exposed to scCO2 for a minimum of ten seconds, the valves (A and B) were 
opened to allow the cells to pass into the 60 ml vessel by a combination of pressure 
and gravity. The valves were then closed immediately and after 10 seconds the 
system was decompressed over 40 seconds. The clamp was then removed from the 
vessel and the cells or cell loaded scaffolds removed. Cells were then either cultured 
for 24 hours in complete medium before being assessed for metabolic activity or, 
cultured in osteogenic medium containing 500 ng/ml of rhBMP-2 and assessed for 
alkaline phosphatase activity. The scaffolds were either retained in whole for µ-CT 
analysis, or, cut into four equal pieces using a size 22 scalpel blade and suspended in 
complete media (1 ml per well) for 24 hours before further analysis or cultured in 
500 ng/ml complete media containing rhBMP-2 for osteogenic differentiation 
studies. The culture of all cell loaded scaffolds was carried out in non-treated tissue 
culture plates (Falcon). 
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Figure 7-5 A PTFE mould used to collect samples from the high pressure injection 
system. 
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7.3 Biochemical Assays 
7.3.1 Alamar BlueTM Cell Metabolic Activity Assay 
The Alamar B1ueTM assay is a relatively simple but extremely sensitive way to 
measure the metabolic activity of cells in culture. The Alamar BIUeTM substrate 
(Serotech, UK) incorporates a colorimetric indicator that turns from an oxidised 
form (blue) to a reduced form (red) in the presence of metabolic activity. This colour 
change can be measured by using absorbance or fluorescence and is directly 
proportional to the level of cellular mitochondrial activity. 
The following procedure was used to measure cell metabolic activity after 
supercritical processing: After 24 hours in culture, cell culture medium was aspirated 
from the cells or cell loaded scaffolds and the cells/scaffolds washed with phosphate 
buffered saline (PBS). The Alamar B1uCTM solution (10% v/v in Hank's Balanced 
Salt Solution, HBSS) was then added in I ml aliquots to each of the wells containing 
cells and the plates incubated for 90 minutes at 37°C (5% C'O2). After 90 minutes 
had elapsed, 200 pl aliquots were taken from each well in triplicate and transferred 
to a 96-well plate (Falcon). This solution was then read on the plate reader 
(Cytofluor, Perceptive Biosystems) at 530 nm excitation and 590 nm emission. After 
data retrieval, the fluorescence readings were compared to that of untreated controls 
to give a percentage of normal cellular metabolic activity and thus, the percentage 
survival for each cell type. 
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7.3.2 DNA Assay 
In order to calculate the specific levels of alkaline phosphatase or testosterone 
expressed in the cell population after supercritical processing, the values were 
corrected to the quantity of DNA present to give a more accurate representation. 
DNA content was estimated using Hoechst 33258 dye binding, as modified from a 
previously described method (Cesarone et al, 1979). Cell cultures were first washed 
in PBS before being fixed in 75% ethanol and homogenised in 600 µI of distilled 
water containing 0.01% tween detergent (Triton x-100) to lyse the cells, thus 
releasing the DNA. The cell homogenate (50 µl) was added to a 96 well plate 
(Falcon) and 100 µl of 2 µg/ml Hoechst 33258 added. Fluorescence was detected at 
an emission wavelength of X460 nm using X360 nm excitation and compared to a 
series of DNA standards from 0 to 20 gg/ml. A standard curve of fluorescence 
against DNA content was plotted using the DNA standards to calculate the amount 
of DNA in each sample. 
7.3.3 Assay for LDH Release from Mammalian Cells as an Indicator of Cell 
Rupture 
This colorimetric assay for the quantification of cell death and cell lysis is based on 
the measurement of lactate dehydrogenase (LDH) activity released from the cytosol 
of damaged cells into the supernatant. Therefore a simple assay for levels of LDH 
was carried out to determine the extent of any damage to the cell membrane after 
exposure to or injection into high pressure or supercritical CO2. C2C 12 cells were 
either, exposed to sCCO2 in DMEM (without phenol red and FCS) for increasing 
exposure times (10 seconds to three minutes) or, injected into a pressurised PTFE 
mould using high pressure CO2. The cells were then separated and removed by 
centrifugation for two minutes (8000 g rpm, SciQuip 3K15) and 100 µ1 of the 
DMEM supernatant assayed for release of LDH using an equal volume of the LDH 
substrate/dye reaction mixture in a 96-well plate (Roche, Penzberg, Germany). 
Absorbance readings were detected at an emission wavelength of X490 nm using 
X600 nm as a reference. Results were then compared to a set of controls. 
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7.3.4 Enzyme-Linked Immunosorbent Assay for Histone Complexes as an 
Indicator of Apoptosis 
To further elucidate the cause of cell death, C2CI2 cells were assessed for scC'O2 
induced apoptosis by way of an enzyme-linked immuno sorbent assay (ELISA) used 
to detect the histone-DNA complexes indicative of apoptotic cells. After processing 
in scCO2 (74 bar, 35(C) for increasing exposure times (10 seconds to three minutes) 
cells were cultured for a further three hours in fresh DMEM (so as to observe 
apoptosis rather than cell mechanical damage). The cells were then assayed using 
the cell death detection ELISA plus (Roche, Penzberg, Germany) used as per 
manufacturers instructions. In brief, cells from each processing cycle were lysed 
using the provided buffer, centrifuged (200 xg for 10 minutes) and 20 µI of' the 
lysate supernatant added to a streptavidin coated ELISA plate. 90 µl of the 
immunoreagent (containing the enzyme-linked antibody) was added to each well and 
the plate was incubated at room temperature (with slight agitation for two hours). 
The solution was then removed from each well and replaced with 100 µl of an 
ABTS solution before a 20 minute incubation to allow the green color to develop in 
the sample wells. Absorbance readings were detected at an emission wavelength of 
X490 nm using k600 nm as a reference. 
7.3.5 Testosterone Assay for Cytochrome P450 Activity using High 
Performance Liquid Chromatography 
The function of cytochrome P450 (CYP450) enzymes in cultured hepatocytes was 
assayed via the hydroxylation of testosterone and detection of the resultant 
metabolites. Presence of these metabolites was detected via the use of high 
performance liquid chromatography (HPLC). The following procedure was used to 
measure testosterone activity after scCO2 processing for 10,30 and 60 seconds. Rat 
cell cultures were incubated for 1 hour at 37°C in 1.5 ml or 320 µl respectively of 
Earl's buffered saline solution (EBSS) supplemented with 1 mM Ca2 
,1 mM Mg2 
and containing 100 µM testosterone. The supernatant was centrifuged to remove cell 
debris, and analysed using a Beckman HPLC 1090 fitted with a Zorbax 300 SB-C 18 
4.6 mm x 15 cm column maintained at 50°C. 
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Mobile phase A consisted of 450 ml H2O, 50 ml acetonitrile and 250 µl formic acid, 
whilst mobile phase B consisted of 50 ml H2O, 450 ml acetonitrile, 75 µl formic 
acid. Mobile phase A was run at 1 ml/minute, starting at 15% B, increasing linearly 
over 10 minutes to 50% B. UV absorbance was detected at 245 nm using an integral 
diode array detector. The sample injection volume was 40 µ1 and each run was 
controlled by intermittent injection of an external standard of 6p- 
hydroxytestosterone, as well as a mix of all metabolite standards. The peak height of 
each sample was recorded, corrected to DNA retrieved from the cell samples and 
compared to untreated controls to calculate the percentage of each metabolite 
present in each sample. 
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7.4 Alkaline Phosphatase Studies using the Murine C2C12 Cell Line 
In order to measure cell function, the differentiation of myogenic C2C 12 cells was 
investigated as this cell line has been shown to be pluri-potent dependent upon the 
cell environment (Ichida et al, 2004). The osteoblast lineage can be induced in the 
C2C12 cell line by bone morphogenetic protein-2 (BMP-2), an indicator of which is 
alkaline phosphatase activity (Okubo et al, 1999, Han et al, 2003). Alkaline 
phosphatase acts by converting p-nitrophenyl phosphate (p-NPP) into p-nitrophenol 
(p-NP) and inorganic orthophosphate. Therefore the rate of this conversion to p-NP 
is given as a measure of alkaline phosphatase activity and thus, evidence of 
osteogenesis (Katagiri et al, 1994). 
7.4.1 BMP-2 Induced Osteogenic Differentiation of the C2C12 Cell Line 
After culture in complete DMEM, cells were further cultured for seven days in 
DMEM supplemented with 2% FCS (v/v) and 500 ng/ml rhBMP-2 (for osteogenic 
differentiation) using a method modified from that already described (Oreffo et al, 
1998). Scaffolds loaded with C2C12 cells were cut into four equal pieces and 
cultured for 24 hours in complete DMEM. Once attached to the PDLLA scaffold, the 
cells were further cultured for seven days in DMEM supplemented with 2% FCS 
(v/v) and 500 ng/ml rhBMP-2 (for osteogenic differentiation). 
7.4.2 p-NPP Assay for Alkaline Phosphatase Activity 
Murine C2C 12 cells were processed in high pressure or supercritical CO, before 
subsequent culture in an osteogenic medium containing 500 ng/ml of BMP-2. Cells 
were fixed in 75% ethanol for 10 minutes and homogenized in 600 µl of distilled 
water containing 0.01% Tween (Triton-X 100) detergent after three cycles of freeze- 
thawing. The assay for alkaline phosphatase is based on a method used by Tare et al 
(2002) and was carried out as follows: 
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The p-NPP substrate (l mg/ml) was added to equal volumes of the cell samples, 
incubated at 37°C for 1 hour and the rate of conversion into p-nitrophenol (p-NP) 
measured by a change in fluorescence at 405 nm. Values were compared against 
known p-NP standards (0 
-I mg/ml), multiplied by the dilution factor and matched 
to DNA content to compensate for changes in cell number. Because the assay was 
carried out over one hour, the final expression of alkaline phosphatase activity is 
given as nM of p-NP per ng of DNA per hour. This process was repeated in 
triplicate over four experiments for osteogenically prompted C2C 12 cells. 
For assessment of alkaline phosphatase activity in PDLLA scaffolds, C2C 12 cells 
were removed by a process of repeatedly pipetting distilled water containing 0.01 % 
of Triton-X 100 detergent and assayed for alkaline phosphatase activity using the 
method previously described. 
7.4.3 Alkaline Phosphatase Staining of the C1C12 Cell Line 
As a measure of the osteogenic status of C2C12 cells, a red color substrate was 
precipitated on the cells by the action of cellular alkaline phosphatase activity. After 
osteogenic culture, each cell loaded scaffold was washed in PBS (1 ml) and then 
incubated at room temperature in 1 ml of the active substrate. The substrate system 
comprised 9.6 ml of dH2O, 400 µl of Napthol AS-MX buffer solution and 10 mg of 
fast violet B salt. After 30 minutes at room temperature the scaffolds were viewed 
using a light microscope (Nikon, SMZ1500). 
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7.5 Genomic Analysis 
Gene expression profiling or microarray analysis enables the measurement of 
thousands of genes in a single RNA sample. The principal behind the technique is 
simple: a glass slide is arrayed with DNA fragments or oligonucleotides that 
represent specific gene coding regions. Purified RNA is then fluorescently labelled 
and hybridised to the slide. The raw data is obtained by scanning the array using a 
laser and a number of statistical tests can then be carried out. Here, hybridisation 
was carried out on a number of RNA samples retrieved from murine C2C 12 cells 
after supercritical processing. Hybridisation was simultaneously carried out with 
reference or control RNA to facilitate a comparison of data between processed and 
non-processed cells. 
7.5.1 RNA Isolation, Purification and Hybridisation 
Batches of C2C12 cells (N=4) were assessed for changes in gene expression using 
an OciChipTM 30k set-A microarray (Ocimum Biosolutions). Murine C2C 12 cells (1 
million per batch) were processed for one minute at 74 bar and 35°C as described in 
section 7.2.1) and cultured for a further three hours in DMEM. Cells were then 
rinsed in 1 ml PBS and homogenised in an RLT buffer containing ß- 
mercaptoethanol (10 pl per ml) before overnight freezing at 
-20°C. When thawed, 
total RNA content of the cell homogenate was assessed using the RNeasy kit 
(Qiagen, Germany). Ethanol (70%) was first added to the cell homogenate and 
mixed thoroughly by pipetting. The sample (700 µl) was added to an RNeasy mini 
spin column and centrifuged for 15 seconds at 8000g (10,000 rpm) before removal 
of the flow through. This process was repeated with all of the samples and untreated 
controls using a series of buffers supplied with the kit (RW 1 and RPE x 2). Finally, 
50 µl of nuclease free water was pipetted directly onto the membrane and the sample 
centrifuged for l minute at 8000g (10,000 rpm) to elute the purified RNA. The 
concentration and quality of the eluted RNA was checked on the nanodrop and 
agilent bioanalyser and the sample stored at 
-70°C. 
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Indirectly labelled probes were generated from 5µg of total sample RNA with 
ambion messageamp II amplification (as per manufacturer's protocols). The probes 
were labelled with alexa 555 or 647 NHS ester dyes (InVitrogen) and 0.5 µg 
(approximately 40 pM of dye-label) of each was used for each channel of 2 colour 
hybridisations. Hybridisations were performed for 16 hours on a TEcan HTS 4800 
hybridisation station with moderate agitation, using the Ocimum recommended 
solutions and temperatures. 
7.5.2 Microarray Analysis 
Arrays were scanned with a GenePix 4000b laser scanner and primary data obtained 
using GenePix Pro 6.0 software (Axon). Filtering of array data and normalization 
using the LOWESS algorithm were performed within the University of Nottingham 
microarray database (a version of BASE vi. 2.16, Lund University, Sweden). Further 
analysis was performed on this data set using Multi Experiment Viewer (MEV) 
software and the statistical analysis of microarrays (SAM) algorithm. 
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7.6 Biological Stains and Histology 
7.6.1 Ethidium Homodimer-1: Calcein AM (LIVE/DEADTM) Stain 
Both cell viability and location in cell loaded scaffolds were assessed with the use of 
LIVE/DEADTM stain (Molecular Probes, UK). The LIVE/DEADTM stain uses 
ubiquitous intracellular esterase activity to distinguish live cells from dead. In live 
cells, the cell permeant calcein AM is converted into the fluorescent calcein which is 
retained within the cell and produces a uniform green fluorescence. In dead cells, the 
ethidium homodimer-I enters cells through the damaged membrane, where it binds 
to nucleic acids to produce a fluorescent red colour. After scCO2 processing cell 
loaded polymers scaffolds were incubated in 10 ml of complete DMEM containing 
20 µl of ethidium homodimer-I (to highlight the dead cells red) and 5 µl of calcein 
AM (to highlight the live cells green) for 1 hour. The cells were then rinsed (x4) in 
phosphate buffered saline (PBS) for 1 hour, before being observed using 
fluorescence microscopy (Leica DM IRB). 
7.6.2 Histology of Cell Loaded Scaffolds with LIVE/DEADTM and Propidium 
Iodide Staining 
Poly(DL-lactic acid) (PDLLA) scaffolds containing C2C12 cells were prepared for 
histology by fixing in 70% methanol for 30 minutes, drying overnight and 
subsequent infiltration with 65°C paraplast wax (Sigma UK). 10 µm sections were 
cut using a microtome (Leica RM2165) and observed using a fluorescence 
microscope for either propidium iodide stained nuclei to identify cell location or for 
LIVE/DEADTM stained cells to show cell activity within the scaffolds. 
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7.7 Techniques used in the Characterisation of Polymer Scaffolds 
7.7.1 Light and Fluorescence Microscopy 
Two light/fluorescence microscopes were used for visualisation of all the samples 
(Nikon, SMZ1500 & Leica DM IRB). Samples were observed using a variety of 
methods. Mammalian cells were visualised in situ using normal light. Cells on 
scaffolds were visualised using fluorescent light for the LIVE/DEADTM stain after 
the scaffold had been cut into four sections and placed upon the stage piece by piece 
in the most suitable orientation. Polymer scaffolds were either cut transversely and 
placed on the microscope stage for scaffold characterisation or, cut into smaller 
pieces for identification of areas stained for alkaline phosphatase and then placed 
upon the microscope stage. All scaffolds viewed without fluorescent light were 
placed on a piece of plain white paper to act as a suitable background. Histological 
samples were visualised with fluorescent light to indicate the areas stained with 
either LIVE/DEADTM or propidium iodide. 
7.7.2 Scanning Electron Microscopy 
7.7.2.1 Preparation of Samples 
The degree of preparation was dependent upon the type of sample used. For non- 
biological samples (no cells attached) the polymer scaffolds required no preparation 
before sputter coating. However, if the polymer scaffolds were loaded with cells 
(biological samples) the scaffolds were fixed to preserve the in vivo state of the 
cells. This was done by first pre-fixing each scaffold in I ml of glutaraldehyde (3%) 
(Fisher, UK) overnight at 4°C. A solution of 1% osmium tetroxide (Fisher, UK) was 
then added to the scaffolds (1 ml per scaffold) before a two hour incubation step at 
room temperature. Osmium tetroxide fixes the cells further and provides a 
conductive coating of osmium, which improves the final image quality by reducing 
the charging of the sample under the electron beam and by enhancing the secondary 
electron emission. The scaffolds were then washed three times in distilled water and 
dehydrated using increasing concentrations of ethanol from 25% to 100%. 
177 
Finally, sufficient hexamethyldisilazane (HMDS) (Fisher, UK) was added to cover 
the scaffolds and left on for five minutes x2 (to chemically dry the scaffolds). The 
scaffolds were then washed in distilled water and left to dry overnight. 
7.7.2.2 Gold (Sputter) Coating 
Before polymer samples were examined under the electron microscope, they needed 
to be gold (sputter) coated. This process allows the electron beam to interact with the 
polymer surface. Scaffolds were cut transversely and correctly orientated to show 
the area of interest before being mounted on aluminium stubs using adhesive carbon 
disks to eliminate background charge. The samples were then placed in the vacuum- 
sealed sputter coater and a coating cycle run for 4 minutes using an argon pressure 
of 13 Pa and a current of 14 mA. 
7.7.2.3 Imaging and Scaffold Characterisation 
For pore measurements, the PDLLA scaffolds were prepared for non-biological SEM, 
placed inside the sample chamber of the microscope (Philips 505 SEM). When 
under vacuum, the filament was switched on and the scaffolds were scanned at 15- 
20 kV with the spot size set to 50. The diameter across the pores of the scaffolds was 
measured using the supplied SEMICAPS software and was taken as the widest part 
of the open-pore windows. Pore diameters were counted randomly beginning at the 
centre and travelling set distances from this point. Only 50 pores were counted: this 
was limited by the number of pores and the large pore size. Histograms of the 
frequency of each diameter were constructed to determine the pore size distribution 
and the mean pore size. Cell loaded scaffolds were prepared for biological SEM and 
scanned at 20kV with a spot size of 50. The magnification control was slowly 
increased (up to 380x) and the contrast altered to distinguish any clusters of cells 
that were attached the surface of the scaffold. 
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7.7.3 Micro-Computed Tomography 
Samples were scanned using this technique to both determine the physical 
characteristics of, and look for the distribution of cells within, PDLLA scaffolds. 
Scaffolds were placed inside a plastic sample tube in an upright position, packed 
with polyurethane foam and loaded into the micro-computed tomography (µ-CT) 
unit. The scanner was set to a voltage of 55 kV and a current of 145 mA using a high 
resolution µ-CT unit (. t-CT 40, Scanco Medical, Bassersdorf, Switzerland). 
Scaffolds were scanned at 8 µm voxel 13D pixel resolution with an integration time 
of 120 ms to produce a set of slices or contours (400 per scaffold) from which 3D 
reconstructed images could be formed. 
The characteristics of the 3D scaffolds were evaluated by defining a region of 
interest (ROI) for each slice or contour and using the Scanco software provided to 
calculate both the average pore size and total porosity for each scaffold within that 
ROI. Histograms of the frequency of each pore diameter were constructed to provide 
the pore size distribution. A threshold of 60 (arbitrary number) was used to view the 
porous polymer scaffolds and a threshold of 190 was used to observe the cells 
entrapped within when appropriate. Note: by altering the threshold value the contrast 
of the image can be changed. Too high a threshold may result in a loss of sample 
data whereas too low a threshold value and the level of noise in the image will be 
increased. 
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